10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark one)

þ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended September 30, 2017

or

o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

For the Transition Period from to .

Commission File Number 1-15202

W. R. BERKLEY CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	22-1867895
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)
475 Steamboat Road, Greenwich, Connecticut	06830
(Address of principal executive offices)	(Zip Code)

	(203) 629-3000
	(Registrant’s telephone number, including area code)
	None
Former name, former address and former fiscal year, if changed since last report.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ     No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ     No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer þ	Accelerated filer o	Non-accelerated filer o	Smaller reporting company o
		(Do not check if a smaller reporting company)	Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o     No þ

Number of shares of common stock, $.20 par value, outstanding as of November 6, 2017: 121,794,758

TABLE OF CONTENTS

Part I — FINANCIAL INFORMATION
	Item 1. Financial Statements
	Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
	Item 3. Quantitative and Qualitative Disclosure About Market Risk
	Item 4. Controls and Procedures
PART II — OTHER INFORMATION
	Item 1. Legal Proceedings
	Item 1A. Risk Factors
	Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
	Item 6. Exhibits
SIGNATURES
EX-10.1
EX-31.1
EX-31.2
EX-32.1
EX-101 INSTANCE DOCUMENT
EX-101 SCHEMA DOCUMENT
EX-101 CALCULATION LINKBASE DOCUMENT
EX-101 LABELS LINKBASE DOCUMENT
EX-101 PRESENTATION LINKBASE DOCUMENT
EX-101 DEFINITION LINKBASE DOCUMENT

Part I — FINANCIAL INFORMATION

Item 1. Financial Statements

W. R. BERKLEY CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

	September 30, 2017			December 31, 2016
	(Unaudited)			(Audited)
Assets
Investments:
Fixed maturity securities	$	13,873,690		$	13,190,668
Investment funds	1,119,907			1,198,146
Real estate	1,391,274			1,184,981
Arbitrage trading account	488,238			299,999
Equity securities available for sale	614,025			669,200
Loans receivable	74,229			106,798
Total investments	17,561,363			16,649,792
Cash and cash equivalents	773,997			795,285
Premiums and fees receivable	1,818,836			1,701,854
Due from reinsurers	1,739,835			1,743,980
Deferred policy acquisition costs	534,091			537,890
Prepaid reinsurance premiums	473,766			413,140
Trading account receivables from brokers and clearing organizations	297,208			484,593
Property, furniture and equipment	399,924			349,432
Goodwill	173,422			144,513
Accrued investment income	139,864			127,047
Other assets	423,770			402,550
Total assets	$	24,336,076		$	23,350,076
Liabilities and Equity
Liabilities:
Reserves for losses and loss expenses	$	11,654,346		$	11,197,195
Unearned premiums	3,409,628			3,283,300
Due to reinsurers	228,539			213,128
Trading account securities sold but not yet purchased	44,937			51,179
Federal and foreign income taxes	116,608			119,597
Other liabilities	923,369			916,318
Senior notes and other debt	1,759,929			1,760,595
Subordinated debentures	728,071			727,630
Total liabilities	18,865,427			18,268,942
Equity:
Preferred stock, par value $.10 per share:
Authorized 5,000,000 shares; issued and outstanding - none	—			—
Common stock, par value $.20 per share:
Authorized 500,000,000 shares, issued and outstanding, net of treasury shares, 121,769,109 and 121,193,599 shares, respectively	47,024			47,024
Additional paid-in capital	1,040,575			1,037,446
Retained earnings	6,880,062			6,595,987
Accumulated other comprehensive income	153,759			55,568
Treasury stock, at cost, 113,348,809 and 113,924,319 shares, respectively	(2,690,884		)	(2,688,817		)
Total stockholders’ equity	5,430,536			5,047,208
Noncontrolling interests	40,113			33,926
Total equity	5,470,649			5,081,134
Total liabilities and equity	$	24,336,076		$	23,350,076

See accompanying notes to interim consolidated financial statements.

1

W. R. BERKLEY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)

(In thousands, except per share data)

	For the Three Months						For the Nine Months
	Ended September 30,						Ended September 30,
	2017			2016			2017			2016
REVENUES:
Net premiums written	$	1,571,183		$	1,607,365		$	4,782,272		$	4,913,656
Change in net unearned premiums	10,317			(21,421		)	(62,028		)	(240,584		)
Net premiums earned	1,581,500			1,585,944			4,720,244			4,673,072
Net investment income	142,479			145,668			426,601			404,850
Net realized investment gains	183,959			175,738			276,760			207,508
Other-than-temporary impairments	—			—			—			(18,114		)
Revenues from non-insurance businesses	89,786			80,242			225,033			305,787
Insurance service fees	33,612			32,135			100,475			109,437
Other income	6			—			695			—
Total revenues	2,031,342			2,019,727			5,749,808			5,682,540
OPERATING COSTS AND EXPENSES:
Losses and loss expenses	1,081,174			965,856			3,025,475			2,852,339
Other operating costs and expenses	600,822			606,348			1,821,155			1,770,450
Expenses from non-insurance businesses	86,412			78,865			221,389			291,127
Interest expense	36,821			37,043			110,419			104,019
Total operating costs and expenses	1,805,229			1,688,112			5,178,438			5,017,935
Income before income taxes	226,113			331,615			571,370			664,605
Income tax expense	(63,295		)	(110,952		)	(174,305		)	(214,789		)
Net income before noncontrolling interests	162,818			220,663			397,065			449,816
Noncontrolling interests	(764		)	(13		)	(2,560		)	(689		)
Net income to common stockholders	$	162,054		$	220,650		$	394,505		$	449,127
NET INCOME PER SHARE:
Basic	$	1.29		$	1.80		$	3.17		$	3.66
Diluted	$	1.26		$	1.72		$	3.05		$	3.50

See accompanying notes to interim consolidated financial statements.

2

W. R. BERKLEY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

(In thousands)

	For the Three Months						For the Nine Months
	Ended September 30,						Ended September 30,
	2017			2016			2017			2016
Net income before noncontrolling interests	$	162,818		$	220,663		$	397,065		$	449,816
Other comprehensive income (loss):
Change in unrealized currency translation adjustments	28,592			(19,470		)	71,574			(77,389		)
Change in unrealized investment gains (losses), net of taxes	(8,168		)	(47,676		)	26,598			134,213
Other comprehensive income (loss):	20,424			(67,146		)	98,172			56,824
Comprehensive income	183,242			153,517			495,237			506,640
Noncontrolling interests	(731		)	44			(2,541		)	(623		)
Comprehensive income to common stockholders	$	182,511		$	153,561		$	492,696		$	506,017

See accompanying notes to interim consolidated financial statements.

3

W. R. BERKLEY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)

(In thousands)

	For the Nine Months
	Ended September 30,
	2017			2016
COMMON STOCK:
Beginning and end of period	$	47,024		$	47,024
ADDITIONAL PAID-IN CAPITAL:
Beginning of period	$	1,037,446		$	1,005,455
Restricted stock units issued	(27,047		)	(3,421		)
Restricted stock units expensed	30,176			25,431
End of period	$	1,040,575		$	1,027,465
RETAINED EARNINGS:
Beginning of period	$	6,595,987		$	6,178,070
Net income to common stockholders	394,505			449,127
Dividends	(110,430		)	(107,661		)
End of period	$	6,880,062		$	6,519,536
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
Unrealized investment gains:
Beginning of period	$	427,154		$	180,695
Unrealized gains on securities not other-than-temporarily impaired	25,712			133,866
Unrealized gains on other-than-temporarily impaired securities	905			413
End of period	453,771			314,974
Currency translation adjustments:
Beginning of period	(371,586		)	(247,393		)
Net change in period	71,574			(77,389		)
End of period	(300,012		)	(324,782		)
Total accumulated other comprehensive income (loss)	$	153,759		$	(9,808	)
TREASURY STOCK:
Beginning of period	$	(2,688,817	)	$	(2,563,605	)
Stock exercised/vested	25,584			5,023
Stock repurchased	(28,378		)	(99,870		)
Stock incentive plans expensed	727			—
End of period	$	(2,690,884	)	$	(2,658,452	)
NONCONTROLLING INTERESTS:
Beginning of period	$	33,926		$	32,962
Contributions	3,646			2,474
Net income	2,560			689
Other comprehensive loss, net of tax	(19		)	(66		)
End of period	$	40,113		$	36,059

See accompanying notes to interim consolidated financial statements.

4

W. R. BERKLEY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(In thousands)

	For the Nine Months
	Ended September 30,
	2017			2016
CASH FROM OPERATING ACTIVITIES:
Net income to common stockholders	$	394,505		$	449,127
Adjustments to reconcile net income to net cash from operating activities:
Net investment gains	(276,760		)	(189,394		)
Depreciation and amortization	78,137			69,153
Noncontrolling interests	2,560			689
Investment funds	(51,907		)	(60,387		)
Stock incentive plans	31,883			27,033
Change in:
Arbitrage trading account	(2,835		)	(4,777		)
Premiums and fees receivable	(112,420		)	(92,372		)
Reinsurance accounts	(42,319		)	(154,939		)
Deferred policy acquisition costs	4,483			(51,795		)
Income taxes	(15,451		)	89,007
Reserves for losses and loss expenses	422,657			440,486
Unearned premiums	121,583			269,287
Other	(32,258		)	(64,608		)
Net cash from operating activities	521,858			726,510
CASH USED IN INVESTING ACTIVITIES:
Proceeds from sale of fixed maturity securities	3,081,619			1,074,630
Proceeds from sale of equity securities	137,062			123,187
Distributions from investment funds	265,371			5,630
Proceeds from maturities and prepayments of fixed maturity securities	2,860,678			2,189,365
Purchase of fixed maturity securities	(6,530,466		)	(4,280,457		)
Purchase of equity securities	(17,049		)	(127,303		)
Real estate purchased	(159,006		)	(207,829		)
Change in loans receivable	32,574			159,128
Net additions to property, furniture and equipment	(74,268		)	(37,895		)
Change in balances due to security brokers	39,978			102,981
Cash received in connection with business disposition	—			250,216
Payment for business purchased net of cash aquired	(70,570		)	(53,524		)
Net cash used in investing activities	(434,077		)	(801,871		)
CASH (USED IN) FROM FINANCING ACTIVITIES:
Repayment of senior notes and other debt	(1,788		)	(70,567		)
Net proceeds from issuance of debt	—			386,848
Cash dividends to common stockholders	(93,371		)	(30,654		)
Purchase of common treasury shares	(28,378		)	(99,870		)
Other, net	(3,835		)	(1,376		)
Net cash (used in) from financing activities	(127,372		)	184,381
Net impact on cash due to change in foreign exchange rates	18,303			413
Net change in cash and cash equivalents	(21,288		)	109,433
Cash and cash equivalents at beginning of year	795,285			763,631
Cash and cash equivalents at end of period	$	773,997		$	873,064

See accompanying notes to interim consolidated financial statements.

5

W. R. Berkley Corporation and Subsidiaries

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(1) General

The unaudited consolidated financial statements, which include the accounts of W. R. Berkley Corporation and its subsidiaries (the “Company”) have been prepared on the basis of U.S. generally accepted accounting principles (“GAAP”) for interim financial information. Accordingly, they do not include all the information and notes required by GAAP for annual financial statements. The unaudited consolidated financial statements reflect all adjustments, consisting only of normal recurring items, which are necessary to present fairly the Company’s financial position and results of operations on a basis consistent with the prior audited consolidated financial statements. Operating results for interim periods are not necessarily indicative of the results that may be expected for the year. All significant intercompany accounts and transactions have been eliminated. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the revenues and expenses reflected during the reporting period. For further information related to a description of areas of judgment and estimates and other information necessary to understand the Company’s financial position and results of operations, refer to the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016. Reclassifications have been made in the 2016 financial statements as originally reported to conform to the presentation of the 2017 financial statements.

The income tax provision has been computed based on the Company’s estimated annual effective tax rate. The effective tax rate for the quarter differs from the federal income tax rate of 35% principally because of tax-exempt investment income, as well as the new requirement in 2017 to recognize tax benefits for stock compensation in income tax expense.

(2) Per Share Data

The Company presents both basic and diluted net income per share (“EPS”) amounts. Basic EPS is calculated by dividing net income by the weighted average number of common shares outstanding during the period (including 4,087,731 common shares held in a grantor trust established in March 2017). The common shares held in the grantor trust are for delivery upon settlement of vested but mandatorily deferred restricted stock units ("RSUs"). Shares held by the grantor trust do not affect diluted shares outstanding since the shares deliverable under vested RSUs were already included in diluted shares outstanding. Diluted EPS is based upon the weighted average number of basic and common equivalent shares outstanding during the period and is calculated using the treasury stock method for stock incentive plans. Common equivalent shares are excluded from the computation in periods in which they have an anti-dilutive effect.

The weighted average number of common shares used in the computation of basic and diluted earnings per share was as follows:

	For the Three Months		For the Nine Months
	Ended September 30,		Ended September 30,
(In thousands)	2017	2016	2017	2016
Basic	125,818	122,562	124,363	122,652
Diluted	128,944	128,556	129,289	128,501

(3) Recent Accounting Pronouncements

Recently adopted accounting pronouncements:

In May 2015, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2015-09, Disclosures about Short-Duration Contracts. ASU 2015-09 requires companies that issue short duration insurance contracts to disclose additional information, including: (i) incurred and paid claims development tables; (ii) frequency and severity of claims; and (iii) information about material changes in judgments made in calculating the liability for unpaid claim adjustment expenses, including reasons for the change and the effects on the financial statements. The Company adopted this updated guidance on January 1, 2016 with regard to the annual requirements and on January 1, 2017 with regard to the interim requirements. The amendments in ASU 2015-09 are applied retrospectively by providing comparative disclosures for each period presented, except for those requirements that apply only to the current period. As the requirements are disclosure only, the adoption of this guidance did not impact our financial condition or results of operations, but did result in additional disclosures.

6

In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting. ASU 2016-09 includes provisions intended to simplify various previous provisions related to how share-based payments are accounted for and presented in the financial statements. Under the new guidance, excess tax benefits (deductions for share based payment awards for tax purposes that exceed the compensation cost recognized for financial reporting purposes) are reported within the income tax expense financial statement line item. Previously, excess tax benefits were reported within additional paid in capital. The Company adopted this updated guidance on January 1, 2017 prospectively. The adoption of this guidance did not have a material impact on the Company's financial condition or results of operations.

All other accounting and reporting standards that became effective in 2017 were either not applicable to the Company or their adoption did not have a material impact on the Company. 

Accounting and reporting standards that are not yet effective:

In May 2014, the FASB issued ASU 2014-09, Revenue from Customers. ASU 2014-09 clarifies the principles for recognizing revenue. While insurance contracts are not within the scope of this updated guidance, the Company’s insurance service fee revenue and non-insurance business revenue will be subject to this updated guidance. The updated guidance requires an entity to recognize revenue as performance obligations are met, in order to reflect the transfer of promised goods or services to customers in an amount that reflects the consideration the entity is entitled to receive for those goods or services. The updated guidance, as amended by ASU 2015-14, is effective for public business entities for annual and interim reporting periods beginning after December 15, 2017. The adoption of this guidance is not expected to have a material effect on the Company’s financial condition or results of operations.

In January 2016, the FASB issued ASU 2016-01, Financial Instruments.  ASU 2016-01 amends the accounting guidance for financial instruments to require all equity investments to be measured at fair value with changes in the fair value recognized through net income (other than those accounted for under equity method of accounting or those that result in consolidation of the investee).  The updated guidance is effective for public business entities for annual reporting periods beginning after December 15, 2017 and interim periods within those years.  The adoption of this guidance is not expected to have a material effect on the Company’s financial condition upon adoption, but will impact results of operations after adoption of this guidance as unrealized gains and losses on equity securities will no longer be reported directly in accumulated other comprehensive income (AOCI), but will instead be reported in net income.

In February 2016, the FASB issued ASU 2016-02, Leases, which amends the accounting and disclosure guidance for leases.  This guidance retains the two classifications of a lease, as either an operating or finance lease, both of which will require lessees to recognize a right-of-use asset and a lease liability for leases with terms of more than 12 months. The right-of-use asset and the lease liability will be determined based upon the present value of cash flows. Finance leases will reflect the financial arrangement by recognizing interest expense on the lease liability separately from the amortization expense of the right-of-use asset. Operating leases will recognize lease expense (with no separate recognition of interest expense) on a straight-line basis over the term of the lease. The accounting by lessors is not significantly changed by the updated guidance.  The updated guidance is effective for reporting periods beginning after December 15, 2018, and will require that the earliest comparative period presented include the measurement and recognition of existing leases with an adjustment to equity as if the updated guidance had always been applied. The Company is currently evaluating the impact that the adoption of this guidance will have on its results of operations, financial position and liquidity.

     In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses, which amends the accounting guidance for credit losses on financial instruments. The updated guidance amends the current other-than-temporary impairment model for available-for-sale debt securities by requiring the recognition of impairments relating to credit losses through an allowance account and limits the amount of credit loss to the difference between a security’s amortized cost basis and its fair value. This guidance also applies a new current expected credit loss model for determining credit-related impairments for financial instruments measured at amortized cost.  The updated guidance is effective for reporting periods beginning after December 15, 2019. The Company will not be able to determine the impact the adoption of this guidance will have on its results of operations, financial position or liquidity until the year the guidance becomes effective.

All other recently issued but not yet effective accounting and reporting standards are either not applicable to the Company or are not expected to have a material impact on the Company.

7

(4) Acquisitions/Disposition

In March 2017, the Company acquired an 89.5% ownership interest for $73.3 million in a company engaged in providing textile solutions world-wide. The fair value of the assets acquired and liabilities assumed have been estimated based on a third party valuation.

The following table summarizes the estimated fair value of net assets acquired and liabilities assumed for the business combination completed in 2017:

(In thousands)	2017
Cash and cash equivalents	$	2,721
Real estate, furniture and equipment	7,042
Goodwill	28,522
Intangible assets	32,395
Other assets	9,862
Total assets acquired	80,542
Other liabilities assumed	(2,251		)
Noncontrolling interest	(5,000		)
Net assets acquired	$	73,291

In February 2016, the Company acquired an 85% ownership interest for $42.3 million in a company engaged in the distribution of promotional merchandise.

8

(5) Consolidated Statement of Comprehensive Income

The following table presents the components of the changes in accumulated other comprehensive income ("AOCI"):

(In thousands)	Unrealized Investment Gains (Losses)				Currency Translation Adjustments			Accumulated Other Comprehensive Income
As of and for the nine months ended September 30, 2017:
Changes in AOCI
Beginning of period	$	427,154			$	(371,586	)	$	55,568
Other comprehensive income before reclassifications	109,277				71,574			180,851
Amounts reclassified from AOCI	(82,679		)		—			(82,679		)
Other comprehensive income	26,598				71,574			98,172
Unrealized investment loss related to non-controlling interest	19				—			19
End of period	$	453,771			$	(300,012	)	$	153,759
Amounts reclassified from AOCI
Pre-tax	$	(127,198	)	(1)	$	—		$	(127,198	)
Tax effect	44,519			(2)	—			44,519
After-tax amounts reclassified	$	(82,679	)		$	—		$	(82,679	)
Other comprehensive income
Pre-tax	$	50,148			$	71,574		$	121,722
Tax effect	(23,550		)		—			(23,550		)
Other comprehensive income	$	26,598			$	71,574		$	98,172
As of and for the three months ended September 30, 2017:
Changes in AOCI
Beginning of period	$	461,906			$	(328,604	)	$	133,302
Other comprehensive income before reclassifications	19,968				28,592			48,560
Amounts reclassified from AOCI	(28,136		)		—			(28,136		)
Other comprehensive (loss) income	(8,168		)		28,592			20,424
Unrealized investment loss related to non-controlling interest	33				—			33
End of period	$	453,771			$	(300,012	)	$	153,759
Amounts reclassified from AOCI
Pre-tax	$	(43,286	)	(1)	$	—		$	(43,286	)
Tax effect	15,150			(2)	—			15,150
After-tax amounts reclassified	$	(28,136	)		$	—		$	(28,136	)
Other comprehensive (loss) income
Pre-tax	$	(8,563	)		$	28,592		$	20,029
Tax effect	395				—			395
Other comprehensive (loss) income	$	(8,168	)		$	28,592		$	20,424

_________________________

⁽¹⁾ Net investment gains in the consolidated statements of income.

⁽²⁾ Income tax expense in the consolidated statements of income.

9

(In thousands)	Unrealized Investment Gains (Losses)				Currency Translation Adjustments			Accumulated Other Comprehensive Income (Loss)
As of and for the nine months ended September 30, 2016:
Changes in AOCI
Beginning of period	$	180,695			$	(247,393	)	$	(66,698	)
Other comprehensive income (loss) before reclassifications	170,824				(77,389		)	93,435
Amounts reclassified from AOCI	(36,611		)		—			(36,611		)
Other comprehensive income (loss)	134,213				(77,389		)	56,824
Unrealized investment loss related to non-controlling interest	66				—			66
End of period	$	314,974			$	(324,782	)	$	(9,808	)
Amounts reclassified from AOCI
Pre-tax	$	(56,325	)	(1)	$	—		$	(56,325	)
Tax effect	19,714			(2)	—			19,714
After-tax amounts reclassified	$	(36,611	)		$	—		$	(36,611	)
Other comprehensive income (loss)
Pre-tax	$	198,808			$	(77,389	)	$	121,419
Tax effect	(64,595		)		—			(64,595		)
Other comprehensive income (loss)	$	134,213			$	(77,389	)	$	56,824
As of and for the three months ended September 30, 2016:
Changes in AOCI
Beginning of period	$	362,593			$	(305,312	)	$	57,281
Other comprehensive loss before reclassifications	(20,968		)		(19,470		)	(40,438		)
Amounts reclassified from AOCI	(26,708		)		—			(26,708		)
Other comprehensive loss	(47,676		)		(19,470		)	(67,146		)
Unrealized investment loss related to non-controlling interest	57				—			57
End of period	$	314,974			$	(324,782	)	$	(9,808	)
Amounts reclassified from AOCI
Pre-tax	$	(41,090	)	(1)	$	—		$	(41,090	)
Tax effect	14,382			(2)	—			14,382
After-tax amounts reclassified	$	(26,708	)		$	—		$	(26,708	)
Other comprehensive loss
Pre-tax	$	(72,188	)		$	(19,470	)	$	(91,658	)
Tax effect	24,512				—			24,512
Other comprehensive loss	$	(47,676	)		$	(19,470	)	$	(67,146	)

_______________

(1) Net investment gains in the consolidated statements of income.

(2) Income tax expense in the consolidated statements of income.

10

(6) Statements of Cash Flow

Interest payments were $134,291,000 and $124,791,000 and income taxes paid were $182,487,000 and $99,161,000 in the nine months ended September 30, 2017 and 2016, respectively.

(7) Investments in Fixed Maturity Securities

At September 30, 2017 and December 31, 2016, investments in fixed maturity securities were as follows:

(In thousands)	Amortized Cost		Gross Unrealized					Fair Value		Carrying Value
			Gains		Losses
September 30, 2017
Held to maturity:
State and municipal	$	65,372	$	15,212	$	—		$	80,584	$	65,372
Residential mortgage-backed	14,024		1,452		—			15,476		14,024
Total held to maturity	79,396		16,664		—			96,060		79,396
Available for sale:
U.S. government and government agency	402,901		10,828		(2,124		)	411,605		411,605
State and municipal:
Special revenue	2,730,653		80,144		(5,469		)	2,805,328		2,805,328
State general obligation	481,070		21,377		(565		)	501,882		501,882
Pre-refunded	282,488		21,052		(173		)	303,367		303,367
Corporate backed	380,351		11,775		(499		)	391,627		391,627
Local general obligation	384,930		26,566		(531		)	410,965		410,965
Total state and municipal	4,259,492		160,914		(7,237		)	4,413,169		4,413,169
Mortgage-backed securities:
Residential (1)	1,064,705		12,696		(8,860		)	1,068,541		1,068,541
Commercial	251,387		1,641		(1,450		)	251,578		251,578
Total mortgage-backed securities	1,316,092		14,337		(10,310		)	1,320,119		1,320,119
Asset-backed	2,389,187		9,836		(10,405		)	2,388,618		2,388,618
Corporate:
Industrial	2,569,673		70,054		(2,842		)	2,636,885		2,636,885
Financial	1,335,101		43,636		(4,716		)	1,374,021		1,374,021
Utilities	255,478		12,760		(907		)	267,331		267,331
Other	42,183		2		(48		)	42,137		42,137
Total corporate	4,202,435		126,452		(8,513		)	4,320,374		4,320,374
Foreign	909,608		32,889		(2,088		)	940,409		940,409
Total available for sale	13,479,715		355,256		(40,677		)	13,794,294		13,794,294
Total investments in fixed maturity securities	$	13,559,111	$	371,920	$	(40,677	)	$	13,890,354	$	13,873,690

11

(In thousands)	Amortized Cost		Gross Unrealized					Fair Value		Carrying Value
			Gains		Losses
December 31, 2016
Held to maturity:
State and municipal	$	72,582	$	12,453	$	—		$	85,035	$	72,582
Residential mortgage-backed	15,944		1,693		—			17,637		15,944
Total held to maturity	88,526		14,146		—			102,672		88,526
Available for sale:
U.S. government and government agency	496,187		20,208		(2,593		)	513,802		513,802
State and municipal:
Special revenue	2,791,211		58,559		(26,315		)	2,823,455		2,823,455
State general obligation	524,682		16,964		(5,139		)	536,507		536,507
Pre-refunded	356,535		19,181		(165		)	375,551		375,551
Corporate backed	410,933		6,172		(6,452		)	410,653		410,653
Local general obligation	360,022		15,682		(2,367		)	373,337		373,337
Total state and municipal	4,443,383		116,558		(40,438		)	4,519,503		4,519,503
Mortgage-backed securities:
Residential (1)	1,034,301		15,431		(12,950		)	1,036,782		1,036,782
Commercial	155,540		304		(2,981		)	152,863		152,863
Total mortgage-backed securities	1,189,841		15,735		(15,931		)	1,189,645		1,189,645
Asset-backed	1,913,830		5,971		(11,941		)	1,907,860		1,907,860
Corporate:
Industrial	2,315,567		71,007		(7,174		)	2,379,400		2,379,400
Financial	1,369,001		39,543		(11,270		)	1,397,274		1,397,274
Utilities	229,154		10,801		(2,411		)	237,544		237,544
Other	54,073		299		(63		)	54,309		54,309
Total corporate	3,967,795		121,650		(20,918		)	4,068,527		4,068,527
Foreign	858,773		46,794		(2,762		)	902,805		902,805
Total available for sale	12,869,809		326,916		(94,583		)	13,102,142		13,102,142
Total investments in fixed maturity securities	$	12,958,335	$	341,062	$	(94,583	)	$	13,204,814	$	13,190,668

____________

(1) Gross unrealized gains and (losses) for residential mortgage-backed securities include $85,907 and $(818,691) as of September 30, 2017 and December 31, 2016, respectively, related to securities with the non-credit portion of other-than-temporary impairments (“OTTI”) recognized in accumulated other comprehensive income.

The amortized cost and fair value of fixed maturity securities at September 30, 2017, by contractual maturity, are shown below. Actual maturities may differ from contractual maturities because certain issuers may have the right to call or prepay obligations.

(In thousands)	Amortized Cost		Fair Value
Due in one year or less	$	745,010	$	750,479
Due after one year through five years	5,089,768		5,210,268
Due after five years through ten years	3,248,254		3,396,461
Due after ten years	3,145,963		3,197,551
Mortgage-backed securities	1,330,116		1,335,595
Total	$	13,559,111	$	13,890,354

At September 30, 2017 and December 31, 2016, there were no investments that exceeded 10% of common stockholders' equity, other than investments in United States government and government agency securities.

12

(8) Investments in Equity Securities Available for Sale

At September 30, 2017 and December 31, 2016, investments in equity securities were as follows:

(In thousands)	Cost		Gross Unrealized					Fair Value		Carrying Value
			Gains		Losses
September 30, 2017
Common stocks	$	83,709	$	339,297	$	(3,486	)	$	419,520	$	419,520
Preferred stocks	125,076		71,147		(1,718		)	194,505		194,505
Total	$	208,785	$	410,444	$	(5,204	)	$	614,025	$	614,025
December 31, 2016
Common stocks	$	94,998	$	351,906	$	(1,046	)	$	445,858	$	445,858
Preferred stocks	125,589		101,392		(3,639		)	223,342		223,342
Total	$	220,587	$	453,298	$	(4,685	)	$	669,200	$	669,200

(9) Arbitrage Trading Account

At September 30, 2017 and December 31, 2016, the fair and carrying values of the arbitrage trading account were $488 million and $300 million, respectively. The primary focus of the trading account is merger arbitrage. Merger arbitrage is the business of investing in the securities of publicly held companies which are the targets in announced tender offers and mergers. Arbitrage investing differs from other types of investing in its focus on transactions and events believed likely to bring about a change in value over a relatively short time period (usually four months or less).

The Company uses put options, call options and swap contracts in order to mitigate the impact of potential changes in market conditions on the merger arbitrage trading account. These options and contracts are reported at fair value. As of September 30, 2017, the fair value of long option contracts outstanding was $1 million (notional amount of $33 million) and the fair value of short option contracts outstanding was $1 million (notional amount of $54 million). Other than with respect to the use of these trading account securities, the Company does not make use of derivatives.

(10) Net Investment Income

Net investment income consists of the following:

	For the Three Months						For the Nine Months
	Ended September 30,						Ended September 30,
(In thousands)	2017			2016			2017			2016
Investment income earned on:
Fixed maturity securities, including cash and cash equivalents and loans receivable	$	118,834		$	114,271		$	347,976		$	331,448
Investment funds	15,200			25,293			50,744			60,385
Arbitrage trading account	4,418			6,441			16,235			12,883
Real estate	5,042			585			14,894			4,552
Equity securities available for sale	604			1,069			1,845			3,217
Gross investment income	144,098			147,659			431,694			412,485
Investment expense	(1,619		)	(1,991		)	(5,093		)	(7,635		)
Net investment income	$	142,479		$	145,668		$	426,601		$	404,850

(11) Investment Funds

The Company evaluates whether it is an investor in a variable interest entity (VIE). Such entities do not have sufficient equity at risk to finance their activities without additional subordinated financial support, or the equity investors, as a group, do not have the characteristics of a controlling financial interest (primary beneficiary).  The Company determines whether it is the

13

primary beneficiary of an entity subject to consolidation based on a qualitative assessment of the VIE's capital structure, contractual terms, nature of the VIE's operations and purpose, and the Company's relative exposure to the related risks of the VIE on the date it becomes initially involved in the VIE and on an ongoing basis. The Company is not the primary beneficiary in any of its investment funds, and accordingly, carries its interests in investment funds under the equity method of accounting.

The Company’s maximum exposure to loss with respect to these investments is limited to the carrying amount reported on the Company’s consolidated balance sheet and its unfunded commitments which were $442 million as of September 30, 2017.

Investment funds consisted of the following:

	Carrying Value as of				Income (Loss) from Investment Funds
	September 30,		December 31,		For the Nine Months Ended September 30,
(In thousands)	2017		2016		2017			2016
Real estate	$	614,508	$	641,783	$	30,661		$	33,028
Energy	85,817		91,448		(12,763		)	7,174
Hedge equity	—		73,913		(1,164		)	791
Other funds	419,582		391,002		34,010			19,392
Total	$	1,119,907	$	1,198,146	$	50,744		$	60,385

The Company's share of the earnings or losses of investment funds is generally reported on a one-quarter lag in order to facilitate the timely completion of the Company's consolidated financial statements.

(12) Real Estate

Investment in real estate represents directly owned property held for investment, as follows:    

	Carrying Value
	September 30,		December 31,
(In thousands)	2017		2016
Properties in operation	$	451,669	$	457,237
Properties under development	939,605		727,744
Total	$	1,391,274	$	1,184,981

In 2017, properties in operation included a long-term ground lease in Washington, D.C., a hotel in Memphis, Tennessee, an office complex in New York City and office buildings in West Palm Beach and Palm Beach, Florida. Properties in operation are net of accumulated depreciation and amortization of $20,378,000 and $14,996,000 as of September 30, 2017 and December 31, 2016, respectively. Related depreciation expense was $5,382,000 and $4,117,000 for the nine months ended September 30, 2017 and 2016, respectively. Future minimum rental income expected on operating leases relating to properties in operation is $4,966,133 in 2017, $28,251,980 in 2018, $30,174,146 in 2019, $29,415,103 in 2020, $30,054,813 in 2021, $29,966,679 in 2022 and $467,192,215 thereafter.

Properties under development include an office building in London and a mixed-use project in Washington, D.C.

14

(13) Loans Receivable

Loans receivable are as follows:

(In thousands)	September 30, 2017			December 31, 2016
Amortized cost (net of valuation allowance):
Real estate loans	$	59,487		$	92,415
Commercial loans	14,742			14,383
Total	$	74,229		$	106,798
Fair value:
Real estate loans	$	60,372		$	92,415
Commercial loans	16,243			15,884
Total	$	76,615		$	108,299
Valuation allowance:
Specific	$	1,200		$	1,200
General	2,183			2,197
Total	$	3,383		$	3,397
	For the Three Months Ended September 30,
	2017			2016
Increase in valuation allowance	$	—		$	467
	For the Nine Months Ended September 30,
	2017			2016
(Decrease) increase in valuation allowance	$	(14	)	$	1,128

Loans receivable in non-accrual status were $4.5 million and $5.4 million as of September 30, 2017 and December 31, 2016, respectively.

The Company monitors the performance of its loans receivable and assesses the ability of the borrower to pay principal and interest based upon loan structure, underlying property values, cash flow and related financial and operating performance of the property and market conditions. Loans receivable with a potential for default are further assessed using discounted cash flow analysis and comparable cost and sales methodologies, if appropriate.

The real estate loans are secured by commercial real estate primarily located in New York. These loans generally earn interest at floating LIBOR-based interest rates and have maturities (inclusive of extension options) through August 2025. The commercial loans are with small business owners who have secured the related financing with the assets of the business. Commercial loans primarily earn interest on a fixed basis and have varying maturities generally not exceeding 10 years.

In evaluating the real estate loans, the Company considers their credit quality indicators, including loan to value ratios, which compare the outstanding loan amount to the estimated value of the property, the borrower’s financial condition and performance with respect to loan terms, the position in the capital structure, the overall leverage in the capital structure and other market conditions. Based on these considerations, none of the real estate loans were considered to be impaired at September 30, 2017, and accordingly, the Company determined that a specific valuation allowance was not required.

15

(14) Realized and Unrealized Investment Gains (Losses)

Realized and unrealized investment gains (losses) are as follows:

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
(In thousands)	2017			2016			2017			2016
Realized investment gains (losses):
Fixed maturity securities:
Gains	$	8,763		$	33,798		$	21,795		$	66,972
Losses	(197		)	(1,150		)	(4,162		)	(5,570		)
Equity securities available for sale	34,720			8,441			109,566			13,037
Investment funds (1)	124,228			(3,788		)	125,383			(9,041		)
Real estate	1,956			687			4,892			5,247
Other (2)	14,489			137,750			19,286			136,863
Net realized gains on investments sales	183,959			175,738			276,760			207,508
Other-than-temporary impairments (3)	—			—			—			(18,114		)
Net investment gains	183,959			175,738			276,760			189,394
Income tax expense	(64,386		)	(61,508		)	(96,866		)	(66,288		)
After-tax net realized investment gains	$	119,573		$	114,230		$	179,894		$	123,106

Change in unrealized investment gains of available for sale securities:
Fixed maturity securities	$	(10,627	)	$	(45,388	)	$	84,214		$	169,933
Previously impaired fixed maturity securities	61			(1,406		)	905			413
Equity securities available for sale	(2,126		)	(28,517		)	(44,812		)	12,433
Investment funds	4,129			3,143			9,841			16,028
Total change in unrealized investment gains	(8,563		)	(72,168		)	50,148			198,807
Income tax benefit (expense)	423			24,493			(23,550		)	(64,594		)
Noncontrolling interests	5			57			19			66
After-tax change in unrealized investment gains of available for sale securities	$	(8,135	)	$	(47,618	)	$	26,617		$	134,279

______________________

(1) Investment funds includes a gain of $124.3 million from the sale of an investment in an office building located in Washington, D.C. for the three and nine months ended September 30, 2017.

(2) Other includes a gain of $134.9 million from the sale of Aero Precision Industries and certain related aviation services business for the three and nine months ended September 30, 2016.

(3) There were no other than temporary impairments (OTTI) for the three and nine months ended September 30, 2017, or for the three months ended September 30, 2016. OTTI for the nine months ended September 30, 2016 of $18.1 million were related to common stock.

16

(15) Securities in an Unrealized Loss Position

The following tables summarize all securities in an unrealized loss position at September 30, 2017 and December 31, 2016 by the length of time those securities have been continuously in an unrealized loss position:

	Less Than 12 Months				12 Months or Greater				Total
(In thousands)	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
September 30, 2017
U.S. government and government agency	$	118,066	$	1,048	$	48,880	$	1,076	$	166,946	$	2,124
State and municipal	650,353		5,797		119,087		1,440		769,440		7,237
Mortgage-backed securities	527,034		5,000		221,923		5,310		748,957		10,310
Asset-backed securities	1,116,878		8,033		130,734		2,372		1,247,612		10,405
Corporate	651,373		5,395		57,557		3,118		708,930		8,513
Foreign government	220,860		2,072		1,599		16		222,459		2,088
Fixed maturity securities	3,284,564		27,345		579,780		13,332		3,864,344		40,677
Common stocks	4,678		3,095		9,387		391		14,065		3,486
Preferred stocks	—		—		23,957		1,718		23,957		1,718
Equity securities available for sale	4,678		3,095		33,344		2,109		38,022		5,204
Total	$	3,289,242	$	30,440	$	613,124	$	15,441	$	3,902,366	$	45,881
December 31, 2016
U.S. government and government agency	$	112,709	$	1,252	$	35,450	$	1,341	$	148,159	$	2,593
State and municipal	1,562,614		35,553		133,034		4,885		1,695,648		40,438
Mortgage-backed securities	625,903		11,103		109,066		4,828		734,969		15,931
Asset-backed securities	1,010,836		5,340		201,693		6,601		1,212,529		11,941
Corporate	1,035,245		13,448		65,147		7,470		1,100,392		20,918
Foreign government	213,246		1,985		24,820		777		238,066		2,762
Fixed maturity securities	4,560,553		68,681		569,210		25,902		5,129,763		94,583
Common stocks	336		22		8,755		1,024		9,091		1,046
Preferred stocks	—		—		22,034		3,639		22,034		3,639
Equity securities available for sale	336		22		30,789		4,663		31,125		4,685
Total	$	4,560,889	$	68,703	$	599,999	$	30,565	$	5,160,888	$	99,268

Fixed Maturity Securities – A summary of the Company’s non-investment grade fixed maturity securities that were in an unrealized loss position at September 30, 2017 is presented in the table below:

($ in thousands)	Number of Securities	Aggregate Fair Value		Gross Unrealized Loss
Foreign government	9	$	55,292	$	462
Mortgage-backed securities	6	5,975		150
Corporate	3	2,852		211
Asset-backed securities	3	1,331		115
Total	21	$	65,450	$	938

17

For OTTI of fixed maturity securities that management does not intend to sell or, to be required to sell, the portion of the decline in value that is considered to be due to credit factors is recognized in earnings, and the portion of the decline in value that is considered to be due to non-credit factors is recognized in other comprehensive income.

The Company has evaluated its fixed maturity securities in an unrealized loss position and believes the unrealized losses are due primarily to temporary market and sector-related factors rather than to issuer-specific factors. None of these securities are delinquent or in default under financial covenants. Based on its assessment of these issuers, the Company expects them to continue to meet their contractual payment obligations as they become due and does not consider any of these securities to be OTTI.

Preferred Stocks – At September 30, 2017, there was one preferred stock in an unrealized loss position, with a fair value of $24.0 million and a gross unrealized loss of $1.7 million. Based upon management’s view of the underlying value of the security, the Company does not consider the equity security to be OTTI. For the nine months ended September 30, 2017 and 2016, there was no OTTI for preferred stocks.

Common Stocks – At September 30, 2017, there were threecommon stocks in an unrealized loss position, with an aggregate fair value of $14.1 million and a gross unrealized loss of $3.5 million. Based upon management's view of the underlying value of these securities, the Company does not consider these equity securities to be OTTI. There was no OTTI of common stocks for the nine months ended September 30, 2017. For the nine months ended September 30, 2016, OTTI for common stocks was $18.1 million.

(16)Fair Value Measurements

The Company’s fixed maturity and equity securities classified as available for sale and its trading account securities are carried at fair value. Fair value is defined as “the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.” The Company utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels, as follows:

Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.  

Level 2 - Quoted prices for similar assets or valuations based on inputs that are observable.

Level 3 - Estimates of fair value based on internal pricing methodologies using unobservable inputs. Unobservable inputs are only used to measure fair value to the extent that observable inputs are not available.

Substantially, all of the Company’s fixed maturity securities were priced by independent pricing services. The prices provided by the independent pricing services are estimated based on observable market data in active markets utilizing pricing models and processes, which may include benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, sector groupings, matrix pricing and reference data. The pricing services may prioritize inputs differently on any given day for any security based on market conditions, and not all inputs are available for each security evaluation on any given day. The pricing services used by the Company have indicated that they will only produce an estimate of fair value if objectively verifiable information is available. The determination of whether markets are active or inactive is based upon the volume and level of activity for a particular asset class. The Company reviews the prices provided by pricing services for reasonableness and periodically performs independent price tests of a sample of securities to ensure proper valuation.

If prices from independent pricing services are not available for fixed maturity securities, the Company estimates the fair value. For Level 2 securities, the Company utilizes pricing models and processes which may include benchmark yields, sector groupings, matrix pricing, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, bids, offers and reference data. Where broker quotes are used, the Company generally requests two or more quotes and sets a price within the range of quotes received based on its assessment of the credibility of the quote and its own evaluation of the security. The Company generally does not adjust quotes received from brokers. For securities traded only in private negotiations, the Company determines fair value based primarily on the cost of such securities, which is adjusted to reflect prices of recent placements of securities of the same issuer, financial projections, credit quality and business developments of the issuer and other relevant information.

For Level 3 securities, the Company generally uses a discounted cash flow model to estimate the fair value of fixed maturity securities. The cash flow models are based upon assumptions as to prevailing credit spreads, interest rate and interest rate volatility, time to maturity and subordination levels. Projected cash flows are discounted at rates that are adjusted to reflect illiquidity, where appropriate.

18

The following tables present the assets and liabilities measured at fair value on a recurring basis as of September 30, 2017 and December 31, 2016 by level:

(In thousands)	Total		Level 1		Level 2		Level 3
September 30, 2017
Assets:
Fixed maturity securities available for sale:
U.S. government and government agency	$	411,605	$	—	$	411,605	$	—
State and municipal	4,413,169		—		4,413,169		—
Mortgage-backed securities	1,320,119		—		1,320,119		—
Asset-backed securities	2,388,618		—		2,388,444		174
Corporate	4,320,374		—		4,320,374		—
Foreign government	940,409		—		940,409		—
Total fixed maturity securities available for sale	13,794,294		—		13,794,120		174
Equity securities available for sale:
Common stocks	419,520		410,133		—		9,387
Preferred stocks	194,505		—		190,649		3,856
Total equity securities available for sale	614,025		410,133		190,649		13,243
Arbitrage trading account	488,238		275,818		212,420		—
Total	$	14,896,557	$	685,951	$	14,197,189	$	13,417
Liabilities:
Trading account securities sold but not yet purchased	$	44,937	$	44,851	$	86	$	—
December 31, 2016
Assets:
Fixed maturity securities available for sale:
U.S. government and government agency	$	513,802	$	—	$	513,802	$	—
State and municipal	4,519,503		—		4,519,503		—
Mortgage-backed securities	1,189,645		—		1,189,645		—
Asset-backed securities	1,907,860		—		1,907,677		183
Corporate	4,068,527		—		4,068,527		—
Foreign government	902,805		—		902,805		—
Total fixed maturity securities available for sale	13,102,142		—		13,101,959		183
Equity securities available for sale:
Common stocks	445,858		429,647		7,457		8,754
Preferred stocks	223,342		—		219,680		3,662
Total equity securities available for sale	669,200		429,647		227,137		12,416
Arbitrage trading account	299,999		224,623		75,376		—
Total	$	14,071,341	$	654,270	$	13,404,472	$	12,599
Liabilities:
Trading account securities sold but not yet purchased	$	51,179	$	51,089	$	90	$	—

There were no significant transfers between Levels 1 and 2 during the nine months ended September 30, 2017 or during the year ended December 31, 2016.

19

The following tables summarize changes in Level 3 assets and liabilities for the nine months ended September 30, 2017 and for the year ended December 31, 2016:

	Gains (Losses) Included in:
(In thousands)	Beginning Balance		Earnings (Losses)			Other Comprehensive Income (Loss)		Impairments		Purchases		(Sales)			Paydowns / Maturities			Transfers		Ending Balance
																		In / (Out)
Nine months ended September 30, 2017:
Assets:
Fixed maturities securities available for sale:
Asset-backed securities	$	183	$	2		$	32	$	—	$	—	$	(43	)	$	—		$	—	$	174
Corporate	—		—			—		—		—		—			—			—		—
Total	183		2			32		—		—		(43		)	—			—		174
Equity securities available for sale:
Common stocks	8,754		—			633		—		—		—			—			—		9,387
Preferred stocks	3,662		19			—		—		175		—			—			—		3,856
Total	12,416		19			633		—		175		—			—			—		13,243
Arbitrage trading account	—		8			—		—		—		(8		)	—			—		—
Total	$	12,599	$	29		$	665	$	—	$	175	$	(51	)	$	—		$	—	$	13,417
Year ended December 31, 2016:
Assets:
Fixed maturities securities available for sale:
Asset-backed securities	$	199	$	3		$	16	$	—	$	—	$	—		$	(35	)	$	—	$	183
Corporate	154		177			—		—		—		(331		)	—			—		—
Total	353		180			16		—		—		(331		)	(35		)	—		183
Equity securities available for sale:
Common stocks	7,829		—			160		—		765		—			—			—		8,754
Preferred stocks	3,624		38			—		—		—		—			—			—		3,662
Total	11,453		38			160		—		765		—			—			—		12,416
Arbitrage trading account	176		(176		)	—		—		—		—			—			—		—
Total	$	11,982	$	42		$	176	$	—	$	765	$	(331	)	$	(35	)	$	—	$	12,599

During the nine months ended September 30, 2017 and for the year ended December 31, 2016, there were no transfers out of Level 3.

20

(17) Reserves for Loss and Loss Expenses

The Company's reserves for losses and loss expenses are comprised of case reserves and incurred but not reported liabilities (IBNR). When a claim is reported, a case reserve is established for the estimated ultimate payment based upon known information about the claim. As more information about the claim becomes available over time, case reserves are adjusted up or down as appropriate. Reserves are also established on an aggregate basis to provide for IBNR liabilities and expected loss reserve development on reported claims.

Loss reserves included in the Company’s financial statements represent management’s best estimates based upon an actuarially derived point estimate and other considerations. The Company uses a variety of actuarial techniques and methods to derive an actuarial point estimate for each operating unit. These methods include paid loss development, incurred loss development, paid and incurred Bornhuetter-Ferguson methods and frequency and severity methods. In circumstances where one actuarial method is considered more credible than the others, that method is used to set the point estimate. The actuarial point estimate may also be based on a judgmental weighting of estimates produced from each of the methods considered. Industry loss experience is used to supplement the Company’s own data in selecting “tail factors” in areas where the Company’s own data is limited. The actuarial data is analyzed by line of business, coverage and accident or policy year, as appropriate, for each operating unit.

The establishment of the actuarially derived loss reserve point estimate also includes consideration of qualitative factors that may affect the ultimate losses. These qualitative considerations include, among others, the impact of re-underwriting initiatives, changes in the mix of business, changes in distribution sources and changes in policy terms and conditions.

The key assumptions used to arrive at the best estimate of loss reserves are the expected loss ratios, rate of loss cost inflation, and reported and paid loss emergence patterns. Expected loss ratios represent management’s expectation of losses at the time the business is priced and written, before any actual claims experience has emerged. This expectation is a significant determinant of the estimate of loss reserves for recently written business where there is little paid or incurred loss data to consider. Expected loss ratios are generally derived from historical loss ratios adjusted for the impact of rate changes, loss cost trends and known changes in the type of risks underwritten. Expected loss ratios are estimated for each key line of business within each operating unit. Expected loss cost inflation is particularly important for the long-tail lines, such as excess casualty, and claims with a high medical component, such as workers’ compensation. Reported and paid loss emergence patterns are used to project current reported or paid loss amounts to their ultimate settlement value. Loss development factors are based on the historical emergence patterns of paid and incurred losses, and are derived from the Company’s own experience and industry data. The paid loss emergence pattern is also significant to excess and assumed workers’ compensation reserves because those reserves are discounted to their estimated present value based upon such estimated payout patterns.

Loss frequency and severity are measures of loss activity that are considered in determining the key assumptions described in our discussion of loss and loss expense reserves, including expected loss ratios, rate of loss cost inflation and reported and paid loss emergence patterns. Loss frequency is a measure of the number of claims per unit of insured exposure, and loss severity is a measure of the average size of claims. Factors affecting loss frequency include the effectiveness of loss controls and safety programs and changes in economic activity or weather patterns. Factors affecting loss severity include changes in policy limits, retentions, rate of inflation and judicial interpretations.

Another factor affecting estimates of loss frequency and severity is the loss reporting lag, which is the period of time between the occurrence of a loss and the date the loss is reported to the Company. The length of the loss reporting lag affects our ability to accurately predict loss frequency (loss frequencies are more predictable for lines with short reporting lags) as well as the amount of reserves needed for incurred but not reported losses (less IBNR is required for lines with short reporting lags). As a result, loss reserves for lines with short reporting lags are likely to have less variation from initial loss estimates. For lines with short reporting lags, which include commercial automobile, primary workers’ compensation, other liability (claims-made) and property business, the key assumption is the loss emergence pattern used to project ultimate loss estimates from known losses paid or reported to date. For lines of business with long reporting lags, which include other liability (occurrence), products liability, excess workers’ compensation and liability reinsurance, the key assumption is the expected loss ratio since there is often little paid or incurred loss data to consider. Historically, the Company has experienced less variation from its initial loss estimates for lines of businesses with short reporting lags than for lines of business with long reporting lags.

The key assumptions used in calculating the most recent estimate of the loss reserves are reviewed each quarter and adjusted, to the extent necessary, to reflect the latest reported loss data, current trends and other factors observed.

21

The table below provides a reconciliation of the beginning and ending reserve balances:

	September 30,
(In thousands)	2017			2016
Net reserves at beginning of year	$	9,590,265		$	9,244,872
Net provision for losses and loss expenses:
Claims occurring during the current year (1)	2,998,687			2,838,777
Decrease in estimates for claims occurring in prior years (2) (3)	(7,648		)	(23,518		)
Loss reserve discount accretion	34,436			37,080
Total	3,025,475			2,852,339
Net payments for claims:
Current year	628,078			612,615
Prior year	1,996,977			1,931,454
Total	2,625,055			2,544,069
Foreign currency translation	57,789			(6,266		)
Net reserves at end of period	10,048,474			9,546,876
Ceded reserve at end of period	1,605,872			1,550,954
Gross reserves at end of period	$	11,654,346		$	11,097,830

_______________________________________

(1) Claims occurring during the current year are net of loss reserve discounts of $16,787,000 and $12,085,000 for the nine months ended September 30, 2017 and 2016, respectively.

(2) The decrease in estimates for claims occurring in prior years is net of loss reserve discount. On an undiscounted basis, the estimates for claims occurring in prior years decreased by $30,609,000 and $45,813,000 for the nine months ended September 30, 2017 and 2016, respectively.

(3) For certain retrospectively rated insurance policies and reinsurance agreements, reserve development is offset by additional or return premiums. Favorable development, net of additional and return premiums, was $31 million and $42 million for the nine months ended September 30, 2017 and 2016, respectively.

In 2017, favorable prior year development (net of additional and return premiums) of $31 million included $62 million of favorable development for the Insurance segment, partially offset by $31 million of adverse development for the Reinsurance segment. The favorable development for the Insurance segment was primarily attributable to workers' compensation business (including excess workers' compensation). The favorable workers' compensation development was spread across many accident years, including prior to 2008, but was most significant in accident years 2014 and 2015. The favorable workers' compensation development reflects a continuation of the benign loss cost trends experienced during 2016, particularly the favorable claim frequency trends (i.e., number of reported claims per unit of exposure). The adverse development for the Reinsurance segment was due to reserve strengthening associated with claims impacted by the change in the Ogden discount rate in the U.K., as well as adverse development in the U.S. facultative casualty excess of loss business. The Ogden rate is the discount rate used to calculate lump-sum bodily injury payouts in the U.K., and was reduced by the U.K. Ministry of Justice from +2.5% to -0.75%; the adverse development mostly related to U.K. motor bodily injury claims which we reinsured on an excess of loss basis in accident years 2012 through 2016. The adverse development on U.S. facultative casualty business related to construction-related risks in accident years 2008 and prior.

In 2016, favorable prior year development (net of additional and return premiums) of $42 million included $38 million for the Insurance segment and $4 million for the Reinsurance segment. The favorable development for the Insurance segment was primarily attributable to workers' compensation business, partially offset by adverse development for commercial auto liability and medical and other professional liability. The favorable development for workers' compensation stems from accident years 2003 through 2015, but is concentrated in accident years 2014 and 2015; it reflects claims frequency trends (i.e., number of reported claims per unit of exposure) that continue to be better than we expected. The unfavorable development for commercial auto liability was driven by higher large loss activity than expected in accident years 2014 and 2015, and the

22

unfavorable development for medical professional liability was primarily in accident years prior to 2013 and stemmed from a class of medical professional liability business that we discontinued writing in 2013.

(18) Fair Value of Financial Instruments

The following table presents the carrying amounts and estimated fair values of the Company’s financial instruments:

	September 30, 2017				December 31, 2016
(In thousands)	Carrying Value		Fair Value		Carrying Value		Fair Value
Assets:
Fixed maturity securities	$	13,873,690	$	13,890,354	$	13,190,668	$	13,204,814
Equity securities available for sale	614,025		614,025		669,200		669,200
Arbitrage trading account	488,238		488,238		299,999		299,999
Loans receivable	74,229		76,615		106,798		108,299
Cash and cash equivalents	773,997		773,997		795,285		795,285
Trading account receivables from brokers and clearing organizations	297,208		297,208		484,593		484,593
Liabilities:
Due to broker	58,973		58,973		19,416		19,416
Trading account securities sold but not yet purchased	44,937		44,937		51,179		51,179
Subordinated debentures	728,071		728,291		727,630		687,504
Senior notes and other debt	1,759,929		1,946,700		1,760,595		1,914,727

The estimated fair values of the Company’s fixed maturity securities, equity securities available for sale and arbitrage trading account securities are based on various valuation techniques that rely on fair value measurements as described in Note 16 above. The fair value of loans receivable are estimated by using current institutional purchaser yield requirements for loans with similar credit characteristics, which is considered a Level 2 input. The fair value of the senior notes and other debt and the subordinated debentures is based on spreads for similar securities, which is considered a Level 2 input.

(19) Reinsurance

The following is a summary of reinsurance financial information:

	For the Three Months						For the Nine Months
	Ended September 30,						Ended September 30,
(In thousands)	2017			2016			2017			2016
Written premiums:
Direct	$	1,679,389		$	1,643,870		$	5,127,465		$	5,061,646
Assumed	194,769			224,979			570,052			702,265
Ceded	(302,975		)	(261,484		)	(915,245		)	(850,255		)
Total net premiums written	$	1,571,183		$	1,607,365		$	4,782,272		$	4,913,656
Earned premiums:
Direct	$	1,692,453		$	1,647,033		$	4,972,755		$	4,824,768
Assumed	202,972			216,758			605,281			635,443
Ceded	(313,925		)	(277,847		)	(857,792		)	(787,139		)
Total net premiums earned	$	1,581,500		$	1,585,944		$	4,720,244		$	4,673,072
Ceded losses and loss expenses incurred	$	247,104		$	213,065		$	424,905		$	507,258
Ceded commissions earned	$	63,222		$	47,315		$	177,524		$	143,809

The Company reinsures a portion of its insurance exposures in order to reduce its net liability on individual risks and catastrophe losses. The Company also cedes premiums to state assigned risk plans and captive insurance companies. Estimated

23

amounts due from reinsurers are reported net of reserves for uncollectible reinsurance of $1 million as of September 30, 2017 and December 31, 2016.

(20) Restricted Stock Units

Pursuant to its stock incentive plan, the Company may issue restricted stock units (RSUs) to employees of the Company and its subsidiaries. The RSUs generally vest three to five years from the award date and are subject to other vesting and forfeiture provisions contained in the award agreement. RSUs are expensed pro-ratably over the vesting period. RSU expenses were $30 million and $25 million for the nine months ended September 30, 2017 and 2016, respectively. A summary of RSUs issued in the nine months ended September 30, 2017 and 2016 follows:

($ in thousands)	Units	Fair Value
2017	855,051	$	58,712
2016	990,487	$	57,959

(21) Litigation and Contingent Liabilities

In the ordinary course of business, the Company is subject to disputes, litigation and arbitration arising from its insurance and reinsurance businesses. These matters are generally related to insurance and reinsurance claims and are considered in the establishment of loss and loss expense reserves. In addition, the Company may also become involved in legal actions which seek extra-contractual damages, punitive damages or penalties, including claims alleging bad faith in handling of insurance claims. The Company expects its ultimate liability with respect to such matters will not be material to its financial condition. However, adverse outcomes on such matters are possible, from time to time, and could be material to the Company’s results of operations in any particular financial reporting period.

(22) Business Segments

The Company’s reportable segments include the following two business segments, plus a corporate segment:

• Insurance - primarily commercial insurance business, including excess and surplus lines and admitted lines in the United States, United Kingdom, Continental Europe, South America, Canada, Mexico, Scandinavia, Asia and Australia; and

• Reinsurance - reinsurance business on a facultative and treaty basis, primarily in the United States, United Kingdom, Continental Europe, Australia, the Asia-Pacific Region and South Africa.

Commencing with the first quarter of 2017, the Company reclassified two businesses from the Insurance Segment to the Reinsurance segment. Reclassifications have been made to the Company's 2016 financial information to conform with this presentation.

The accounting policies of the segments are the same as those described in the summary of significant accounting policies. Income tax expense and benefits are calculated based upon the Company's overall effective tax rate.

24

Summary financial information about the Company's reporting segments is presented in the following tables. Income (loss) before income taxes by segment includes allocated investment income. Identifiable assets by segment are those assets used in or allocated to the operation of each segment.

	Revenues
(In thousands)	Earned Premiums		Investment Income		Other		Total (1)		Pre-Tax Income (Loss)			Net Income (Loss) to Common Stockholders
Three months ended September 30, 2017
Insurance	$	1,433,729	$	105,924	$	—	$	1,539,653	$	171,478		$	123,240
Reinsurance	147,771		21,528		—		169,299		(57,643		)	(35,074		)
Corporate, other and eliminations (2)	—		15,027		123,404		138,431		(71,681		)	(45,685		)
Net investment gains	—		—		183,959		183,959		183,959			119,573
Total	$	1,581,500	$	142,479	$	307,363	$	2,031,342	$	226,113		$	162,054
Three months ended September 30, 2016
Insurance	$	1,423,635	$	111,300	$	—	$	1,534,935	$	210,498		$	140,730
Reinsurance	162,309		27,567		—		189,876		27,321			18,725
Corporate, other and eliminations (2)	—		6,801		112,377		119,178		(81,942		)	(53,035		)
Net investment gains	—		—		175,738		175,738		175,738			114,230
Total	$	1,585,944	$	145,668	$	288,115	$	2,019,727	$	331,615		$	220,650
Nine months ended September 30, 2017:
Insurance	$	4,262,485	320,552		$	—	$	4,583,037	$	557,605		$	381,736
Reinsurance	457,759		67,798		—		525,557		(38,279		)	(20,801		)
Corporate, other and eliminations (2)	—		38,251		326,203		364,454		(224,716		)	(146,324		)
Net investment gains	—		—		276,760		276,760		276,760			179,894
Total	$	4,720,244	$	426,601	$	602,963	$	5,749,808	$	571,370		$	394,505
Nine months ended September 30, 2016:
Insurance	$	4,180,985	$	304,904	$	—	$	4,485,889	$	586,651		$	394,746
Reinsurance	492,087		77,119		—		569,206		79,215			54,885
Corporate, other and eliminations (2)	—		22,827		415,224		438,051		(190,655		)	(123,610		)
Net investment gains	—		—		189,394		189,394		189,394			123,106
Total	$	4,673,072	$	404,850	$	604,618	$	5,682,540	$	664,605		$	449,127

_________________

(1) Revenues for Insurance from foreign countries for the three months ended September 30, 2017 and 2016 were $166 million and $187 million, respectively, and for the nine months ended September 30, 2017 and 2016 were $513 million and $546 million, respectively. Revenues for Reinsurance from foreign countries for the three months ended September 30, 2017 and 2016 were $49 million and $48 million, respectively, and for the nine months ended September 30, 2017 and 2016 were $150 million and $153 million, respectively.

(2) Corporate, other and eliminations represent corporate revenues and expenses that are not allocated to business segments.

Identifiable Assets

(In thousands)	September 30, 2017		December 31, 2016
Insurance	$	19,136,776	$	19,137,758
Reinsurance	3,243,610		2,524,338
Corporate, other and eliminations	1,955,690		1,687,980
Consolidated	$	24,336,076	$	23,350,076

25

Net premiums earned by major line of business are as follows:

	For the Three Months				For the Nine Months
	Ended September 30,				Ended September 30,
(In thousands)	2017		2016		2017		2016
Insurance:
Other liability	$	466,616	$	455,841	$	1,378,505	$	1,302,841
Workers’ compensation	378,529		354,185		1,106,616		1,042,503
Short-tail lines (1)	287,860		312,865		887,791		962,435
Commercial automobile	163,277		164,540		482,929		481,249
Professional liability	137,447		136,204		406,644		391,957
Total Insurance	1,433,729		1,423,635		4,262,485		4,180,985
Reinsurance:
Casualty	94,478		97,153		282,430		301,571
Property	53,293		65,156		175,329		190,516
Total Reinsurance	147,771		162,309		457,759		492,087
Total	$	1,581,500	$	1,585,944	$	4,720,244	$	4,673,072

______________

(1) Short-tail lines include commercial multi-peril (non-liability), inland marine, accident and health, fidelity and surety, boiler and machinery and other lines.

26

SAFE HARBOR STATEMENT

This is a “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein, including statements related to our outlook for the industry and for our performance for the year 2017 and beyond, are based upon the Company’s historical performance and on current plans, estimates and expectations. The inclusion of this forward-looking information should not be regarded as a representation by us or any other person that the future plans, estimates or expectations contemplated by us will be achieved. They are subject to various risks and uncertainties, including but not limited to: the cyclical nature of the property casualty industry; the impact of significant competition, including new alternative entrants to the industry; the long-tail and potentially volatile nature of the insurance and reinsurance business; product demand and pricing; claims development and the process of estimating reserves; investment risks, including those of our portfolio of fixed maturity securities and investments in equity securities, including investments in financial institutions, municipal bonds, mortgage-backed securities, loans receivable, investment funds, including real estate, merger arbitrage, energy related and private equity investments; the effects of emerging claim and coverage issues; the uncertain nature of damage theories and loss amounts; natural and man-made catastrophic losses, including as a result of terrorist activities; general economic and market activities, including inflation, interest rates, and volatility in the credit and capital markets; the impact of the conditions in the financial markets and the global economy, and the potential effect of legislative, regulatory, accounting or other initiatives taken in response, on our results and financial condition; foreign currency and political risks (including those associated with the United Kingdom's expected withdrawal from the European Union, or "Brexit") relating to our international operations; our ability to attract and retain key personnel and qualified employees; continued availability of capital and financing; the success of our new ventures or acquisitions and the availability of other opportunities; the availability of reinsurance; our retention under the Terrorism Risk Insurance Program Reauthorization Act of 2015; the ability of our reinsurers to pay reinsurance recoverables owed to us; other legislative and regulatory developments, including those related to business practices in the insurance industry; credit risk related to our policyholders, independent agents and brokers; changes in the ratings assigned to us or our insurance company subsidiaries by rating agencies; the availability of dividends from our insurance company subsidiaries; potential difficulties with technology and/or data security; the effectiveness of our controls to ensure compliance with guidelines, policies and legal and regulatory standards; and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission. These risks and uncertainties could cause our actual results for the year 2017 and beyond to differ materially from those expressed in any forward-looking statement we make. Any projections of growth in our revenues would not necessarily result in commensurate levels of earnings. Our future financial performance is dependent upon factors discussed in our Annual Report on Form 10-K, elsewhere in this Form 10-Q and our other SEC filings. Forward-looking statements speak only as of the date on which they are made. Except to the extent required by applicable laws, the Company does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise.

27

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

W. R. Berkley Corporation is an insurance holding company that is among the largest commercial lines writers in the United States and operates in two business segments: Insurance and Reinsurance. Our decentralized structure provides us with the flexibility to respond quickly and efficiently to local or specific market conditions and to pursue specialty business niches. It also allows us to be closer to our customers in order to better understand their individual needs and risk characteristics. While providing our business units with certain operating autonomy, our structure allows us to capitalize on the benefits of economies of scale through centralized capital, investment, reinsurance, enterprise risk management, and actuarial, financial and corporate legal staff support. The Company’s primary sources of revenues and earnings are its insurance operations and its investments.

An important part of our strategy is to form new operating units to capitalize on various business opportunities. Over the years, the Company has formed numerous operating units that are focused on important parts of the economy in the U.S., including healthcare, cyber security, energy and agriculture, and on growing international markets, including the Asia-Pacific region, South America and Mexico.

The profitability of the Company’s insurance business is affected primarily by the adequacy of premium rates. The ultimate adequacy of premium rates is not known with certainty at the time an insurance policy is issued because premiums are determined before claims are reported. The ultimate adequacy of premium rates is affected mainly by the severity and frequency of claims, which are influenced by many factors, including natural and other disasters, regulatory measures and court decisions that define and change the extent of coverage and the effects of economic inflation on the amount of compensation for injuries or losses. General insurance prices are also influenced by available insurance capacity, i.e., the level of statutory capital and surplus employed in the industry, and the industry’s willingness to deploy that capital.

The Company’s profitability is also affected by its investment income and investment gains. The Company’s invested assets are invested principally in fixed maturity securities. The return on fixed maturity securities is affected primarily by general interest rates, as well as the credit quality and duration of the securities. Returns available on fixed maturity investments are at historically low levels.

The Company invests in equity securities, merger arbitrage securities, investment funds (including energy related funds), private equity, loans and real estate related assets. The Company's investments in investment funds and its other alternative investments have experienced, and the Company expects to continue to experience, greater fluctuations in investment income.

During the third quarter of 2017, catastrophe losses were $119 million, including $107 million related to Hurricanes Harvey, Irma, and Maria and two earthquakes in Mexico.

Commencing with the first quarter of 2017, the Company reclassified two businesses from the Insurance segment to the Reinsurance segment. Reclassifications have been made to the Company's 2016 financial information to conform with this presentation.

Critical Accounting Estimates

The following presents a discussion of accounting policies and estimates relating to reserves for losses and loss expenses, assumed premiums and other-than-temporary impairments of investments. Management believes these policies and estimates are the most critical to its operations and require the most difficult, subjective and complex judgments.

Reserves for Losses and Loss Expenses.To recognize liabilities for unpaid losses, either known or unknown, insurers establish reserves, which is a balance sheet account representing estimates of future amounts needed to pay claims and related expenses with respect to insured events which have occurred. Estimates and assumptions relating to reserves for losses and loss expenses are based on complex and subjective judgments, often including the interplay of specific uncertainties with related accounting and actuarial measurements. Such estimates are also susceptible to change as significant periods of time may elapse between the occurrence of an insured loss, the report of the loss to the insurer, the ultimate determination of the cost of the loss and the insurer’s payment of that loss.

In general, when a claim is reported, claims personnel establish a “case reserve” for the estimated amount of the ultimate payment based upon known information about the claim at that time. The estimate represents an informed judgment based on general reserving practices and reflects the experience and knowledge of the claims personnel regarding the nature and value of the specific type of claim. Reserves are also established on an aggregate basis to provide for losses incurred but not reported (“IBNR”) to the insurer, potential inadequacy of case reserves and the estimated expenses of settling claims, including legal and other fees and general expenses of administrating the claims adjustment process. Reserves are established based upon the then current legal interpretation of coverage provided.

28

In examining reserve adequacy, several factors are considered in estimating the ultimate economic value of losses. These factors include, among other things, historical data, legal developments, changes in social attitudes and economic conditions, including the effects of inflation. The actuarial process relies on the basic assumption that past experience, adjusted judgmentally for the effects of current developments and anticipated trends, is an appropriate basis for predicting future outcomes. Reserve amounts are based on management’s informed estimates and judgments using currently available data. As additional experience and other data become available and are reviewed, these estimates and judgments may be revised. This may result in reserve increases or decreases that would be reflected in our results in periods in which such estimates and assumptions are changed.

Reserves do not represent an exact calculation of liability. Rather, reserves represent an estimate of what management expects the ultimate settlement and claim administration will cost. While the methods for establishing reserves are well tested over time, some of the major assumptions about anticipated loss emergence patterns are subject to uncertainty. These estimates, which generally involve actuarial projections, are based on management’s assessment of facts and circumstances then known, as well as estimates of trends in claims severity and frequency, judicial theories of liability and other factors, including the actions of third parties which are beyond the Company’s control. These variables are affected by external and internal events, such as inflation and economic volatility, judicial and litigation trends, reinsurance coverage, legislative changes and claim handling and reserving practices, which make it more difficult to accurately predict claim costs. The inherent uncertainties of estimating reserves are greater for certain types of liabilities where long periods of time elapse before a definitive determination of liability is made. Because setting reserves is inherently uncertain, the Company cannot provide assurance that its current reserves will prove adequate in light of subsequent events.

Loss reserves included in the Company’s financial statements represent management’s best estimates based upon an actuarially derived point estimate and other considerations. The Company uses a variety of actuarial techniques and methods to derive an actuarial point estimate for each operating unit. These methods include paid loss development, incurred loss development, paid and incurred Bornhuetter-Ferguson methods and frequency and severity methods. In circumstances where one actuarial method is considered more credible than the others, that method is used to set the point estimate. For example, the paid loss and incurred loss development methods rely on historical paid and incurred loss data. For new lines of business, where there is insufficient history of paid and incurred claims data, or in circumstances where there have been significant changes in claim practices, the paid and incurred loss development methods would be less credible than other actuarial methods. The actuarial point estimate may also be based on a judgmental weighting of estimates produced from each of the methods considered. Industry loss experience is used to supplement the Company’s own data in selecting “tail factors” and in areas where the Company’s own data is limited. The actuarial data is analyzed by line of business, coverage and accident or policy year, as appropriate, for each operating unit.

The establishment of the actuarially derived loss reserve point estimate also includes consideration of qualitative factors that may affect the ultimate losses. These qualitative considerations include, among others, the impact of re-underwriting initiatives, changes in the mix of business, changes in distribution sources and changes in policy terms and conditions. Examples of changes in terms and conditions that can have a significant impact on reserve levels are the use of aggregate policy limits, the expansion of coverage exclusions, whether or not defense costs are within policy limits, and changes in deductibles and attachment points.

The key assumptions used to arrive at the best estimate of loss reserves are the expected loss ratios, rate of loss cost inflation, and reported and paid loss emergence patterns. Expected loss ratios represent management’s expectation of losses at the time the business is written, before any actual claims experience has emerged. This expectation is a significant determinant of the estimate of loss reserves for recently written business where there is little paid or incurred loss data to consider. Expected loss ratios are generally derived from historical loss ratios adjusted for the impact of rate changes, loss cost trends and known changes in the type of risks underwritten. Expected loss ratios are estimated for each key line of business within each operating unit. Expected loss cost inflation is particularly important for the long-tail lines, such as excess casualty, and claims with a high medical component, such as workers’ compensation. Reported and paid loss emergence patterns are used to project current reported or paid loss amounts to their ultimate settlement value. Loss development factors are based on the historical emergence patterns of paid and incurred losses, and are derived from the Company’s own experience and industry data. The paid loss emergence pattern is also significant to excess and assumed workers’ compensation reserves because those reserves are discounted to their estimated present value based upon such estimated payout patterns. Management believes the estimates and assumptions it makes in the reserving process provide the best estimate of the ultimate cost of settling claims and related expenses with respect to insured events which have occurred; however, different assumptions and variables could lead to significantly different reserve estimates.

Loss frequency and severity are measures of loss activity that are considered in determining the key assumptions described in our discussion of loss and loss expense reserves, including expected loss ratios, rate of loss cost inflation and reported and paid loss emergence patterns. Loss frequency is a measure of the number of claims per unit of insured exposure, and loss severity is a measure of the average size of claims. Factors affecting loss frequency include the effectiveness of loss

29

controls and safety programs and changes in economic activity or weather patterns. Factors affecting loss severity include changes in policy limits, retentions, rate of inflation and judicial interpretations.

Another factor affecting estimates of loss frequency and severity is the loss reporting lag, which is the period of time between the occurrence of a loss and the date the loss is reported to the Company. The length of the loss reporting lag affects our ability to accurately predict loss frequency (loss frequencies are more predictable for lines with short reporting lags) as well as the amount of reserves needed for incurred but not reported losses (less IBNR is required for lines with short reporting lags). As a result, loss reserves for lines with short reporting lags are likely to have less variation from initial loss estimates. For lines with short reporting lags, which include commercial automobile, primary workers’ compensation, other liability (claims-made) and property business, the key assumption is the loss emergence pattern used to project ultimate loss estimates from known losses paid or reported to date. For lines of business with long reporting lags, which include other liability (occurrence), products liability, excess workers’ compensation and liability reinsurance, the key assumption is the expected loss ratio since there is often little paid or incurred loss data to consider. Historically, the Company has experienced less variation from its initial loss estimates for lines of businesses with short reporting lags than for lines of business with long reporting lags.

The key assumptions used in calculating the most recent estimate of the loss reserves are reviewed each quarter and adjusted, to the extent necessary, to reflect the latest reported loss data, current trends and other factors observed. If the actual level of loss frequency and severity are higher or lower than expected, the ultimate losses will be different than management’s estimate. The following table reflects the impact of changes (which could be favorable or unfavorable) in frequency and severity, relative to our assumptions, on our loss estimate for claims occurring in 2016:

(In thousands)	Frequency (+/-)
Severity (+/-)	1%		5%		10%
1%	$	76,915	$	231,511	$	424,755
5%	231,511		392,229		593,126
10%	424,755		593,126		803,590

Our net reserves for losses and loss expenses of approximately $10.0 billion as of September 30, 2017 relate to multiple accident years. Therefore, the impact of changes in frequency or severity for more than one accident year could be higher or lower than the amounts reflected above. The impact of such changes would likely be manifested gradually over the course of many years, as the magnitude of the changes became evident.

Approximately $1.8 billion, or 17%, of the Company’s net loss reserves as of September 30, 2017 relate to the Reinsurance segment. There is a higher degree of uncertainty and greater variability regarding estimates of assumed loss reserves because those estimates are based, in part, upon information received from ceding companies. If information received from ceding companies is not timely or correct, the Company’s estimate of ultimate losses may not be accurate. Furthermore, due to delayed reporting of claim information by ceding companies, the claim settlement tail for assumed reinsurance is extended. Management considers the impact of delayed reporting in its selection of assumed loss development factors.

Information received from ceding companies is used to set initial expected loss ratios, to establish case reserves and to estimate reserves for incurred but not reported losses on assumed reinsurance business. This information, which is generally provided through reinsurance intermediaries, is gathered through the underwriting process and from periodic claim reports and other correspondence with ceding companies. The Company performs underwriting and claim audits of selected ceding companies to determine the accuracy and completeness of information provided to the Company. The information received from the ceding companies is supplemented by the Company’s own loss development experience with similar lines of business as well as industry loss trends and loss development benchmarks.

Following is a summary of the Company’s reserves for losses and loss expenses by business segment:

(In thousands)	September 30, 2017		December 31, 2016
Insurance	$	8,291,708	$	7,913,074
Reinsurance	1,756,766		1,677,191
Net reserves for losses and loss expenses	10,048,474		9,590,265
Ceded reserves for losses and loss expenses	1,605,872		1,606,930
Gross reserves for losses and loss expenses	$	11,654,346	$	11,197,195

Following is a summary of the Company’s net reserves for losses and loss expenses by major line of business:

30

(In thousands)	Reported Case Reserves		Incurred But Not Reported		Total
September 30, 2017
Other liability	$	1,243,208	$	2,162,031	$	3,405,239
Workers’ compensation (1)	1,530,194		1,246,084		2,776,278
Professional liability	299,418		584,606		884,024
Commercial automobile	341,998		267,136		609,134
Short-tail lines (2)	309,692		307,341		617,033
Total Insurance	3,724,510		4,567,198		8,291,708
Reinsurance (1)	909,690		847,076		1,756,766
Total	$	4,634,200	$	5,414,274	$	10,048,474
December 31, 2016
Other liability	$	1,159,082	$	2,061,966	$	3,221,048
Workers’ compensation (1)	1,453,318		1,228,774		2,682,092
Professional liability	264,188		542,539		806,727
Commercial automobile	344,143		252,978		597,121
Short-tail lines (2)	322,872		283,214		606,086
Total Insurance	3,543,603		4,369,471		7,913,074
Reinsurance (1)	823,516		853,675		1,677,191
Total	$	4,367,119	$	5,223,146	$	9,590,265

___________

(1) Reserves for workers’ compensation and reinsurance are net of an aggregate net discount of $599 million and $640

million as of September 30, 2017 and December 31, 2016, respectively.

(2) Short-tail lines include commercial multi-peril (non-liability), inland marine, accident and health, fidelity and surety, boiler and machinery and other lines.

The Company evaluates reserves for losses and loss adjustment expenses on a quarterly basis. Changes in estimates of prior year losses are reported when such changes are made. The changes in prior year loss reserve estimates are generally the result of ongoing analysis of recent loss development trends. Original estimates are increased or decreased as additional information becomes known regarding individual claims and aggregate claim trends.

Certain of the Company's insurance and reinsurance contracts are retrospectively rated, whereby the Company collects more or less premiums based on the level of loss activity. For those contracts, changes in loss and loss adjustment expenses for prior years may be fully or partially offset by additional or return premiums.

Net prior year development (i.e. the sum of prior year reserve changes and prior year earned premiums changes) for the nine months ended September 30, 2017 and 2016 are as follows:

(In thousands)	2017		2016
Net decrease in prior year loss reserves	$	7,648	$	23,518
Increase in prior year earned premiums	22,940		18,039
Net favorable prior year development	$	30,588	$	41,557

In 2017, favorable prior year development (net of additional and return premiums) of $31 million included $62 million of favorable development for the Insurance segment, partially offset by $31 million of adverse development for the Reinsurance segment. The favorable development for the Insurance segment was primarily attributable to workers' compensation business (including excess workers' compensation). The favorable workers' compensation development was spread across many accident years, including prior to 2008, but was most significant in accident years 2014 and 2015. The favorable workers' compensation development reflects a continuation of the benign loss cost trends experienced during 2016, particularly the favorable claim frequency trends (i.e., number of reported claims per unit of exposure). The adverse development for the Reinsurance segment was due to reserve strengthening associated with claims impacted by the change in

31

the Ogden discount rate in the U.K., as well as adverse development on the U.S. facultative casualty excess of loss business. The Ogden rate is the discount rate used to calculate lump-sum bodily injury payouts in the U.K., and was reduced by the U.K. Ministry of Justice from +2.5% to -0.75%; the adverse development mostly related to U.K. motor bodily injury claims which we reinsured on an excess of loss basis in accident years 2012 through 2016. The adverse development on U.S. facultative casualty business was due to construction-related risks in accident years 2008 and prior.

In 2016, favorable prior year development (net of additional and return premiums) of $42 million included $38 million for the Insurance segment and $4 million for the Reinsurance segment. The favorable development for the Insurance segment was primarily attributable to workers' compensation business, partially offset by adverse development for commercial auto liability and medical and other professional liability. The favorable development for workers' compensation stems from accident years 2003 through 2015, but is concentrated in accident years 2014 and 2015; it reflects claims frequency trends (i.e., number of reported claims per unit of exposure) that continue to be better than we expected. The unfavorable development for commercial auto liability was driven by higher large loss activity than expected in accident years 2014 and 2015, and the unfavorable development for medical professional liability was primarily in accident years prior to 2013 and stemmed from a class of medical professional liability business that we discontinued writing in 2013.

Reserve Discount. The Company discounts its liabilities for certain workers’ compensation reserves. The amount of workers’ compensation reserves that were discounted was $1,849 million and $1,907 million at September 30, 2017 and December 31, 2016, respectively. The aggregate net discount for those reserves, after reflecting the effects of ceded reinsurance, was $599 million and $640 million at September 30, 2017 and December 31, 2016, respectively. At September 30, 2017, discount rates by year ranged from 2.0% to 6.5%, with a weighted average discount rate of 3.8%.

             Substantially all of the workers’ compensation discount (97% of total discounted reserves at September 30, 2017) relates to excess workers’ compensation reserves. In order to properly match loss expenses with income earned on investment securities supporting the liabilities, reserves for excess workers’ compensation business are discounted using risk-free discount rates determined by reference to the U.S. Treasury yield curve. These rates are determined annually based on the weighted average rate for the period. Once established, no adjustments are made to the discount rate for that period, and any increases or decreases in loss reserves in subsequent years are discounted at the same rate, without regard to when any such adjustments are recognized. The expected loss and loss expense payout patterns subject to discounting are derived from the Company’s loss payout experience.  

        The Company also discounts reserves for certain other long-duration workers’ compensation reserves (representing approximately 3% of total discounted reserves at September 30, 2017), including reserves for quota share reinsurance and reserves related to losses regarding occupational lung disease. These reserves are discounted at statutory rates permitted by the Department of Insurance of the State of Delaware.

Assumed Reinsurance Premiums. The Company estimates the amount of assumed reinsurance premiums that it will receive under treaty reinsurance agreements at the inception of the contracts. These premium estimates are revised as the actual amount of assumed premiums is reported to the Company by the ceding companies. As estimates of assumed premiums are made or revised, the related amount of earned premiums, commissions and incurred losses associated with those premiums are recorded. Estimated assumed premiums receivable were approximately $56 million at September 30, 2017 and $68 million at December 31, 2016. The assumed premium estimates are based upon terms set forth in reinsurance agreements, information received from ceding companies during the underwriting and negotiation of agreements, reports received from ceding companies and discussions and correspondence with reinsurance intermediaries. The Company also considers its own view of market conditions, economic trends and experience with similar lines of business. These premium estimates represent management’s best estimate of the ultimate amount of premiums to be received under its assumed reinsurance agreements.

Other-Than-Temporary Impairments (OTTI) of Investments. The cost of securities is adjusted where appropriate to include a provision for decline in value which is considered to be other-than-temporary. An other-than-temporary decline is considered to occur in investments where there has been a sustained reduction in fair value and where the Company does not expect the fair value to recover prior to the time of sale or maturity. Since equity securities do not have a contractual cash flow or maturity, the Company considers whether the price of an equity security is expected to recover within a reasonable period of time.

The Company classifies its fixed maturity securities and preferred stocks by credit rating, primarily based on ratings assigned by credit rating agencies. For purposes of classifying securities with different ratings, the Company uses the average of the credit ratings assigned, unless in limited situations the Company’s own analysis indicates an internal rating is more appropriate. Securities that are not rated by a rating agency are evaluated and classified by the Company on a case-by-case basis.

32

Fixed Maturity Securities – For securities that we intend to sell or, more likely than not, would be required to sell, a decline in value below amortized cost is considered to be OTTI. The amount of OTTI is equal to the difference between amortized cost and fair value at the balance sheet date. For securities that we do not intend to sell or expect to be required to sell, a decline in value below amortized cost is considered to be an OTTI if we do not expect to recover the entire amortized cost basis of a security (i.e., the present value of cash flows expected to be collected is less than the amortized cost basis of the security).

The portion of the decline in value considered to be a credit loss (i.e., the difference between the present value of cash flows expected to be collected and the amortized cost basis of the security) is recognized in earnings. The portion of the decline in value not considered to be a credit loss (i.e., the difference in the present value of cash flows expected to be collected and the fair value of the security) is recognized in other comprehensive income.

Impairment assessments for structured securities, including mortgage-backed securities and asset-backed securities, collateralized debt obligations and corporate debt, are generally evaluated based on the performance of the underlying collateral under various economic and default scenarios that may involve subjective judgments and estimates by management. Modeling these securities involves various factors, such as projected default rates, the nature and realizable value of the collateral, if any, the ability of the issuer to make scheduled payments, historical performance and other relevant economic and performance factors. If an OTTI determination is made, a discounted cash flow analysis is used to ascertain the amount of the credit impairment.

The following table provides a summary of fixed maturity securities in an unrealized loss position as of September 30, 2017:

($ in thousands)	Number of Securities	Aggregate Fair Value		Gross Unrealized Loss
Unrealized loss less than 20% of amortized cost	592	$	3,864,164	$	40,565
Unrealized loss of 20% or greater of amortized cost:
Twelve months and longer	3	180		112
Total	595	$	3,864,344	$	40,677

A summary of the Company’s non-investment grade fixed maturity securities that were in an unrealized loss position at September 30, 2017 is presented in the table below:

($ in thousands)	Number of Securities	Aggregate Fair Value		Gross Unrealized Loss
Foreign government	9	$	55,292	$	462
Mortgage-backed securities	6	5,975		150
Corporate	3	2,852		211
Asset-backed securities	3	1,331		115
Total	21	$	65,450	$	938

The Company has evaluated its fixed maturity securities in an unrealized loss position and believes the unrealized loss is due primarily to temporary market and sector-related factors rather than to issuer-specific factors. None of these securities are delinquent or in default under financial covenants. Based on its assessment of these issuers, the Company expects them to continue to meet their contractual payment obligations as they become due and does not consider any of these securities to be OTTI.

Preferred Stocks– At September 30, 2017, there was one preferred stock in an unrealized loss position, with a fair value of $24.0 million and a gross unrealized loss of $1.7 million. Based upon management's view of the underlying value of the security, the Company does not consider the equity security to be OTTI. For the nine months ended September 30, 2017 and 2016, there was no OTTI for preferred stocks.

Common Stocks – At September 30, 2017, there were three common stocks in an unrealized loss position, with an aggregate fair value of $14.1 million and a gross unrealized loss of $3.5 million. Based upon management’s view of the underlying value of these securities, the Company does not consider these equity securities to be OTTI. There was no OTTI of common stocks for the nine months ended September 30, 2017. For the nine months ended September 30, 2016, OTTI for common stocks was $18.1 million.

33

Loans Receivable – The Company monitors the performance of its loans receivable, including current market conditions for each loan and the ability to collect principal and interest. For loans where the Company determines it is probable that the contractual terms will not be met, an analysis is performed and a valuation reserve is established, if necessary, with a charge to earnings. Loans receivable are reported net of a valuation reserve of $3 million at both September 30, 2017 and December 31, 2016.

The Company monitors the performance of its loans receivable and assesses the ability of each borrower to pay principal and interest based upon loan structure, underlying property values, cash flow and related financial and operating performance of the property and market conditions. Loans receivable with a potential for default are further assessed using discounted cash flow analysis and comparable cost and sales methodologies, if appropriate.

Fair Value Measurements.The Company’s fixed maturity and equity securities available for sale and its trading account securities are carried at fair value. Fair value is defined as “the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.” The Company utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for similar assets in active markets. Level 3 inputs are unobservable inputs for the asset or liability. Unobservable inputs may only be used to measure fair value to the extent that observable inputs are not available. The fair value of the vast majority of the Company’s portfolio is based on observable data (other than quoted prices) and, accordingly, is classified as Level 2.

In classifying particular financial securities in the fair value hierarchy, the Company uses its judgment to determine whether the market for a security is active and whether significant pricing inputs are observable. The Company determines the existence of an active market by assessing whether transactions occur with sufficient frequency and volume to provide reliable pricing information. The Company determines whether inputs are observable based on the use of such information by pricing services and external investment managers, the uninterrupted availability of such inputs, the need to make significant adjustments to such inputs and the volatility of such inputs over time. If the market for a security is determined to be inactive or if significant inputs used to price a security are determined to be unobservable, the security is categorized in Level 3 of the fair value hierarchy.

Because many fixed maturity securities do not trade on a daily basis, the Company utilizes pricing models and processes which may include benchmark curves, benchmarking of like securities, sector groupings and matrix pricing. Market inputs used to evaluate securities include benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data. Quoted prices are often unavailable for recently issued securities that are infrequently traded or securities that are only traded in private transactions. For publicly traded securities for which quoted prices are unavailable, the Company determines fair value based on independent broker quotations and other observable market data. For securities traded only in private negotiations, the Company determines fair value based primarily on the cost of such securities, which is adjusted to reflect prices of recent placements of securities of the same issuer, financial data, projections and business developments of the issuer and other relevant information.

The following is a summary of pricing sources for the Company's fixed maturity securities available for sale as of September 30, 2017:

($ in thousands)	Carrying Value		Percent of Total
Pricing source:
Independent pricing services	$	13,570,457	98.4	%
Syndicate manager	43,196		0.3
Directly by the Company based on:
Observable data	180,467		1.3
Cash flow model	174		—
Total	$	13,794,294	100.0	%

Independent pricing services – Substantially all of the Company’s fixed maturity securities available for sale were priced by independent pricing services (generally one U.S. pricing service plus additional pricing services with respect to a limited number of foreign securities held by the Company). The prices provided by the independent pricing services are generally based on observable market data in active markets (e.g., broker quotes and prices observed for comparable securities). The determination of whether markets are active or inactive is based upon the volume and level of activity for a particular asset class. The Company reviews the prices provided by pricing services for reasonableness based upon current trading levels for

34

similar securities. If the prices appear unusual to the Company, they are re-examined and the value is either confirmed or revised. In addition, the Company periodically performs independent price tests of a sample of securities to ensure proper valuation and to verify our understanding of how securities are priced. As of September 30, 2017, the Company did not make any adjustments to the prices provided by the pricing services. Based upon the Company’s review of the methodologies used by the independent pricing services, these securities were classified as Level 2.

Syndicate manager – The Company has a 15% participation in a Lloyd’s syndicate, and the Company’s share of the securities owned by the syndicate is priced by the syndicate’s manager. The majority of the securities are liquid, short duration fixed maturity securities. The Company reviews the syndicate manager’s pricing methodology and audited financial statements and holds discussions with the syndicate manager as necessary to confirm its understanding and agreement with security prices. Based upon the Company’s review of the methodologies used by the syndicate manager, these securities were classified as Level 2.

Observable data – If independent pricing is not available, the Company prices the securities directly. Prices are based on observable market data where available, including current trading levels for similar securities and non-binding quotations from brokers. The Company generally requests two or more quotes. If more than one quote is received, the Company sets a price within the range of quotes received based on its assessment of the credibility of the quote and its own evaluation of the security. The Company generally does not adjust quotes obtained from brokers. Since these securities were priced based on observable data, they were classified as Level 2.

Cash flow model – If the above methodologies are not available, the Company prices securities using a discounted cash flow model based upon assumptions as to prevailing credit spreads, interest rates and interest rate volatility, time to maturity and subordination levels. Discount rates are adjusted to reflect illiquidity where appropriate. These securities were classified as Level 3.

35

Results of Operations for the Nine Months Ended September 30,2017 and 2016

Business Segment Results

Following is a summary of gross and net premiums written, net premiums earned, loss ratios (losses and loss expenses incurred expressed as a percentage of premiums earned), expense ratios (underwriting expenses expressed as a percentage of premiums earned) and United States Generally Accepted Accounting Principles (“GAAP”) combined ratios (sum of loss ratio and expense ratio) for each of our business segments for the nine months ended September 30, 2017 and 2016. The GAAP combined ratio represents a measure of underwriting profitability, excluding investment income. A GAAP combined ratio in excess of 100 indicates an underwriting loss; a number below 100 indicates an underwriting profit.

($ in thousands)	2017			2016
Insurance:
Gross premiums written	$	5,233,692		$	5,184,033
Net premiums written	4,364,638			4,386,944
Net premiums earned	4,262,485			4,180,985
Loss ratio	61.7		%	61.1		%
Expense ratio	32.8		%	32.3		%
GAAP combined ratio	94.5		%	93.4		%
Reinsurance:
Gross premiums written	$	463,825		$	579,878
Net premiums written	417,634			526,712
Net premiums earned	457,759			492,087
Loss ratio	86.1		%	60.5		%
Expense ratio	37.1		%	39.1		%
GAAP combined ratio	123.2		%	99.6		%
Consolidated:
Gross premiums written	$	5,697,517		$	5,763,911
Net premiums written	4,782,272			4,913,656
Net premiums earned	4,720,244			4,673,072
Loss ratio	64.1		%	61.0		%
Expense ratio	33.2		%	33.1		%
GAAP combined ratio	97.3		%	94.1		%

Net Income to Common Stockholders. The following table presents the Company’s net income to common stockholders and net income per diluted share for the nine months ended September 30, 2017 and 2016:

(In thousands, except per share data)	2017		2016
Net income to common stockholders	$	394,505	$	449,127
Weighted average diluted shares	129,289		128,501
Net income per diluted share	$	3.05	$	3.50

The Company reported net income of $395 million in 2017 compared to $449 million in 2016. The 12% decrease in net income was primarily due to an after-tax decrease in underwriting income of $97 million mainly driven by increased catastrophe losses from Hurricanes Harvey, Irma and Maria, as well as two earthquakes in Mexico, an after-tax increase in net foreign currency losses of $17 million, and an after-tax decrease in income from non-insurance businesses of $7 million, partially offset by an increase in after-tax net investment gains of $57 million and an after-tax increase in investment income of $14 million. The number of weighted average diluted shares remained relatively unchanged for the nine months ended September 30, 2017 and 2016.

Premiums. Gross premiums written were $5,698 million in 2017, a decrease of 1% from $5,764 million in 2016. The decrease was due to a decrease in the Reinsurance segment of $116 million, partially offset by an increase in the Insurance segment of $50 million. Approximately 77.7% of policies expiring in 2017 were renewed, compared with a 77.8% renewal retention rate for policies expiring in 2016.

    Average renewal premium rates for insurance and facultative reinsurance increased 1.0% in 2017 when adjusted for change in exposures.

36

A summary of gross premiums written in 2017 compared with 2016 by line of business within each business segment follows:

• Insurance - gross premiums increased 1% to $5,234 million in 2017 from $5,184 million in 2016. Gross premiums increased $25 million (5%) for professional liability, $19 million (4%) for commercial auto, $8 million (1%) for workers' compensation, and $2 million (less than 1%) for short-tail lines and decreased $4 million (less than 1%) for other liability.

• Reinsurance - gross premiums decreased 20% to $464 million in 2017 from $580 million in 2016. Gross premiums decreased $87 million (35%) for property lines and $29 million (9%) for casualty lines.

Net premiums written were $4,782 million in 2017, a decrease of 3% from $4,914 million in 2016. Ceded reinsurance premiums as a percentage of gross written premiums were 16% in 2017 and 15% in 2016.

Premiums earned increased 1% to $4,720 million in 2017 from $4,673 million in 2016. Insurance premiums (including the impact of rate changes) are generally earned evenly over the policy term, and accordingly, recent rate increases will be earned over the upcoming quarters. Premiums earned in 2017 are related to business written during both 2017 and 2016. Audit premiums were $137 million in 2017 compared with $116 million in 2016.

Net investment Income. Following is a summary of net investment income for the nine months ended September 30, 2017 and 2016:

	Amount						Average Annualized Yield
($ in thousands)	2017			2016			2017		2016
Fixed maturity securities, including cash and cash equivalents and loans receivable	$	347,976		$	331,448		3.3	%	3.3	%
Investment funds	50,744			60,385			5.5		6.6
Arbitrage trading account	16,235			12,883			4.0		4.4
Real estate	14,894			4,552			1.6		0.6
Equity securities available for sale	1,845			3,217			1.2		2.2
Gross investment income	431,694			412,485			3.3		3.3
Investment expenses	(5,093		)	(7,635		)
Total	$	426,601		$	404,850		3.3	%	3.3	%

Net investment income increased 5% to $427 million in 2017 from $405 million in 2016 due primarily to a $16 million increase in income from fixed maturity securities, a $10 million increase from real estate, a $3 million increase from the arbitrage trading account, and a reduction of investment expenses of $3 million, partially offset by a $10 million decrease from investment funds. Average invested assets, at cost (including cash and cash equivalents), were $17.4 billion in 2017 and $16.6 billion in 2016.

Insurance Service Fees. The Company earns fees from an insurance distribution business and as a servicing carrier of workers' compensation assigned risk plans for certain states. Service fees decreased to $100 million in 2017 from $109 million in 2016.

Net Realized Gains on Investment Sales. The Company buys and sells securities and other investment assets on a regular basis in order to maximize its total return on investments. Decisions to sell securities and other investment assets are based on management’s view of the underlying fundamentals of specific investments as well as management’s expectations regarding interest rates, credit spreads, currency values and general economic conditions. Net realized gains on investment sales were $277 million in 2017 compared with $208 million in 2016. The nine months ended September 30, 2017 include a gain of $124 million from the sale of an investment in an office building located in Washington D.C. The nine months ended September 30, 2016 include a gain of $135 million from the sale of Aero Precision Industries and certain related aviation services business.

Other-Than-Temporary Impairments. There were no impairments in 2017. Other-than-temporary impairments of $18.1 million in 2016 related to common stocks.

Revenues from Non-Insurance Businesses. Revenues from non-insurance businesses were derived from businesses engaged in the distribution of promotional merchandise, world-wide textile solutions and aviation-related businesses that

37

provide services to aviation markets, including (i) the distribution, manufacturing, repair and overhaul of aircraft parts and components, (ii) the sale of new and used aircraft, and (iii) avionics, fuel, maintenance, storage and charter services. Revenues from non-insurance businesses were $225 million in 2017 and $306 million in 2016. The decrease was primarily related to the sale of Aero Precision Industries in August 2016, partially offset by revenues from the textile business purchased in March 2017.

Losses and Loss Expenses. Losses and loss expenses increased to $3,025 million in 2017 from $2,852 million in 2016. The consolidated loss ratio was 64.1% in 2017 and 61.0% in 2016. Catastrophe losses, net of reinsurance recoveries and reinstatement premiums, were $167 million in 2017 and $68 million in 2016. Hurricanes Harvey, Irma and Maria, along with two earthquakes in Mexico, resulted in catastrophe losses of $107 million. Favorable prior year reserve development (net of premium offsets) was $31 million in 2017 and $42 million in 2016. The loss ratio excluding catastrophe losses and prior year reserve development increased 0.8 points to 61.2% in 2017 from 60.4% in 2016.

A summary of loss ratios in 2017 compared with 2016 by business segment follows:

• Insurance - The loss ratio was 61.7% in 2017 and 61.1% in 2016. Catastrophe losses were $94 million in 2017 compared with $58 million in 2016. Favorable prior year reserve development was $62 million in 2017 and $38 million in 2016. The loss ratio excluding catastrophe losses and prior year reserve development increased 0.4 points to 61.0% in 2017 from 60.6% in 2016.

• Reinsurance - The loss ratio of 86.1% in 2017 was 25.6 points higherthan the loss ratio of 60.5% in 2016. Catastrophe losses were $73 million in 2017 compared with $10 million in 2016. Adverse prior year reserve development was $31 million in 2017 largely due to the impact of the change in the Ogden discount rate in the U.K. and adverse development related to the U.S. facultative casualty excess of loss business, compared with favorable prior year development of $4 million in 2016. The loss ratio excluding catastrophe losses and prior year reserve development increased 4.1points to 63.3% in 2017 from 59.2% in 2016.

Other Operating Costs and Expenses. Following is a summary of other operating costs and expenses:

($ in thousands)	2017		2016
Policy acquisition and operating insurance expenses	$	1,567,359	$	1,544,792
Insurance service expenses	97,308		103,868
Net foreign currency (gains) losses	14,255		(11,547		)
Other costs and expenses	142,233		133,337
Total	$	1,821,155	$	1,770,450

Policy acquisition and operating insurance expenses are comprised of commissions paid to agents and brokers, premium taxes and other assessments and internal underwriting costs. Policy acquisition and operating insurance expenses increased 1% compared with an increase in net premiums earned of 1%. The expense ratio (underwriting expenses expressed as a percentage of premiums earned) was 33.2% and 33.1% for the nine months ended September 30, 2017 and 2016, respectively.

Service expenses, which represent the costs associated with the fee-based businesses, decreased to $97 million in 2017 from $104 million in 2016.

Net foreign currency (gains) losses result from transactions denominated in a currency other than a company's operating functional currency. Net foreign currency losses were $14 million in 2017 compared to gains of $12 million in 2016.

Other costs and expenses represent general and administrative expenses of the parent company and other expenses not allocated to business segments, including the cost of certain long-term incentive plans and new business ventures. Other costs and expenses increased to $142 million in 2017 from $133 million in 2016 primarily because of startup costs for new business ventures.

Expenses from Non-Insurance Businesses. Expenses from non-insurance businesses represent costs associated with businesses engaged in the distribution of promotional merchandise, world-wide textile solutions and aviation-related businesses that include (i) cost of goods sold related to aircraft and products sold and services provided, and (ii) general and administrative expenses. Expenses from non-insurance businesses were $221 million in 2017 compared to $291 million in 2016. The decline mainly relates to the sale of Aero Precision Industries in August 2016, partially offset by the expense from the textile business purchased in March 2017.

38

Interest Expense. Interest expense was $110 million in 2017 compared with $104 million in 2016. During 2017, the Company repaid $2 million of debt compared to $83 million in 2016, mainly in connection with the sale of Aero Precision Industries. In February 2016, the Company issued $110 million of 5.9% subordinated debentures maturing in 2056, and in May 2016, the Company issued $290 million of 5.75% subordinated debentures maturing in 2056.

Income Taxes. The effective income tax rate was 31% in 2017 and 32% in 2016. The effective income tax rate differs from the federal income tax rate of 35% primarily because of tax-exempt investment income.

The Company has not provided U.S. deferred income taxes on the undistributed earnings of approximately $40 million of its non-U.S. subsidiaries since these earnings are intended to be permanently reinvested in the non-U.S. subsidiaries. However, in the future, if such earnings were distributed to the Company, taxes of approximately $4 million, assuming all tax credits are realized, would be payable on such undistributed earnings and would be reflected in the tax provision for the year in which these earnings are no longer intended to be permanently reinvested in the foreign subsidiary.

Results of Operations for the Three Months Ended September 30,2017 and 2016

Business Segment Results

Following is a summary of gross and net premiums written, net premiums earned, loss ratios (losses and loss expenses incurred expressed as a percentage of premiums earned), expense ratios (underwriting expenses expressed as a percentage of premiums earned) and United States Generally Accepted Accounting Principles (“GAAP”) combined ratios (sum of loss ratio and expense ratio) for each of our business segments for the three months ended September 30, 2017 and 2016. The GAAP combined ratio represents a measure of underwriting profitability, excluding investment income. A GAAP combined ratio in excess of 100 indicates an underwriting loss; a number below 100 indicates an underwriting profit.

($ in thousands)	2017			2016
Insurance:
Gross premiums written	$	1,718,552		$	1,688,712
Net premiums written	1,432,334			1,443,986
Net premiums earned	1,433,729			1,423,635
Loss ratio	63.2		%	60.9		%
Expense ratio	32.4		%	32.3		%
GAAP combined ratio	95.6		%	93.2		%
Reinsurance:
Gross premiums written	$	155,606		$	180,137
Net premiums written	138,849			163,379
Net premiums earned	147,771			162,309
Loss ratio	118.7		%	61.3		%
Expense ratio	34.9		%	38.9		%
GAAP combined ratio	153.6		%	100.2		%
Consolidated:
Gross premiums written	$	1,874,158		$	1,868,849
Net premiums written	1,571,183			1,607,365
Net premiums earned	1,581,500			1,585,944
Loss ratio	68.4		%	60.9		%
Expense ratio	32.6		%	33.0		%
GAAP combined ratio	101.0		%	93.9		%

Net Income to Common Stockholders. The following table presents the Company’s net income to common stockholders and net income per diluted share for the three months ended September 30, 2017 and 2016:

(in thousands, except per share data)	2017		2016
Net income to common stockholders	$	162,054	$	220,650
Weighted average diluted shares	128,944		128,556
Net income per diluted share	$	1.26	$	1.72

The Company reported net income of $162 million in 2017 compared to$221 million in 2016. The 27% decrease in net income was primarily due to an after-tax decrease in underwriting income of $73 million mainly driven by increased catastrophe losses from Hurricanes Harvey, Irma and Maria, as well as two earthquakes in Mexico, partially offset by an $11

39

million benefit related to stock compensation tax benefits being recognized within income tax expense starting in 2017 and an after-tax increase in net investment gains of $5 million. The number of weighted average diluted shares remained relatively unchanged for the three months ended September 30, 2017 and 2016.

Premiums. Gross premiums written were $1,874 million in 2017, an increase of less than 1% from $1,869 million in 2016. Approximately 77.5% of policies expiring in 2017 were renewed, compared with a 77.7% renewal retention rate for policies expiring in 2016.

Average renewal premium rates for insurance and facultative reinsurance increased 0.7% in 2017 when adjusted for change in exposures.

     A summary of gross premiums written in 2017 compared with 2016 by line of business within each business segment follows:

• Insurance - gross premiums increased 2% to $1,719 million in 2017 from $1,689 million in 2016. Gross premiums increased $13 million (3%) for short tail lines, $12 million (3%) for workers' compensation, $6 million (3%) for commercial auto and $4 million (2%) for professional liability and decreased $5 million (1%) for other liability.

• Reinsurance - gross premiums decreased 14% to $156 million in 2017 from $180 million in 2016. Gross premiums decreased $26 million (34%) for property lines and increased $2 million (2%) for casualty lines.

Net premiums written were $1,571 million in 2017, a decrease of 2% from $1,607 million in 2016. Ceded reinsurance premiums as a percentage of gross written premiums were 16% in 2017 and 14% in 2016.

Premiums earned decreased less than 1% to $1,582 million in 2017 from $1,586 million in 2016. Insurance premiums (including the impact of rate changes) are generally earned evenly over the policy term. Premiums earned in 2017 are related to business written during both 2017 and 2016. Audit premiums were $46 million in 2017 compared with $35 million in 2016.

Net Investment Income. Following is a summary of net investment income for the three months ended September 30, 2017 and 2016:

	Amount						Average Annualized Yield
($ in thousands)	2017			2016			2017		2016
Fixed maturity securities, including cash and cash equivalents and loans receivable	$	118,834		$	114,271		3.4	%	3.3	%
Investment funds	15,200			25,293			5.2		8.1
Arbitrage trading account	4,418			6,441			3.5		5.6
Real estate	5,042			585			1.5		0.2
Equity securities available for sale	604			1,069			1.2		2.0
Gross investment income	144,098			147,659			3.3		3.5
Investment expenses	(1,619		)	(1,991		)
Total	$	142,479		$	145,668		3.2	%	3.4	%

Net investment income decreased 2% to $142 million in 2017 from $146 million in 2016 due primarily to a $10 million decrease from investment funds and a $2 million decrease from the arbitrage trading account, partially offset by a $4 million increase from fixed maturity securities and an increase of $4 million in income from real estate. Average invested assets, at cost (including cash and cash equivalents), were $17.6 billion in 2017 up from $17.0 billion in 2016.

Insurance Service Fees. The Company earns fees from an insurance distribution business and as a servicing carrier of workers' compensation assigned risk plans for certain states. Service fees increasedto $34 million in 2017 from $32 million in 2016.

Net Realized Gains on Investment Sales. The Company buys and sells securities and other investment assets on a regular basis in order to maximize its total return on investments. Decisions to sell securities and other investment assets are based on management’s view of the underlying fundamentals of specific investments as well as management’s expectations regarding interest rates, credit spreads, currency values and general economic conditions. Net realized gains on investment sales were $184 million in 2017 compared with $176 million in 2016. The three months ended September 30, 2017 include a gain of $124 million from the sale of an investment in an office building located in Washington D.C. The three months ended

40

September 30, 2016 include a gain of $135 million from the sale of Aero Precision Industries and certain related aviation services business.

Other-Than-Temporary Impairments. There were no other-than-temporary impairments during the three months ended September 30, 2017 and 2016.

Revenues from Non-Insurance Businesses. Revenues from non-insurance businesses were derived from businesses engaged in the distribution of promotional merchandise, world-wide textile solutions and aviation-related businesses that provide services to aviation markets, including (i) the distribution, manufacturing, repair and overhaul of aircraft parts and components, (ii) the sale of new and used aircraft, and (iii) avionics, fuel, maintenance, storage and charter services. Revenues from non-insurance businesses were $90 million in 2017 and $80 million in 2016. The increase was primarily related to the textile business purchased in March 2017.

Losses and Loss Expenses. Losses and loss expenses increased to $1,081 million in 2017 from $966 million in 2016. The consolidated loss ratio was 68.4% in 2017 and 60.9% in 2016. Catastrophe losses, net of reinsurance recoveries and reinstatement premiums, were $119 million in 2017 and $12 million in 2016. Hurricanes Harvey, Irma and Maria, along with two earthquakes in Mexico, resulted in catastrophe losses of $107 million. Favorable prior year reserve development (net of premium offsets) was $7 million in 2017 and $13 million in 2016. The loss ratio, excluding catastrophe losses and prior year reserve development, increased 0.4 points to 61.3% in 2017 from 60.9% in 2016.

A summary of loss ratios in 2017 compared with 2016 by business segment follows:

• Insurance - The loss ratio of 63.2% in 2017 was 2.3 points higher than the loss ratio of 60.9% in 2016. Catastrophe losses were $47 million in 2017 and $9 million in 2016. Favorable prior year reserve development was $13 million in both 2017 and 2016. The loss ratio, excluding catastrophe losses and prior year reserve development, decreased 0.4 points to 60.8% in 2017 from 61.2% in 2016.

• Reinsurance - The loss ratio of 118.7% in 2017 was 57.4 points higher than the loss ratio of 61.3% in 2016. Catastrophe losses were $72 million in 2017 compared with $3 million in 2016. Adverse prior year reserve development was $6 million in 2017 compared with favorable prior year reserve development of $0.2 million in 2016. The loss ratio, excluding catastrophe losses and prior year reserve development, increased 6.9 points to 66.1% in 2017 from 59.2% in 2016 largely due to increased attritional losses.

Other Operating Costs and Expenses. Following is a summary of other operating costs and expenses:

(In thousands)	2017		2016
Policy acquisition and operating insurance expenses	$	516,243	$	523,254
Insurance service expenses	32,451		32,441
Net foreign currency (gains) losses	1,779		(2,193		)
Other costs and expenses	50,349		52,846
Total	$	600,822	$	606,348

Policy acquisition and operating insurance expenses are comprised of commissions paid to agents and brokers, premium taxes and other assessments and internal underwriting costs. Policy acquisition and operating insurance expenses decreased 1% compared with a decrease in net premiums earned of less than 1%. The expense ratio (underwriting expenses expressed as a percentage of premiums earned) decreased to 32.6% from 33.0% in 2016.

Service expenses, which represent the costs associated with the fee-based businesses, remained flat at $32 million for 2017 and 2016.

Net foreign currency (gains) losses result from transactions denominated in a currency other than a company's operating functional currency. Net foreign currency losses were $2 million in 2017 compared to gains of $2 million in 2016.

Other costs and expenses represent general and administrative expenses of the parent company and other expenses not allocated to business segments, including the cost of certain long-term incentive plans and new business ventures. Other costs and expenses decreased to $50 million in 2017 from $53 million in 2016.

Expenses from Non-Insurance Businesses. Expenses from non-insurance businesses represent costs associated with businesses engaged in the distribution of promotional merchandise, world-wide textile solutions and aviation-related businesses that include (i) cost of goods sold related to aircraft and products sold and services provided, and (ii) general and administrative

41

expenses. Expenses from non-insurance businesses were $86 million in 2017 compared to $79 million in 2016. The increase was primarily related to the textile business purchased in March 2017.

Interest Expense. Interest expense was $37 million in both 2017 and 2016. During 2017, the Company repaid $2 million of debt compared to $83 million in 2016, mainly in connection with the sale of Aero Precision Industries.

Income Taxes. The effective income tax rate was 28% in 2017 and 33% in 2016. The effective income tax rate differs from the federal income tax rate of 35% primarily because of tax-exempt investment income, as well as the new requirement in 2017 to recognize tax benefits for stock compensation in income tax expense.

The Company has not provided U.S. deferred income taxes on the undistributed earnings of approximately $40 million of its non-U.S. subsidiaries since these earnings are intended to be permanently reinvested in the non-U.S. subsidiaries. However, in the future, if such earnings were distributed to the Company, taxes of approximately $4 million, assuming all tax credits are realized, would be payable on such undistributed earnings and would be reflected in the tax provision for the year in which these earnings are no longer intended to be permanently reinvested in the foreign subsidiary.

42

Investments

As part of its investment strategy, the Company establishes a level of cash and highly liquid short-term and intermediate-term securities that, combined with expected cash flow, it believes is adequate to meet its payment obligations. Due to the historically low fixed maturity investment returns, the Company invests in equity securities, merger arbitrage securities, investment funds, private equity, loans and real estate related assets. The Company's investments in investment funds and its other alternative investments have experienced, and the Company expects to continue to experience, greater fluctuations in investment income.

The Company also attempts to maintain an appropriate relationship between the average duration of the investment portfolio and the approximate duration of its liabilities (i.e., policy claims and debt obligations). The average duration of the fixed maturity portfolio, including cash and cash equivalents, was 2.9 years at September 30, 2017, down from 3.1 years at December 31, 2016. The Company’s fixed maturity investment portfolio and investment-related assets as of September 30, 2017 were as follows:

($ in thousands)	Carrying Value		Percent of Total
Fixed maturity securities:
U.S. government and government agency	$	411,605	2.2	%
State and municipal:
Special revenue	2,829,795		15.4
State general obligation	537,537		2.9
Local general obligation	415,635		2.3
Corporate backed	391,627		2.1
Pre-refunded (1)	303,947		1.8
Total state and municipal	4,478,541		24.4
Mortgage-backed securities:
Agency	832,993		4.5
Commercial	251,578		1.4
Residential-Prime	226,274		1.2
Residential-Alt A	23,298		0.2
Total mortgage-backed securities	1,334,143		7.2
Asset-backed securities	2,388,618		13.0
Corporate:
Industrial	2,636,885		14.4
Financial	1,374,021		7.5
Utilities	267,331		1.5
Other	42,137		0.2
Total corporate	4,320,374		23.6
Foreign government and foreign government agencies	940,409		5.1
Total fixed maturity securities	13,873,690		75.7
Equity securities available for sale:
Common stocks	419,520		2.3
Preferred stocks	194,505		1.1
Total equity securities available for sale	614,025		3.4
Real estate	1,391,274		7.5
Investment funds	1,119,907		6.0
Cash and cash equivalents	773,997		4.2
Arbitrage trading account	488,238		2.7
Loans receivable	74,229		0.5
Total investments	$	18,335,360	100.0	%

________________________

(1) Pre-refunded securities are securities for which an escrow account has been established to fund the remaining payments of principal and interest through maturity. Such escrow accounts are funded almost exclusively with U.S. Treasury and U.S. government agency securities.

Fixed Maturity Securities. The Company’s investment policy with respect to fixed maturity securities is generally to purchase instruments with the expectation of holding them to their maturity. However, management of the available for sale

43

portfolio is considered necessary to maintain an approximate matching of assets and liabilities as well as to adjust the portfolio as a result of changes in financial market conditions and tax considerations.

The Company’s philosophy related to holding or selling fixed maturity securities is based on its objective of maximizing total return. The key factors that management considers in its investment decisions as to whether to hold or sell fixed maturity securities are its view of the underlying fundamentals of specific securities as well as its expectations regarding interest rates, credit spreads and currency values. In a period in which management expects interest rates to rise, the Company may sell longer duration securities in order to mitigate the impact of an interest rate rise on the fair value of the portfolio. Similarly, in a period in which management expects credit spreads to widen, the Company may sell lower quality securities, and in a period in which management expects certain foreign currencies to decline in value, the Company may sell securities denominated in those foreign currencies. The sale of fixed maturity securities in order to achieve the objective of maximizing total return may result in realized gains; however, there is no reason to expect these gains to continue in future periods.

At September 30, 2017, investments in foreign government fixed maturity securities (which are generally held by the Company's foreign operations) were as follows:

(In thousands)	Carrying Value
Argentina	$	259,720
Australia	217,397
Canada	175,816
United Kingdom	84,894
Brazil	53,547
Germany	48,794
Supranational (1)	40,591
Singapore	25,326
Norway	9,930
Mexico	9,490
Colombia	7,696
Uruguay	7,208
Total	$	940,409

________

(1) Supranational represents investments in the North American Development Bank, European Investment Bank and International Bank for Reconstruction and Development.

Equity Securities. Equity securities primarily represent investments in common and preferred stocks in companies with potential growth opportunities in different sectors, including healthcare and financial institutions.

Investment Funds. At September 30, 2017, the carrying value of investment funds was $1,120 million, including investments in real estate funds of $615 million, energy funds of $86 million, and other funds of $419 million. Investment funds are generally reported on a one-quarter lag.

Real Estate. Real estate is directly owned property held for investment. At September 30, 2017, real estate properties in operation included a long-term ground lease in Washington, D.C., a hotel in Memphis, Tennessee, an office complex in New York City and office buildings in West Palm Beach and Palm Beach, Florida. In addition, there are two properties under development: an office building in London and a mixed-use project in Washington, D.C. The Company expects to fund further development costs for these projects with a combination of its own funds and external financing.

Arbitrage Trading Account. The arbitrage trading account is comprised of direct investments in arbitrage securities. Merger arbitrage is the business of investing in the securities of publicly held companies that are the targets in announced tender offers and mergers.

Loans Receivable. Loans receivable, which are carried at amortized cost, had an aggregate cost of $74 million and an aggregate fair value of $77 million at September 30, 2017. The amortized cost of loans receivable is net of a valuation allowance of $3 million as of September 30, 2017. Loans receivable include real estate loans of $59 million that are secured by commercial real estate located primarily in New York. Real estate loans receivable generally earn interest at floating LIBOR-based interest rates and have maturities (inclusive of extension options) through August 2025. Loans receivable include commercial loans of $15 million that are secured by business assets and have fixed interest rates with varying maturities not exceeding 10 years.

44

Market Risk. The fair value of the Company’s investments is subject to risks of fluctuations in credit quality and interest rates. The Company uses various models and stress test scenarios to monitor and manage interest rate risk. The Company attempts to manage its interest rate risk by maintaining an appropriate relationship between the effective duration of the investment portfolio and the approximate duration of its liabilities (i.e., policy claims and debt obligations). The effective duration for the fixed maturity portfolio (including cash and cash equivalents) was 2.9 years at September 30, 2017, down from 3.1 years at December 31, 2016.

In addition, the fair value of the Company’s international investments is subject to currency risk. The Company attempts to manage its currency risk by matching its foreign currency assets and liabilities where considered appropriate.

45

Liquidity and Capital Resources

Cash Flow. Cash flow provided from operating activitiesdecreasedto $522 million in the first nine months of 2017 from $727 million in the comparable period in 2016, primarily due to the timing of loss and loss expense payments and payments to taxing authorities.

The Company's insurance subsidiaries' principal sources of cash are premiums, investment income, service fees and proceeds from sales and maturities of portfolio investments. The principal uses of cash are payments for claims, taxes, operating expenses and dividends. The Company expects its insurance subsidiaries to fund the payment of losses with cash received from premiums, investment income and fees. The Company targets an average duration for its investment portfolio that is within one year of the average duration of its liabilities so that portions of its investment portfolio mature throughout the claim cycle and are available for the payment of claims if necessary. In the event operating cash flow and proceeds from maturities and prepayments of fixed income securities are not sufficient to fund claim payments and other cash requirements, the remainder of the Company's cash and investments is available to pay claims and other obligations as they become due. The Company's investment portfolio is highly liquid, with approximately 80% invested in cash, cash equivalents and marketable fixed maturity securities as of September 30, 2017. If the sale of fixed maturity securities were to become necessary, a realized gain or loss equal to the difference between the cost and sales price of securities sold would be recognized.

Debt. At September 30, 2017, the Company had senior notes, subordinated debentures and other debt outstanding with a carrying value of $2,488 million and a face amount of $2,521 million. The maturities of the outstanding debt are $442 million in 2019, $302 million in 2020, $427 million in 2022, $250 million in 2037, $350 million in 2044, $350 million in 2053 and $400 million in 2056.

In February 2016, the Company issued $110 million aggregate principal amount of its 5.9% subordinated debentures due 2056, and in May 2016, the Company issued $290 million aggregate principal amount of its 5.75% subordinated debentures due 2056. During 2017, the Company repaid $2 million of debt compared to $83 million of debt in 2016 mainly in connection with the sale of Areo Precision Industries.

Equity. At September 30, 2017, total common stockholders’ equity was $5.4 billion, common shares outstanding were 121,769,109 and stockholders’ equity per outstanding share was $44.60. The Company repurchased 441,119 common shares for $28.4 million during the three months ended September 30, 2017. The number of common shares outstanding excludes shares held in a grantor trust established by the Company for delivery upon settlement of vested but mandatorily deferred RSUs.

Total Capital.Total capitalization (equity, debt and subordinated debentures) was $7.9 billion at September 30, 2017. The percentage of the Company’s capital attributable to senior notes, subordinated debentures and other debt was 31% at September 30, 2017 and 33% at December 31, 2016.

Item 3.Quantitative and Qualitative Disclosure About Market Risk

Reference is made to the information under “Investments - Market Risk” under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this Form 10-Q.

Item 4.Controls and Procedures

Disclosure Controls and Procedures. The Company’s management, including its Chief Executive Officer and Chief Financial Officer, has conducted an evaluation of the effectiveness of the Company’s disclosure controls and procedures pursuant to Securities Exchange Act Rule 13a-14 as of the end of the period covered by this quarterly report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company has in place effective controls and procedures designed to ensure that information required to be disclosed by the Company in the reports it files or submits under the Securities Exchange Act of 1934, as amended, and the rules thereunder, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms.

Changes in Internal Control over Financial Reporting. During the quarter ended September 30, 2017, there were no changes in the Company’s internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II — OTHER INFORMATION

Item 1.Legal Proceedings

Please see Note 21 to the notes to the interim consolidated financial statements.

46

Item 1A.Risk Factors

There have been no material changes from the risk factors previously disclosed in the Company's annual report on From 10-K for the fiscal year ended December 31, 2016.

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds

Set forth below is a summary of the shares repurchased by the Company during the three months ended September 30, 2017 and the number of shares remaining authorized for purchase by the Company:

	Total number of shares purchased	Average price paid per share		Total number of shares purchased as part of publicly announced plans or programs	Maximum number of shares that may yet be purchased under the plans or programs
July 2017	—	—		—	6,851,086
August 2017	—	—		—	10,000,000 (1)
September 2017	441,119	$	64.333	441,119	9,558,881

⁽¹⁾ The Company's repurchase authorization was increased to 10,000,000 shares on August 8, 2017.

Item 6.Exhibits

Number
(10.1)	Form of 2017 Performance-Based Restricted Stock Unit Agreement Under the W. R. Berkley Corporation 2012 Stock Incentive Plan
(31.1)	Certification of the Chief Executive Officer pursuant to Rule 13a-14(a)/ 15d-14(a).
(31.2)	Certification of the Chief Financial Officer pursuant to Rule 13a-14(a)/ 15d-14(a).
(32.1)	Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

47

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

		W. R. BERKLEY CORPORATION
Date:	November 8, 2017	/s/ W. Robert Berkley, Jr.
		W. Robert Berkley, Jr.
		President and Chief Executive Officer
Date:	November 8, 2017	/s/ Richard M. Baio
		Richard M. Baio
		Senior Vice President - Chief Financial Officer and Treasurer

48

EX-10.1

L12
PERF

PERFORMANCE-BASED RESTRICTED STOCK UNIT AGREEMENT

Under the W. R. Berkley Corporation 2012 Stock Incentive Plan

as Amended and Restated Effective June 2, 2015

THIS AGREEMENT, dated as of August 15, 2017, by and between W. R. BERKLEY CORPORATION, a Delaware corporation (the “Company”), and grantee as set forth on Exhibit A hereto (the “Grantee”). Important jurisdiction-specific modifications to this Agreement are contained in Exhibit B hereto and are incorporated herein by reference.

WITNESSETH:

WHEREAS, the Grantee is an employee of the Company or subsidiary thereof, and the Company wishes to grant the Grantee a notional interest in shares of the Company’s common stock, par value $0.20 per share (the “Stock”), in the form of restricted stock units, subject to certain restrictions and on the terms and conditions set forth herein; and

WHEREAS, through the grant of these restricted stock units, the Company hopes to incentivize and retain the services of Grantee and encourage stock ownership by Grantee in order to give Grantee a proprietary interest in the Company’s success and align Grantee’s interest with those of the stockholders of the Company; and

WHEREAS, the Restricted Stock Units (as defined below) awarded Grantee hereunder vest based on the Company’s performance during the applicable Performance Period (as defined below), however, the issuance of the Stock after vesting is generally deferred until ninety (90) days following Grantee’s “separation from service” (as such term is used in Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”)); and

WHEREAS, the Company and Grantee recognize that if Grantee engages in certain activities during or, in certain instances, following the termination of Grantee’s employment with the Company (the “Competitive Actions” or “Misconduct” as defined in Section 3 below), Grantee’s interests are no longer aligned with the interests of the Company and Grantee will no longer be entitled to retain certain benefits of the grants made herein.

NOW, THEREFORE, in consideration of the covenants and agreements herein contained, the parties hereto hereby agree as follows:

SECTION 1.Grant of Restricted Stock Units. As of the date hereof, subject to the terms and conditions of this Agreement and the W. R. Berkley Corporation 2012 Stock Incentive Plan, as amended and restated effective June 2, 2015 (the “Plan”), the Company hereby grants to the Grantee the targeted number of restricted stock units set forth on Exhibit A hereto (the restricted stock units granted or earned hereunder are hereafter referred to as the “Restricted Stock Units”). A portion of the Restricted Stock Units shall be designated as Tranche 1 Restricted Stock Units, Tranche 2 Restricted Stock Units and Tranche 3 Restricted Stock Units, as set forth on Exhibit A. The number of Restricted Stock Units granted represents the number of Restricted Stock Units that would be earned if the Company were to achieve the target level of

- 1 -

ROE Relative Performance for each of the Performance Periods. The number of Restricted Stock Units earned respectively, if any, is subject to increase or decrease based on the Company’s actual ROE Relative Performance and may range from 0% to 110% of the Restricted Stock Units. Each Restricted Stock Unit shall represent the right to receive one share of Stock subject to the terms and conditions set forth herein. Capitalized terms not defined herein, including Section 21, shall have the meaning ascribed to them in the Plan. This grant shall be administered by the Compensation Committee (the “Committee”) of the Board of Directors of the Company (the “Board”).

SECTION 2.Non‑Transferability. Except as specifically consented to by the Committee, the Grantee may not sell, transfer, pledge, or otherwise encumber or dispose of the Restricted Stock Units other than by will, the laws of descent and distribution, or as otherwise provided for in the Plan.

SECTION 3.Vesting; Forfeiture; Recapture; Other Remedies.

(a)Following the completion of each Performance Period, the Committee shall determine for such Performance Period, the Average Return on Equity, the ROE Relative Performance, the ROE Relative Performance Vesting Percentage and, respectively, the portion of the Tranche 1 Restricted Stock Units, Tranche 2 Restricted Stock Units and Tranche 3 Restricted Stock Units, as applicable, that have become earned (determined by multiplying the number of Restricted Stock Units subject to the applicable tranche by the ROE Relative Performance Vesting Percentage). Immediately following the Committee’s determination of the number of earned Tranche 1 Restricted Stock Units, Tranche 2 Restricted Stock Units and Tranche 3 Restricted Stock Units for a respective Performance Period, the earned Restricted Stock Units shall vest as of the last day of the applicable Performance Period (subject to forfeiture, as set forth in Section 3(d) below), provided the Grantee has remained continuously employed by the Company from the date hereof through the completion of the applicable Performance Period. Restricted Stock Units granted herein which have not become vested Restricted Stock Units following the completion of the applicable Performance Period or otherwise vested shall be immediately forfeited without payment of any consideration and the Grantee shall have no further rights with respect to such Restricted Stock Units.

(b)In the event that Grantee’s employment with the Company is terminated for any reason, all unvested Restricted Stock Units (except for those that vest immediately upon termination as provided in Sections 3(c) and 3(h) below) shall be forfeited, and the Grantee shall have no further rights with respect to such Restricted Stock Units. For purposes of this Agreement, Grantee’s employment will be considered terminated as of the date Grantee is no longer actively providing services to the Company (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Grantee is employed or the terms of Grantee’s employment agreement, if any), and unless otherwise expressly provided in this Agreement or determined by the Company, Grantee’s right to continue to vest in the Restricted Stock Units granted hereunder, if any, will terminate as of such date and will not be extended by any notice period arising under local law or contract. However, Grantee’s period of service would not include any contractual notice period (except for such period of time Grantee is actively providing substantial services during any notice period as

- 2 -

required by the Company) or any period of “garden leave” or similar period arising under employment laws in the jurisdictions where Grantee is employed or the terms of Grantee’s employment agreement, if any.

(c)In the event the Grantee’s employment with the Company is terminated on account of death or Disability prior to the completion of the applicable Performance Period, the number of earned Restricted Stock Units for any incomplete Performance Period (including, for the avoidance of doubt, any Performance Period that has yet to commence as of the date of such termination) shall be immediately determined assuming the Company achieved the target level of ROE Relative Performance for such Performance Period and the number of earned Tranche 1 Restricted Stock Units, earned Tranche 2 Restricted Stock Units and earned Tranche 3 Restricted Stock Units that become vested shall be determined by multiplying the number of earned Restricted Stock Units by a fraction, the numerator of which is the number of days the Grantee served as an employee from the date of this Agreement to the date of such termination and the denominator of which is 1,095 with respect to the Tranche 1 Restricted Stock Units, 1,460 with respect to the Tranche 2 Restricted Stock Units and 1,825 with respect to the Tranche 3 Restricted Stock Units.

(d)The Restricted Stock Units granted hereunder shall be subject to the following forfeiture, recapture and other remedial provisions as provided below:

a. In the event that the Committee determines that the Grantee, prior to the Vesting Date during Grantee’s employment, has engaged in a Competitive Action or enters into, or has entered into, an agreement (written, oral or otherwise) to engage in a Competitive Action or has engaged in Misconduct, all of the unvested Restricted Stock Units granted hereunder shall be immediately forfeited, and the Grantee shall have no further rights with respect to such Restricted Stock Units.

b. In the event that the Committee determines that the Grantee, (1) on or after the Vesting Date during Grantee’s employment or within one year following Grantee’s termination of employment for any reason, has engaged in a Competitive Action or has entered into an agreement (written, oral or otherwise) to engage in a Competitive Action, or (2) on or after the Vesting Date, has engaged in Misconduct, or prior to the Vesting Date Grantee has engaged in Misconduct that is not discovered or acted upon by the Company until on or after the Vesting Date, (x) the Grantee shall immediately forfeit all shares of Stock not yet delivered to Grantee with respect to the Restricted Stock Units and all rights to future payments of Dividend Equivalents (as defined below), and (y) the Grantee shall pay to the Company, upon demand by the Company, an amount equal to (i) the value, as of the Settlement Date (as defined below), of the number of shares of Stock delivered to the Grantee with respect to the Restricted Stock Units, (ii) all amounts paid to Grantee on or at any time prior to the Settlement Date in respect of Dividend Equivalents, and (iii) the value of all dividends, if any, paid to the Grantee in respect of the shares of Stock delivered to the Grantee on the Settlement Date. The Grantee

- 3 -

may satisfy the payment obligation to the Company of the portion due under (i) above by returning the shares delivered to the Grantee on the Settlement Date, provided that any amounts due under (ii) and (iii) above must be remitted to the Company in addition to the return of the shares.

C. Grantee acknowledges that engaging in (1) a Competitive Action during the Restricted Period within the geographic areas set forth in Section 3(e) below or (2) Misconduct is contrary to the interests of the Company and would result in irreparable injuries to the Company and would cause loss in an amount that cannot be readily quantified. Grantee acknowledges that retaining the amounts required to be paid to the Company pursuant to this Section 3(d) once Grantee has (x) chosen to engage in or to agree to engage in a Competitive Action or (y) engaged in Misconduct is contrary to the interests of the Company. The amounts forfeited or paid to the Company hereunder do not and are not intended to constitute actual or liquidated damages. Any action or inaction by the Company with respect to enforcing the forfeiture or recapture provisions set forth herein shall not reduce, eliminate or in any way affect the Company’s right to enforce the forfeiture or recapture provisions in any other agreement with Grantee.

D. The term “Restricted Period” as used herein shall mean the period beginning on the date hereof and ending one year following Grantee’s termination of employment for any reason.

E. Furthermore, if the Grantee engages in Misconduct or a Competitive Action or has entered into an agreement (written, oral or otherwise) to engage in a Competitive Action during the Restricted Period, then the Company shall be entitled to, and reserves the right to, pursue any other legal or equitable remedies in addition to the right to receive forfeitures and/or payments pursuant to this Section 3(d), including, but not limited to, the recovery of monetary damages resulting from such action set forth in Section 3(e) and injunctive relief.

(e)For purposes of this Agreement, the Grantee has engaged in a “Competitive Action” if, either directly or indirectly, and whether as an employee, consultant, independent contractor, partner, joint venturer or otherwise, the Grantee (i) who was employed by W. R. Berkley Corporation, engages in or directs any business activities, except those which are ministerial or clerical in nature, which are competitive with any business activities conducted by the Company, in or directed into any geographical area (x) where Grantee had responsibilities on behalf of the Company or about which Grantee received Confidential Information (defined below) and (y) in which the Company is engaged in business at the relevant time of enforcement, (ii) who was employed by, or previously employed by, a subsidiary or subsidiaries of the Company, engages in or directs any business activities, except those which are ministerial or clerical in nature, which are competitive with any business activities conducted by such subsidiary or subsidiaries, in or directed into any geographical area (x) where Grantee had responsibilities on behalf of such subsidiary or subsidiaries or about which Grantee received

- 4 -

Confidential Information and (y) in which the subsidiary/subsidiaries is or are engaged in business at the relevant time of enforcement, (iii) on behalf of any person or entity engaged in business activities competitive with the business activities of the Company, solicits or induces, or in any manner attempts to solicit or induce, any person employed by, or as an agent or producer of, the Company to terminate such person’s employment, agency or producer relationship, as the case may be, with the Company, (iv) diverts, or attempts to divert, any Covered Business Partner (defined below) from doing business with the Company or attempts to induce any Covered Business Partner to cease being a customer of the Company, (v) solicits a Covered Business Partner to do business with a competitor or prospective competitor of the Company or (vi) makes use of, or attempts to make use of, the Company’s property or Confidential Information, other than in the course of the performance of services to the Company or at the direction of the Company. The determination as to whether the Grantee has engaged in a Competitive Action shall be made by the Committee in its sole and absolute discretion. The Committee has sole and absolute discretion to determine whether, notwithstanding its determination that Grantee has engaged in a Competitive Action, recapture or forfeiture as provided herein shall not occur. The Committee’s exercise or nonexercise of its discretion with respect to any particular event or occurrence by or with respect to the Grantee or any other recipient of restricted stock units shall not in any way reduce or eliminate the authority of the Committee to (i) determine that any event or occurrence by or with respect to the Grantee constitutes engaging in a Competitive Action or (ii) determine the related Competitive Action date.

(f)For purposes of this Agreement, the Grantee has engaged in “Misconduct” if the Grantee, during Grantee’s employment with the Company, has engaged in an act which would, in the judgment of the Committee, constitute fraud that could be punishable as a crime or embezzlement against either the Company or any of its subsidiaries. The determination as to whether the Grantee has engaged in Misconduct shall be made by the Committee in its sole and absolute discretion. The Committee has sole and absolute discretion to determine whether, notwithstanding its determination that Grantee has engaged in Misconduct, recapture or forfeiture as provided herein shall not occur. The Committee’s exercise or nonexercise of such discretion with respect to any particular event or occurrence by or with respect to the Grantee or any other recipient of restricted stock units shall not in any way reduce or eliminate the authority of the Committee to (i) determine that any event or occurrence by or with respect to the Grantee constitutes an act of Misconduct or (ii) determine the related Misconduct date.

(g)The Grantee hereby agrees to notify the Company within ten (10) days of commencing any employment or other service provider relationship with any company or business during the Restricted Period, specifying in reasonable detail (i) the name of such company or business and the line of business in which it is engaged, and (ii) the Grantee’s position or title and the types of services to be rendered by the Grantee in such position or title. The Grantee hereby acknowledges that this notice requirement is reasonable and necessary for the Company to enforce the provisions of Sections 3(d) hereof. Furthermore, if the Grantee fails to so notify the Company, the Grantee shall be required to repay (at the Committee’s sole discretion) to the Company the amounts described in Section 3(d) hereof as if the Grantee had engaged in a Competitive Action during the Restricted Period, unless the Grantee can provide dispositive evidence, which shall be determined in the Committee’s sole discretion, that a Competitive Action did not occur.

- 5 -

(h)Certain Definitions. (i) “Client” shall mean any insured, agent, producer or other intermediary to or through whom the Company provides insurance or reinsurance or related services;

(ii) “Confidential Information” shall mean an item of information or a compilation of information, in any form (tangible or intangible), related to the business of the Company or of a subsidiary for whom Grantee performs services that the Company/subsidiary has not made public or authorized public disclosure of, and that is not generally known to the public through proper means, including but not limited to:

(1) underwriting premiums or quotes, income and receipts, claims records and levels, renewals, policy wording and terms, reinsurance quotas, profit commission;

(2) operating unit or other business projections and forecasts;

(3) Client lists, brokers lists and price sensitive information;

(4) technical information, reports, interpretations, forecasts, corporate and business plans and accounts, business methods, financial details, projections and targets;

(5) remuneration and personnel details;

(6) planned products, planned services, marketing surveys, research reports, market share and pricing statistics, budgets, fee levels;

(7) computer passwords, the contents of any databases, tables, know how documents or materials;

(8) commissions, commission charges, pricing policies and all information about research and development; and

(9) the Company’s suppliers’, Clients’ or Prospective Clients’ names, addresses (including email addresses), telephone, facsimile or other contact numbers and contact names, the nature of their business operations, their requirements for services supplied by the Company and all confidential aspects of their relationship with the Company;

(iii) “Covered Business Partner” shall mean any person, concern or entity (including, without limitation, any Client) as to which Grantee, or persons supervised by Grantee, had material business-related contact or received Confidential Information during the most recent two years of Grantee’s employment with the Company or such shorter period of time as employed (the “Look Back Period”); and

(iv) “Prospective Client” shall mean any person, concern or entity (including, without limitation, any potential insured, agent, producer or other intermediary) to or through whom the Company has been in negotiations during the Look Back Period to provide insurance or reinsurance or related services.

(i)In the event of a Change in Control, unless otherwise specifically prohibited under applicable laws or by the rules and regulations of any governing governmental agencies or

- 6 -

national securities exchanges, in the event that the Grantee’s employment with the Company is terminated (i) by the Company without Cause or (ii) by the Grantee for Good Reason, in each case during the eighteen (18) month period following such Change in Control, the number of earned Restricted Stock Units for any incomplete Performance Period (including, for the avoidance of doubt, any Performance Period that has yet to commence as of the date of such termination) shall be immediately determined assuming the Company achieved the target level of ROE Relative Performance for such Performance Period and the number of earned Tranche 1 Restricted Stock Units, earned Tranche 2 Restricted Stock Units and earned Tranche 3 Restricted Stock Units shall immediately become vested Restricted Stock Units. All vested Restricted Stock Units pursuant to this Section 3(h) shall be settled in accordance with Section 4.

SECTION 4.Delivery and Possession of Share Certificates. Ninety (90) days following the Grantee’s “separation from service” (for purposes of Section 409A of the Code) for any reason, including death or Disability (the “Settlement Date”), provided the Grantee has neither engaged in, nor entered into an agreement (written, oral or otherwise) to engage in, a Competitive Action nor engaged in Misconduct, the Company shall deliver to the Grantee (or the Grantee’s estate in the event of death) a certificate or certificates representing the number of shares of Stock equal to the number of vested Restricted Stock Units, if any, as of the date of such separation from service and Grantee shall take possession thereof; provided, however, that if the Grantee is a “specified employee” pursuant to Section 409A(a)(2)(B)(i) of the Code, distribution of shares of Stock shall be delayed for such period of time as may be necessary to satisfy Section 409A(a)(2)(B)(i) of the Code (generally six months), and on the earliest date on which such distribution can be made following such delay without violating the requirements of Section 409A(a)(2)(B)(i) of the Code, the Company shall deliver to the Grantee a certificate or certificates representing the number of shares of Stock equal to the number of such vested Restricted Stock Units. A delay shall not be required to the extent the Grantee terminates employment on account of death or Disability, provided that if in the event of a Disability the Grantee is “disabled” within the meaning of Section 409A(a)(2)(C) of the Code, then the Restricted Stock Units shall be settled ninety (90) days following the occurrence of such death or Disability. Notwithstanding the foregoing, in the event of a Change in Control, which also constitutes a change in the ownership or effective control of the Company or in the ownership of a substantial portion of the assets of the Company within the meaning of Section 409A(a)(2)(A)(v) of the Code, the Company shall immediately deliver to the Grantee a certificate or certificates representing the number of then vested Restricted Stock Units.

SECTION 5.Dividends and Dividend Equivalents. No dividends or dividend equivalents shall accrue or be paid with respect to any outstanding unvested Restricted Stock Units. On the second Tuesday of each January, April, July and October (each, a “Dividend Equivalent Payment Date”) occurring during the period commencing on the Vesting Date and ending on the Settlement Date, the Grantee shall be paid an amount in cash, with respect to each vested Restricted Stock Unit then outstanding and held by such Grantee, equal to the aggregate cash dividends paid by the Company in respect of one share of Stock (the “Dividend Equivalent”) following the immediately prior Dividend Equivalent Payment Date, or with respect to the first Dividend Equivalent Payment Date only, on or following the Vesting Date; provided, however, that with respect to the first Dividend Equivalent Payment Date, no Dividend Equivalents shall be paid to the Grantee in respect of any cash dividends declared or paid by the

- 7 -

Company prior to such Vesting Date. To the extent a cash dividend is paid by the Company on or prior to the Settlement Date but the Dividend Equivalent Payment Date relating thereto would not occur prior to the Settlement Date, the Dividend Equivalents relating thereto shall be paid to the Grantee on the Settlement Date. The Grantee’s right to future payments of Dividend Equivalents shall be subject to forfeiture to the same extent that the corresponding Restricted Stock Units are subject to forfeiture pursuant to Section 3.

SECTION 6.Rights of Stockholder. Neither the Grantee nor any transferee will have any rights as a stockholder with respect to any share covered by this Agreement until the Grantee or transferee becomes the holder of record of such shares.

SECTION 7.Company; Grantee.

(a)The term “Company” as used in Section 3 or otherwise in this Agreement with reference to the Grantee’s employment shall include the Company and its subsidiaries. The term “subsidiary” as used in this Agreement shall mean any subsidiary of the Company within the meaning of Section 424(f) of the Code.

(b)Whenever the word “Grantee” is used in any provision of this Agreement under circumstances where the provision should logically be construed to apply to the executors, the administrators, or the person or persons to whom the Restricted Stock Units may be transferred by will or by the laws of descent and distribution, the word “Grantee” shall be deemed to include such person or persons.

SECTION 8.Compliance with Law. Notwithstanding any of the provisions hereof, the Grantee hereby agrees and the Company will not be obligated to issue or transfer shares to Grantee hereunder, if the issuance or transfer of such shares will constitute a violation by the Grantee or the Company of any provision of any law or regulation of any governmental authority. Any determination in this connection by the Committee will be final, binding and conclusive. The Company shall in no event be obliged to register any securities pursuant to the Securities Act or to take any other affirmative action in order to cause the issuance or transfer of shares acquired pursuant to this Agreement to comply with any law or regulation of any governmental authority.

SECTION 9.Notice. Every notice or other communication relating to this Agreement shall be in writing, and shall be mailed to or delivered to the party for whom it is intended at such address as may from time to time be designated by it in a notice mailed or delivered to the other party as herein provided, provided that, unless and until some other address be so designated, all notices or communications by the Grantee to the Company shall be mailed or delivered to the Company at its principal executive office, and all notices or communications by the Company to the Grantee may be given to the Grantee personally or may be mailed to Grantee at the Grantee’s last known address, as reflected in the Company’s records.

SECTION 10.Changes in Capital Structure. The existence of this Agreement will not affect in any way the right or power of the Company or its stockholders to make or authorize any of the following:

- 8 -

(a)any adjustments, recapitalization, reorganizations or other changes in the Company’s capital structure or its business;

(b)any merger or consolidation of the Company;

(c)any issue of stock or of options, warrants or rights to purchase stock or of bonds, debentures, preferred to prior preference stocks ahead of or affecting the Stock or the rights thereof or convertible into or exchangeable for Stock;

(d)the dissolution or liquidation of the Company;

(e)any sale or transfer of all or any part of its assets or business; or

(f)any other corporate act or proceeding.

- 9 -

SECTION 11.Other Share Issues. Except as expressly provided in the Plan, the issue by the Company of shares of stock of any class, or securities convertible into or exchangeable for shares of stock of any class, for cash, property or services, either upon direct sale or upon the exercise of options, rights or warrants, or upon conversion of shares or obligations of the Company convertible into such shares or other securities will not affect, and no adjustment by reason thereof will be made with respect to, the number of shares subject to this Agreement.

SECTION 12.Withholding. At the time of vesting and/or settlement of the Restricted Stock Units, as appropriate, the Committee shall require the Grantee to pay to the Company an amount sufficient to pay all federal, state and local withholding taxes applicable (including FICA taxes upon vesting), in the Committee’s judgment, to the vesting or settlement of the Restricted Stock Units, and the Grantee’s right to vesting and/or settlement, as appropriate, shall be contingent upon such payment. Such payment to the Company may be effected through (a) payment by the recipient to the Company of the aggregate withholding taxes in cash or cash equivalents; (b) at the discretion of the Committee, the Company’s withholding from the number of shares of Stock that would otherwise be delivered to the Grantee upon settlement of the Restricted Stock Units, a number of shares of Stock with an aggregate fair market value on the date of settlement (as determined by the Committee) equal to the aggregate amount of withholding taxes; or (c) at the discretion of the Committee, any combination of these two methods.

SECTION 13.Grantee’s Tax Considerations. The tax impact of the award hereunder can be quite complex and will vary with each Grantee. It is recommended that each Grantee review such Grantee’s own tax situation and consult their tax advisor.

SECTION 14.Waiver of Right to Trial by Jury. AS ALLOWED BY APPLICABLE LAW, BOTH PARTIES HEREBY WAIVE AND RELEASE ANY CLAIM UNDER STATE OR FEDERAL LAW THEY MAY HAVE HAD TO A JURY TRIAL IN CONNECTION WITH CLAIMS ARISING UNDER OR RELATED TO THIS AGREEMENT OR ANY ACTIONS TAKEN OR DETERMINATIONS MADE HEREUNDER.

SECTION 15.No Right to Continued Service. This Agreement does not confer upon the Grantee any right to continue as an employee of the Company, nor shall it interfere in any way with the right of the Company to terminate Grantee’s employment at any time for any reason.

SECTION 16.Agreement Confidentiality. Grantee understands and agrees that Grantee will keep the terms and conditions of this Agreement strictly confidential unless Grantee is compelled to do otherwise by a court of competent jurisdiction, and Grantee further agrees not to disclose the terms and conditions of this Agreement to any third party other than Grantee’s immediate family members, attorney, financial advisor, or accountant, all of whom must also agree to keep these terms and conditions strictly confidential unless compelled to do otherwise by a court of competent jurisdiction. Notwithstanding anything herein to the contrary, Grantee shall notify any subsequent employer, prior to commencing employment, of the restrictions and obligations in Sections 3(d), (e), (f) and (g) of this Agreement (as modified by Exhibit B to this Agreement, if and as applicable to the Grantee).

- 10 -

SECTION 17.Binding Effect. This Agreement shall be binding upon the heirs, executors, administrators and successors of the parties hereto.    

SECTION 18.The Plan and Prior Agreements. The terms and provisions of the Plan are incorporated herein by reference. In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall govern. If there is any inconsistency between this Agreement and Exhibit B, Exhibit B shall prevail. The Grantee hereby acknowledges that he or she has received a copy of the Plan and understands and agrees to the terms thereof. This Agreement, together with the Plan, constitutes the entire agreement by and between the parties hereto with respect to the subject matter hereof, and this Agreement and the Plan supersede all prior agreements, correspondence and understandings and all prior and contemporaneous oral agreements and understandings, among the parties hereto with regard to the subject matter hereof. As additional consideration for the grant of Restricted Stock Units made pursuant to this Agreement, the parties agree that the provisions in Sections 3(b), (d), (e), (f), (g) and (h); Section 12; Section 14; Section 16; Section 18; Section 19; Section 22; Section 23; and Exhibit B of this Agreement shall supersede and replace, and be substituted for inconsistent provisions (and, for new provisions herein, added to the covenants and obligations) in any previous restricted stock unit award agreements between Grantee and the Company, including for the avoidance of doubt any dispute resolution provisions therein, whether the awards under those agreements have vested or are unvested.

SECTION 19.Governing Law. This Agreement shall be construed and interpreted in accordance with the laws of the State of Delaware, without regard to the principles of conflicts of law thereof. The jurisdiction and venue for any dispute arising under, or any action brought to enforce or otherwise relating to, this Agreement will be exclusively in the courts of the State of Delaware, including the federal courts located in Delaware in the event federal jurisdiction exists. Grantee hereby irrevocably consents to the exclusive personal jurisdiction and venue of the federal and State courts of the State of Delaware for the resolution of any disputes arising out of, or relating to, this Agreement and irrevocably waives any claim or argument that the courts of the State of Delaware are an inconvenient forum. In any action arising under or relating to this Agreement, the court shall not have the authority to, and shall not, conduct a de novo review of any determination made by the Committee or the Company but is instead authorized to determine solely whether the determination was the result of fraud or bad faith under Delaware law.

SECTION 20.Severability. The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision or provisions of this Agreement, which shall remain in full force and effect. If any provision of this Agreement is held to be invalid, void or unenforceable in any jurisdiction, any court so holding shall substitute a valid, enforceable provision that preserves, to the maximum lawful extent, the terms and intent of such provisions of this Agreement. If any of the provisions of, or covenants contained in, this Agreement are hereafter construed to be invalid or unenforceable in any jurisdiction, the same shall not affect the remainder of the provisions or the enforceability thereof in any other jurisdiction, which shall be given full effect, without regard to the invalidity or unenforceability in such other jurisdiction. Any such holding shall affect such provision of this Agreement, solely as to that jurisdiction, without rendering that or any other provisions of

- 11 -

this Agreement invalid, illegal or unenforceable in any other jurisdiction. If any covenant should be deemed invalid, illegal or unenforceable because its scope is considered excessive, such covenant will be modified so that the scope of the covenant is reduced only to the minimum extent necessary to render the modified covenant valid, legal and enforceable.

SECTION 21.Definitions. The following terms shall have the following meanings:

(a)“Average Return on Equity” means the percentage equal to the product of four (4) times the result of (i) the sum of the Return on Equity for each quarter in the applicable Performance Period, divided by (ii) the number of quarters in the applicable Performance Period.

(b)“Cause” means “Cause” as defined in any active employment agreement between the Grantee and the Company or, in the absence of any such definition, means the occurrence of any one of the following events: (i) fraud, personal dishonesty, embezzlement or acts of gross negligence or gross misconduct on the part of the Grantee in the course of his or her employment or services; (ii) the Grantee’s engagement in conduct that is materially injurious to the Company; (iii) the Grantee’s conviction by a court of competent jurisdiction of, or pleading “guilty” or “no contest” to, (x) a felony or (y) any other criminal charge (other than minor traffic violations) which could reasonably be expected to have a material adverse impact on the Company’s reputation or business; (iv) public or consistent drunkenness by the Grantee or his or her illegal use of narcotics which is, or could reasonably be expected to become, materially injurious to the reputation or business of the Company or which impairs, or could reasonably be expected to impair, the performance of the Grantee’s duties to the Company; (v) willful failure by the Grantee to follow the lawful directions of a superior officer; or (vi) the Grantee’s continued and material failure to fulfill his or her employment obligations to the Company.

(c)“Disability” means the total and permanent disability of the Grantee, as determined by the Committee in its sole discretion.

(d)“Good Reason” means “Good Reason” as defined in any active employment agreement between the Grantee and the Company or, in the absence of any such definition, means the occurrence of any one of the following events, unless the Grantee agrees in writing that such event shall not constitute Good Reason: (i) a material reduction in the Grantee’s duties or responsibilities from those in effect immediately prior to a Change in Control; (ii) a material reduction in the Grantee’s base salary below the levels in effect immediately prior to a Change in Control; or (iii) relocation of the Grantee’s primary place of employment to a location more than fifty (50) miles from its location, and further from the Grantee’s primary residence, immediately prior to a Change in Control; provided, however, that with respect to any Good Reason termination, the Company will be given not less than thirty (30) days’ written notice by the Grantee (within sixty (60) days of the occurrence of the event constituting Good Reason) of the Grantee’s intention to terminate the Grantee’s employment for Good Reason, such notice to state in detail the particular act or acts or failure or failures to act that constitute the grounds on which the proposed termination for Good Reason is based, and such termination shall be effective at the expiration of such thirty (30) day notice period only if the Company has not fully cured such act or acts or failure or failures to act that give rise to Good Reason during such period. Further notwithstanding any provision in this definition to the contrary, in order to constitute a

- 12 -

termination for Good Reason, such termination must occur within six (6) months of the initial existence of the applicable condition.

(e)“Performance Period” means the Tranche 1 Performance Period, Tranche 2 Performance Period or Tranche 3 Performance Period, respectively.

(f)“ROE Relative Performance” means the Average Return on Equity less the Treasury Note Rate of Return, expressed in basis points.

(g)“ROE Relative Performance Vesting Percentage” means a function of the ROE Relative Performance during the applicable Performance Period, and shall be determined as follows:

ROE Relative Performance*	ROE Relative Performance Vesting Percentage (% of Target)*
+	0%
+	80.0%
≥+633 basis points	90.0%
≥+766 basis points	100.0% (target)
+	110.0%

* In the event that the ROE Relative Performance falls between any two values listed in the table above, the ROE Relative Performance Vesting Percentage shall be determined using a straight line interpolation between such two values. For the avoidance of doubt if the ROE Relative Performance is less than +500 basis points (i.e., the Average Return on Equity is less than 6.89%), the ROE Relative Vesting Percentage shall be 0% (i.e., no linear interpolation between 0% and 80%) and if the ROE Relative Performance is equal to or greater than +900 basis points (i.e., the Average Return on Equity at least 10.89%), the ROE Relative Vesting Percentage shall be 110%.

(h)“Return on Equity” means for a quarter, a fraction (expressed as percentage) equal to the consolidated net income from continuing operations of the Company as determined under U.S. Generally Accepted Accounting Principles divided by the stockholders’ equity at the beginning of the calendar year for that quarter.

(i)“Tranche 1 Performance Period” means the period commencing July 1, 2017 and ending on June 30, 2020.

(j)“Tranche 2 Performance Period” means the period commencing July 1, 2018 and ending on June 30, 2021.

(k)“Tranche 3 Performance Period” means the period commencing July 1, 2019 and ending on June 30, 2022.

(l)“Treasury Note Rate of Return” means the five-year Treasury Note rate on June 30, 2017, which is 1.89%.

- 13 -

(m)“Vesting Date” means the date on which the Tranche 1 Restricted Stock Units, Tranche 2 Restricted Stock Units, and Tranche 3 Restricted Stock Units, as applicable, vest hereunder.

SECTION 22.Signature in Counterparts. This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.

SECTION 23.Protected Conduct. Nothing in this Agreement prohibits Grantee from reporting an event that Grantee reasonably and in good faith believes is a violation of law to the relevant law-enforcement agency (such as the Securities and Exchange Commission or Department of Labor), requires notice to or approval from the Company before doing so, or prohibits Grantee from cooperating in an investigation conducted by such a government agency. This may include a disclosure of trade secret information provided that it must comply with the restrictions in the Defend Trade Secrets Act of 2016 (DTSA). The DTSA provides that no individual will be held criminally or civilly liable under Federal or State trade secret law for the disclosure of a trade secret that: (i) is made in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and made solely for the purpose of reporting or investigating a suspected violation of law; or, (ii) is made in a complaint or other document if such filing is under seal so that it is not made public. Also, the DTSA further provides that an individual who pursues a lawsuit for retaliation by an employer for reporting a suspected violation of the law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal, and does not disclose the trade secret, except as permitted by court order. To the extent that Grantee is covered by Section 7 of the National Labor Relations Act (NLRA) because Grantee is not in a supervisor or management role, nothing in this Agreement shall be construed to prohibit Grantee from using information Grantee acquires regarding the wages, benefits, or other terms and conditions of employment at the Company for any purpose protected under the NLRA.

SECTION 24. The Grantee agrees that he or she has entered into this Agreement voluntarily and that the Grantee has not been induced to participate in the distribution of Restricted Stock Units by the Company by expectation of appointment, employment, continued appointment or continued employment of the Grantee with the Company or a related entity of the Company. The Grantee further agrees that the Company has not made any representations or warranties with respect to the Restricted Stock Units, the Company, the business of the Company or its prospects, and that no securities commission, agency, governmental authority, regulatory body, stock exchange or similar regulatory authority has reviewed or passed on the merits of the Restricted Stock Units and that the Grantee’s ability to transfer the Restricted Stock Units will be limited by the Plan, this Agreement and applicable securities laws.

*    *    *

- 14 -

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.

W. R. BERKLEY CORPORATION

By:__________________________

Name: William R. Berkley

Title:     Executive Chairman

__________________________________

Grantee

RSU Agreement L12 Perf (8.2017)

- 15 -

EXHIBIT A

TO THE RESTRICTED STOCK UNIT AGREEMENT DATED

AS OF _________UNDER THE W. R. BERKLEY CORPORATION

2012 STOCK INCENTIVE PLAN

NAME OF GRANTEE: ________________________________________

TARGET NUMBER OF TRANCHE 1 RESTRICTED STOCK UNITS AWARDED TO GRANTEE: _____________

TARGET NUMBER OF TRANCHE 2 RESTRICTED STOCK UNITS AWARDED TO GRANTEE: _____________

TARGET NUMBER OF TRANCHE 3 RESTRICTED STOCK UNITS AWARDED TO GRANTEE: _____________

TOTAL TARGET NUMBER OF RESTRICTED STOCK UNITS AWARDED TO GRANTEE: _____________

By accepting the terms and conditions of the above grant agreement, you expressly acknowledge that you have read and agree to all the terms and conditions set forth above.

If you decide to reject the terms and conditions of the grant, you will decline your right to receive the grant, and the grant of the Restricted Stock Units to you will be cancelled ab initio.

Please select one of the following actions. You will be asked to confirm your selection on the following page.

- 16 -

EXHIBIT B

JURISDICTION SPECIFIC MODIFICATIONS

I. States of the United States of America

A.    Arkansas, Connecticut, Illinois, Indiana, Maryland, Minnesota, South Carolina, South Dakota, Texas, and Virginia: Sections 3(e)(i) and 3(e)(ii) are further limited to situations where Grantee is performing services that are the same as or similar in function or purpose to the services Grantee performed for W. R. Berkley Corporation or its subsidiary/subsidiaries (as appropriate) during the Look Back Period.

B.    Arizona. For an Arizona resident, for so long as the Grantee resides in Arizona and is subject to the laws of Arizona: (i) the restrictions in Sections 3(e)(i), (ii), (iv) and (v) will only apply within any geographical area (x) where Grantee had responsibilities on behalf of the Company or about which Grantee received Confidential Information during the Look Back Period and (y) in which the Company is engaged in business; (ii) Sections 3(e)(i) and 3(e)(ii) are further limited to situations where Grantee is performing services that are the same as or similar in function or purpose to the services Grantee performed for W. R. Berkley Corporation or its subsidiary/subsidiaries (as appropriate) during the Look Back Period; and (iii) with respect to Grantee’s nondisclosure obligation under Section 3(e)(vi), Grantee’s nondisclosure obligation only extends during the Restricted Period (this is not a deviation from the text of the Agreement, but a clarification for the avoidance of any doubt).

C.    California. For a resident of California, for so long as Grantee resides in California and is subject to the laws of California: (i) no provision or requirement of this Agreement will be construed or interpreted in a manner contrary to the public policy of the State of California; (ii) the restrictions in Sections 3(e)(i) and (ii) shall not apply; (iii) Sections 3(e)(iv) and (v) shall be limited to situations where Grantee is aided in his or her conduct by Grantee’s use or disclosure of trade secrets (as defined by applicable law); (iv) the last sentence of Section (3)(g) shall not apply and the remainder of Section 3(g) shall apply; and (v) Section 14 shall not apply.

D.    Nebraska. For a Nebraska resident, for so long as Grantee resides in Nebraska and is subject to the laws of Nebraska: (i) Sections 3(e)(i) and (ii) shall not apply; and (ii) the definition of “Covered Business Partner” in Section 3(h) is modified so that it means any persons or entities with which Grantee, or persons supervised by Grantee, did business and had personal business-related contact during the Look Back Period.

E.    North Carolina. For a North Carolina resident, for so long as Grantee resides in North Carolina and is subject to the laws of North Carolina: (i) Sections 3(e)(i) and 3(e)(ii) are further limited to situations where Grantee is performing services that are the same as or similar in function or purpose to the services Grantee performed for W. R. Berkley Corporation or its subsidiary/subsidiaries (as appropriate) during the Look Back Period; and (ii) the Look Back Period shall be calculated looking back two years from the date of enforcement and not from the date employment ends.

- 17 -

F.    North Dakota. For a resident of North Dakota, for so long as Grantee resides in and is subject to the laws of North Dakota: (i) no provision or requirement of this Agreement will be construed or interpreted in a manner contrary to the public policy of the State of North Dakota; (ii) the restrictions in Sections 3(e)(i) and (ii) shall not apply; (iii) Sections 3(e)(iv) and (v) shall be limited to situations where Grantee is aided in his or her conduct by Grantee’s use or disclosure of trade secrets (as defined by applicable law); and (iv) the last sentence of Section (3)(g) shall not apply and the remainder of Section 3(g) shall apply.

G.    Oklahoma. For an Oklahoma resident, for so long as Grantee resides in Oklahoma and is subject to the laws of Oklahoma: the restrictions in Sections 3(e)(i) and (ii) shall not apply and “Covered Business Partner” of the Company means any individual, company, or business entity (including, without limitation, any Client) with which the Company has transacted business within the Look Back Period and with which Grantee, or persons supervised by Grantee, had material business-related contact or about which Grantee had access to Confidential Information during the Look Back Period.

H.Wisconsin. For a Wisconsin resident, for so long as Grantee resides in Wisconsin and is subject to the laws of Wisconsin: (i) Sections 3(e)(i) and 3(e)(ii) are further limited to situations where Grantee is performing services that are the same as or similar in function or purpose to the services Grantee performed for W. R. Berkley Corporation or its subsidiary/subsidiaries (as appropriate) during the Look Back Period; and (ii) Section 3(e)(iii) is rewritten as follows: “participates in soliciting or attempting to solicit any employee of the Company that is in a Sensitive Position to leave the employment of the Company on behalf of (or for the benefit of) a competing business, or knowingly assists a competing business in efforts to hire such an employee away from the Company.  An employee in a “Sensitive Position” refers to an employee of the Company who is in a management, supervisory, sales, research and development, underwriting, claims, actuarial, loss control or similar role where the employee is provided Confidential Information or is involved in business dealings with the Company’s customers.”

- 18 -

II. Countries Other than the United States of America

Argentina. For an Argentinian resident, for so long as Grantee resides in Argentina and is subject to the laws of Argentina:

(i)Section 19 shall be deleted in its entirety and replaced with the following:

“SECTION 19. Governing Law. This Agreement shall be construed and interpreted in accordance with the laws of Argentina. Grantee hereby irrevocably consents to the exclusive personal jurisdiction of the Argentine courts for the resolution of any disputes arising out of, or relating, to this Agreement.”

(ii) This Agreement shall not be effective unless the Grantee physically signs an original Agreement.

Australia. For an Australian resident, for so long as Grantee resides in Australia and is subject to the laws of Australia:

(i) Section 19 shall be deleted in its entirety and replaced with the following:

“SECTION 19. Governing Law. This Agreement shall be construed and interpreted in accordance with the laws of the State of New South Wales in Australia. Grantee hereby irrevocably consents to the personal jurisdiction of the federal and state courts of the State of New South Wales in Australia for the resolution of any disputes arising out of, or relating to, this Agreement.”

(ii) The provisions in “Addendum for Australia, Canada, Hong Kong and Singapore” set forth below shall be applicable.

Brazil. For a Brazilian resident, for so long as Grantee resides in Brazil and is subject to the laws of Brazil:

A new sentence shall be added at the end of SECTION 18 as follows:

“The Grantee acknowledges that the provisions of this Agreement set forth above that supersede, replace and are added to previous restricted stock unit agreements are not detrimental in comparison to those provided in any previous restricted stock unit award agreements between the Grantee and the Company.”

Canada. For a Canadian resident, for so long as Grantee resides in Canada and is subject to the laws of Canada:

(i) A new Section 24 shall be added as follows:

SECTION 24. Release. In consideration of the grant of the Restricted Stock Units from the Company to Grantee and a further cash payment of CAN$100 to be made to Grantee on a regular pay date as soon as administratively practicable after Grantee accepts such grant (the “Consideration”), and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Grantee on behalf

- 19 -

of him or herself, his or her heirs, successors, administrators and assigns (hereinafter collectively referred to as the “Releasor”) hereby releases and forever discharges the Company, along with all parents, subsidiaries, affiliates and associated companies, and together with all respective officers, directors, employees, servants and agents and their successors and assigns (hereinafter collectively referred to as the “Releasee”) jointly and severally from any and all actions, causes of actions, contracts, covenants, whether express or implied of any nature and kind whatsoever, made under or in relation to the Restricted Stock Unit Agreement under the Plan including any claims for damages, contractual breach, indemnity, costs, interest, and/or claims for loss of every nature and kind whatsoever and howsoever arising which the Releasor may heretofore have had, may now have, or may hereinafter have, in any way relating to vested entitlements or grants of any kind under the Plan to the date of this Agreement and any and all matters raised or which could have been raised by the Grantor in relation to the Plan prior to entering into this Agreement. The Releasor further acknowledges, covenants and warrants that he or she has not filed with any Court, Commission, Tribunal or Agency or any other judicial or quasi-judicial body, any claim or complaint of the type described above, and that if such a claim or complaint has been filed, this Release and Indemnity, entered into freely and without duress, constitutes a full and final bar and/or answer to such claim or complaint. For clarity, the Releasor further agrees that he or she will take all necessary steps to ensure the withdrawal or dismissal of such claim or complaint. And for said consideration the Releasor further acknowledges, covenants and agrees that in the event that he or she should hereafter make any claim, or demand or take any action or proceeding against the Releasee in connection with any matter covered by this Release or threaten to do so, this document may be raised as an estoppel and complete bar to any such claim, demand, action or proceeding, and that the Releasor will be liable to the Releasee for its costs and expenses, including reasonable legal fees, incurred in responding thereto. And for said consideration, the Releasor further acknowledges, covenants and agrees that he or she shall not make any claim or demand or take any action or proceeding in connection with any matter covered by this Release against any other person or corporation who might claim contribution or indemnity from the Releasee by virtue of the said claim or proceeding. The Releasor agrees that, if any such claim, demand, action or proceeding is made by the Releasor against the Releasee, the Releasee may raise this document as an estoppel and complete bar to any such claim, demand, action or proceeding and that the Releasor will be liable to the Releasee for its costs and expenses, including reasonable legal fees, incurred in responding thereto. The Releasor acknowledges and agrees that he or she is executing these terms voluntarily and without duress after having been afforded the opportunity to obtain legal advice and having either received such advice or chosen not to do so.

(ii) The provisions in “Addendum for Australia, Canada, Hong Kong and Singapore” set forth below shall be applicable.

- 20 -

Colombia. For a Colombian resident, for so long as Grantee resides in Colombia and is subject to the laws of Colombia:

Grantee agrees that the Restricted Stock Units rights derived from this Agreement are not consideration for the services rendered by the Grantee in Colombia. For this Agreement to be effective, the Grantee must enter into a local agreement, governed by Colombian laws, with Grantee’s current employer in which Grantee agrees to the statement in the prior sentence.

Hong Kong. For a Hong Kong resident, for so long as Grantee resides in Hong Kong and is subject to the laws of Hong Kong:

(i) Section 2 shall be deleted in its entirety and replaced with the following:

SECTION 2. Non-Transferability. (a) Subject to Section 2(b) below and except as specifically consented to by the Committee, the Grantee may not sell, transfer, pledge, or otherwise encumber or dispose of the Restricted Stock Units other than by will, the laws of descent and distribution, or as otherwise provided for in the Plan.

(b) Notwithstanding any other provisions of this Agreement, if the Grantee resides in, or received this offer in Hong Kong, the Grantee shall have no rights or entitlement to sell, transfer or otherwise dispose of the Restricted Stock Units, except if such sale, transfer or disposal is permitted pursuant to the Plan and specifically consented to by the Committee.

(ii) Section 23 is amended to add the following two paragraphs at the end thereof:

“The contents of this Agreement have not been reviewed by any regulatory authority in Hong Kong. You are advised to exercise caution in relation to the offer. If you are in any doubt about any of the contents of this Agreement, you should obtain independent professional advice.

This Agreement must not be issued, circulated or distributed in Hong Kong other than (1) to “professional investors” as defined in the Securities and Futures Ordinance (“SFO”) and any rules made under the SFO, (2) to persons and in circumstances which do not result in this Agreement being a “prospectus” as defined in section 2(1) of the CWMO or which do not constitute an offer to the public within the meaning of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (“CWMO”) or an invitation to the public within the meaning of the SFO or (3) otherwise pursuant to, and in accordance with the conditions of, any other applicable provisions of the SFO and CWMO.”

(iii) In addition to the grant of the Restricted Stock Units, the Company shall pay the Grantee a further cash payment of HK$700 to be made on a regular pay date as soon as administratively practicable after Grantee accepts such grant as further consideration for the agreement contained in the last sentence of Section 18.

- 21 -

(iv) The provisions in “Addendum for Australia, Canada, Hong Kong and Singapore” set forth below shall be applicable.

Norway. For a Norwegian resident, for so long as Grantee resides in Norway and is subject to the laws of Norway:

(i) In the third recital under WITNESSETH the words “or Solicitation” shall be added after the word “Misconduct”;

(ii) In Section 3(d)A., the words “or Solicitation” shall be added after the word “Misconduct”;

(iii) In Section 3(d)B., the phrase, “or (3) on or after the Vesting Date or within one year following Grantee’s termination of employment, has engaged in Solicitation,” shall be added after the phrase “until on or after the Vesting Date” in subsection (2) of Section 3(d)B;

(iv) In Section 3(d)C., the phrase, “or (3) Solicitation” shall be added after the phrase “(2) Misconduct”;

(v) In Section 3(d)C., the phrase, “or (z) engaged in Solicitation” shall be added after the phrase “(y) engaged in Misconduct,”;

(vi) In Section 3(d)E., the words “or Solicitation” shall be added after the words “Misconduct,”;

(vii) In Section 3(e), subsections (iv) and (v) shall be deleted and subsection (vi) shall be renumbered as subsection (iv); and

(viii) In Section 3, the following new subsections shall be added after subsection (g):

“(h) For purposes of this Agreement, the Grantee has engaged in "Solicitation" if the Grantee during the term of employment, and for a period of 12 months after the expiry of the agreed notice period (alternatively from the date of summary dismissal), directly or indirectly (i) diverts, or attempts to divert, any person, concern or entity from doing business with the Company or attempts to induce any such person, concern or entity to cease being a customer of the Company, (ii) solicits the business of the Company or (iii) influences customers, suppliers and/or other business associates/contract parties of the Company or any subsidiary to limit or terminate their relationship with the Company and/or any subsidiary. With respect to customers, the preceding sentence only applies to customers which the Grantee has had contact with and/or responsibility for during the last 12 months prior to the time of the written statement as mentioned below.

(i) The Company may, upon the request from the Grantee and in connection with termination, summary dismissal or other cessation of employment, decide whether

- 22 -

and to what extent the Grantee’s obligation to refrain from Solicitation shall be invoked. With respect to customers, the procedure in connection with such a decision shall comply with the mandatory provisions of Chapter 14A in the Norwegian Working Environment Act, including the specification of which customers are covered by the Grantee’s obligation to refrain from Solicitation in a written statement.”

Singapore. For a Singaporean resident, for so long as Grantee resides in Singapore and is subject to the laws of the Republic of Singapore:

(i) In Section 3(d)B., the phrase “that, in the Committee’s sole and absolute discretion, reflects the seriousness of the Competitive Action and/or the Misconduct. The maximum amount that the Company may demand from the Grantee is” shall be added after the words “an amount” in subsection (2) of Section 3(d)B;

(ii)     In Section 3(d)B, the last sentence shall be deleted and replaced with the following sentence:

“The Grantee may satisfy the payment obligation to the Company, in whole or in part (as the case may be), by returning the shares delivered to the Grantee on the Settlement Date.";

(iii)     In Section 3(d)C., the following sentence shall be deleted:

“The amounts forfeited or paid to the Company hereunder do not and are not intended to constitute actual or liquidated damages.”;

(iv)     In Section 3(g), the last sentence shall be deleted;

(v)     Section 19 shall be deleted in its entirety and replaced with the following:

“SECTION 19. Governing Law. This Agreement shall be construed and interpreted in accordance with the laws of the State of Delaware. Grantee hereby irrevocably consents to the personal jurisdiction of the courts of the Republic of Singapore for the resolution of any disputes arising out of, or relating to, this Agreement.”

(vi)     The provisions in “Addendum for Australia, Canada, Hong Kong and Singapore” set forth below shall be applicable.

United Kingdom. For a United Kingdom resident, for so long as Grantee resides in the United Kingdom and is subject to the laws of England and Wales or if the Grantee is employed under an employment contract which is governed by English law at the time of grant of the Restricted Stock Units: (i) delete the parenthetical phrase in the third recital under “WITNESSETH” and (ii) the following terms and provisions shall amend and supersede the terms and provisions of Section 3(b), (d), (e), (f), (g) and (h) and Section 19 of this Agreement as follows:

- 23 -

1.     TERMINATION OF EMPLOYMENT

With effect from the earlier of the date of termination of the Grantee’s employment or the date that the Grantee gives or receives notice of termination of the Grantee’s employment for any reason, any unvested Restricted Stock Units shall lapse and be forfeited (except for those that vest immediately upon termination as set out in Section 3(a) of this Agreement and subject to the forfeiture provisions in paragraph 3 below) and the Grantee shall have no further rights with respect to any such unvested Restricted Stock Units.

2. RESTRICTIVE COVENANTS

2.1 The Grantee covenants with the Company and the Group that the Grantee will not, save with the prior written consent of the Committee (in its absolute discretion):

2.1.1. during the Restricted Period directly or indirectly be employed, engaged or retained by or otherwise concerned or interested in any Competing Business. For this purpose, the Grantee is directly or indirectly employed, engaged or retained by or concerned or interested in a Competing Business if:

(a)    the Grantee carries it on as principal or agent; or

(b) the Grantee is a partner, director, employee, secondee, consultant or agent in, of or to any person who carries on the Competing Business;

(c) the Grantee has any direct or indirect financial interest (as shareholder, creditor or otherwise) in any person who carries on the Competing Business; and/or

(d) the Grantee is a partner, director, employee, secondee, consultant or agent in, of or to any person who has a direct or indirect financial interest (as shareholder, creditor or otherwise) in any person who carries on the Competing Business,

disregarding any financial interest the Grantee may have in securities which are listed or dealt in on a recognised investment exchange if the Grantee is interested in securities which amount to less than 3% of the issued securities of that class and which, in all circumstances, carry less than 3% of the voting rights (if any) attaching to the issued securities of that class;

2.1.2 during the Restricted Period and whether directly or indirectly, either alone or with or on behalf of any person, firm, company or entity and whether on his or her own account or as principal, partner, shareholder, director, employee, consultant or in any other capacity whatsoever, have any business dealings with any Client or Prospective Client in relation to or for the benefit of a Competing Business;    

2.1.3 during the Restricted Period and whether directly or indirectly, either alone or with or on behalf of any person, firm, company or entity and whether on his or her own account or as principal, partner, shareholder, director, employee, consultant or in any other capacity whatsoever, canvass or solicit business or custom from or seek to entice away any Client

- 24 -

or Prospective Client from the Company or any Group Company in relation to or for the benefit of a Competing Business;

2.1.4 during the Restricted Period, directly or indirectly, solicit or endeavour to solicit the employment or engagement of any Key Employee (whether or not such person would thereby breach their contract of employment or engagement);

2.1.5 at any time after the Termination Date represent himself as being in any way connected with (other than as a former employee) or interested in the business of the Company or any Group Company or use any registered names, domain names or trading names the same as or that could reasonably be expected to be confused with any such names used by the Company or any Group Company.

2.1.6 before or after the Termination Date, and except in the proper performance of his or her duties of employment by the Company or any Group Company, directly or indirectly use for his or her own purposes or those of a third party or disclose to any third party any Confidential Information. The Grantee will use his or her best endeavours to prevent any unauthorised use or disclosure of Confidential Information. The obligations contained in this clause 2.1.6 will not apply to any disclosures required by law or to any information or documents which after the Termination Date are in the public domain other than by way of unauthorised disclosure.

2.2 The Grantee gives the covenants above to the Company as trustee for itself (and any company forming part of the Group).

2.3 Each restriction contained in this clause 2 is an entirely separate and independent restriction, despite the fact that they may be contained in the same phrase, and if any part is found to be unenforceable the remainder will remain valid and enforceable.

2.4 While the restrictions in this clause 2 are considered by the parties to be fair and reasonable in the circumstances, it is agreed that if any such restriction should be held to be void or ineffective for any reason but would be treated as valid and effective if some part of parts of the restriction were deleted, the restriction in question will apply with such deletion as may be necessary to make it valid and effective.

2.5 If, during the Grantee’s employment or any period during which these restrictions apply, any person, firm, company or entity offers the Grantee any employment, engagement, arrangement or contract which might or would cause him or her to breach any of the restrictions, he or she will notify that person, firm, company or entity of the terms of these restrictions.

2.6 The period of any restraint on the Grantee’s activities after the Termination Date imposed pursuant to clauses 2.1.1 to 2.1.4 shall be reduced pro rata by any period of garden leave served by the Grantee pursuant to his or her service agreement with the Company or any Group Company.

- 25 -

2.7 If the Grantee breaches any of the covenants contained in clauses 2.1.1 to 2.1.6, then any unvested Restricted Stock Units will lapse with immediate effect and the Grantee will be obliged to return all shares of Company stock issued or issuable in respect of Restricted Stock Units which have vested within the three years immediately preceding the breach or their equivalent value (determined by reference to the date of vesting) granted under this Agreement or any Prior Agreement to the Company within 14 days of being notified by the Company of its discovery of the breach.

2.8 In this clause, the following definitions shall apply:

“Client”

means any person, firm, company or other business entity whom or which during the Relevant Period: (a) to whom the Company or any Group Company provided insurance or reinsurance; or (b) was an insurance intermediary which introduced such insurance or reinsurance business to the Company or any Group Company, and in each case with whom or which during the Relevant Period: i)the Grantee (or any person reporting to the Grantee) had Material Dealings in relation to Relevant Business; or ii)about whom or which the Grantee has had Confidential Information during the course of his or her employment.

“Competing Business”

means any business which at any time is in or which intends to be in competition with any Relevant Business.

- 26 -

“Confidential Information” means any and all information which is of a confidential nature or which the Company reasonably regards as being confidential or a trade secret concerning the business, business performance or prospective business, financial information or arrangements, plans or internal affairs of the Company, any Group Company or any of their respective Clients or Prospective Clients including without prejudice to the generality of the foregoing all information, records and materials relating to: (1)underwriting premiums or quotes, income and receipts, claims records and levels, renewals, policy wording and terms, reinsurance quotas, profit commission; (2)syndicate or other business projections and forecasts; (3)Client lists, brokers lists and price sensitive information; (4)technical information, reports, interpretations, forecasts, corporate and business plans and accounts, business methods, financial details, projections and targets; (5)remuneration and personnel details; (6)planned products, planned services, marketing surveys, research reports, market share and pricing statistics, budgets, fee levels; (7)computer passwords, the contents of any databases, tables, know how documents or materials; (8)commissions, commission charges, pricing policies and all information about research and development; and (9)the Company’s or any Group Company’s suppliers’, Clients’ or Prospective Clients’ names, addresses (including email addresses), telephone, facsimile or other contact numbers and contact names, the nature of their business operations, their requirements for services supplied by the Company or any Group Company and all confidential aspects of their relationship with the Company or any Group Company.

- 27 -

“directly or indirectly”	means (without prejudice to the generality of the expression) either alone or jointly with or on behalf of any other person and whether on his or her own account or in partnership with another or others or as the holder of any interest in or as officer, employee or agent of or consultant to any other person.
“Group”	means the Company, its subsidiaries or holding companies from time to time and any subsidiary of any holding company from time to time; and “Group Company” means any company within the Group.
“Key Employee”	means any director or officer of the Company or any Group Company and/or any employee (other than administrative or clerical personnel) of the Company or any Group Company, in each case who, at any time during the Relevant Period: i)was employed by the Company or any Group Company; and ii)with whom the Grantee has had Material Dealings or exercised control or had management responsibility for; and/or iii)has had access to or has obtained Confidential Information during the Relevant Period.
“Material Dealings”	means receiving orders, instructions or enquiries from, contracting or making preparations to contract with, making sales or presenting to or with, tendering for business from, having responsibility with or for, having personal knowledge of or otherwise having significant other contact.
“Prior Agreements”	means any previous restricted stock unit award agreement between Grantee and the Company whether the awards under those agreements have vested or are unvested.

- 28 -

“Prospective Client”	means any person, firm, company or other business entity who was at any time during the Relevant Period: (a) in negotiations with the Company or any Group Company for the provision of insurance or reinsurance; or (b) an insurance intermediary who may introduce such insurance or reinsurance business to the Company or any Group Company, and in each case with whom or which during the Relevant Period: i)the Grantee (or any person reporting to the Grantee) had Material Dealings in relation to Relevant Business; or ii)about whom or which the Grantee has had Confidential Information during the course of Grantee’s employment. Provided that this definition shall not apply to any such person, firm, company or other business entity which has withdrawn from or discontinued such negotiations or discussions, having stated its intention to do so (other than through any unlawful activity by the Grantee).
“Relevant Business”	means any class or classes of insurance or reinsurance business which was underwritten in the twelve months immediately prior to the Termination Date by the Company or any Group Company and with which the Grantee was directly or indirectly materially concerned or involved or had personal knowledge in the course of Grantee’s duties during the Relevant Period.
“Relevant Period”	means (1) during employment, the twelve month period immediately prior to the action or activity that may be in breach of clauses 2.1.1 to 2.1.4 and (2) after termination of employment, the twelve month period immediately prior to the Termination Date.
“Restricted Period”	means the period beginning on the date hereof and ending one year following the Termination Date.
“Termination Date”	means the date on which the Grantee’s employment or engagement with the Company terminates for any reason.

3. CLAWBACK

- 29 -

3.1 If at any time after any Restricted Stock Units have vested under the terms of this Agreement the Committee becomes aware of any material wrongdoing, negligence or misconduct on the part of the Grantee that would have entitled the Company to terminate the Grantee's employment with or without notice for Cause, any unvested Restricted Stock Units will lapse with immediate effect and the Company will be entitled, in its absolute discretion, to recover from the Grantee up to 100% of the shares of Company common stock issued or issuable in respect of the Restricted Stock Units (which have vested within the 7 years prior to such determination by the Committee) or their equivalent value (determined by reference to the date of vesting) granted under this Agreement or any Prior Agreement to the Company within 14 days of being notified in writing by the Company of its discovery of the material wrongdoing, negligence or misconduct.

3.2 Clause 3.1 is without prejudice to the Company's other remedies for such wrongdoing or any other clawback policy that the Company may adopt from time to time as required by applicable laws or the applicable listing rules of any securities exchange.

3.3 The Committee may review any Restricted Stock Units granted to the Grantee under the terms of this Agreement, in light of:

a. there being a significant deterioration in the financial health of the Company, the Group or the business area or team in which the Grantee worked;

b. the Grantee having caused harm to the reputation of the Company or the Group;

c. the Grantee having deliberately misled the Company in relation to the financial performance of the Company, the Group or the business area or team in which he or she worked; and/or

d. the Grantee’s actions having amounted to gross misconduct, incompetence or negligence.

Following a review, the Committee may, in its sole discretion, determine that up to 100% of any unvested Restricted Stock Units granted under this Agreement or any Prior Agreement will lapse with immediate effect and, in addition, the Company will be entitled in its absolute discretion to recover from the Grantee up to 100% of the shares issued or issuable on the vesting of the Restricted Stock Units granted under this Agreement or any Prior Agreement (which have vested within the 7 years prior to such determination by the Committee) or their equivalent value (determined by reference to the date of vesting).

3.4 The Grantee agrees that any sums owed to the Company or any Group Company under this Agreement including any adjustment, forfeiture or repayment may be deducted from any sums due to the Grantee from the Company or any Group Company. For the avoidance of doubt, this is without prejudice to any right the Company or the Group may have at any time to recover any sums from the Grantee and the Grantee agrees that such sums are recoverable by the Company or any Group Company as a debt.

- 30 -

3.5 In this Clause 3, “Cause” means:

a. any serious negligence or gross misconduct by the Grantee in connection with or affecting the business or affairs of the Company or any member of the Group;

b. the Grantee being convicted of any arrestable offence other than an offence under road traffic legislation in the UK; or

c. the Grantee being convicted of an offence under any statutory enactment or regulation relating to insider dealing or market abuse.

4.     CHOICE OF LAW

4.1 Any dispute or claim (including non-contractual disputes or claims) arising out of or in connection with this Agreement or its subject matter or formation shall be governed by and construed in accordance with the law of England and Wales.

5.    ARBITRATION

5.1 If at any time any dispute or question shall arise between the parties arising out of or in connection with this Agreement or its or their validity, construction or performance then the same shall be referred to and finally resolved by arbitration under the London Court of International Arbitration Rules, which Rules are deemed to be incorporated by reference into this clause.

The number of arbitrators shall be three.

The seat, or legal place, of arbitration shall be London, England.

The language to be used in the arbitral proceedings shall be English.

The governing law of the contract shall be the substantive law of England and Wales.

Addendum for Australia, Canada, Hong Kong and Singapore. For residents of Australia, Canada, Hong Kong or Singapore, for so long as Grantee resides in his or her respective country and is subject to the laws of such country, Sections 3(e) and (h) shall be deleted and replaced as follows:

(e)    The Grantee covenants with the Company and the Group that the Grantee will not, save with the prior written consent of the Committee (in its absolute discretion):

A. during the Restricted Period, directly or indirectly, be employed, engaged or retained by or otherwise concerned or interested in any Competing Business. For this purpose, the Grantee is directly or indirectly employed, engaged or retained by or concerned or interested in a Competing Business if:

(i)    the Grantee carries it on as principal or agent; or

- 31 -

(ii) the Grantee is a partner, director, employee, secondee, consultant or agent in, of or to any person who carries on the Competing Business;

(iii) the Grantee has any direct or indirect financial interest (as shareholder, creditor or otherwise) in any person who carries on the Competing Business; and/or

(iv) the Grantee is a partner, director, employee, secondee, consultant or agent in, of or to any person who has a direct or indirect financial interest (as shareholder, creditor or otherwise) in any person who carries on the Competing Business,

disregarding any financial interest the Grantee may have in securities which are listed or dealt in on a recognised investment exchange if the Grantee is interested in securities which amount to less than 3% of the issued securities of that class and which, in all circumstances, carry less than 3% of the voting rights (if any) attaching to the issued securities of that class;

B. during the Restricted Period and whether directly or indirectly, either alone or with or on behalf of any person, firm, company or entity and whether on his or her own account or as principal, partner, shareholder, director, employee, consultant or in any other capacity whatsoever, have any business dealings with any Client or Prospective Client in relation to or for the benefit of a Competing Business;    

C. during the Restricted Period and whether directly or indirectly, either alone or with or on behalf of any person, firm, company or entity and whether on his or her own account or as principal, partner, shareholder, director, employee, consultant or in any other capacity whatsoever, canvass or solicit business or custom from or seek to entice away any Client or Prospective Client from the Company or any Group Company in relation to or for the benefit of a Competing Business;

D. during the Restricted Period, directly or indirectly, solicit or endeavour to solicit the employment or engagement of any Key Employee (whether or not such person would thereby breach their contract of employment or engagement);

E. at any time after the Termination Date represent himself or herself as being in any way connected with (other than as a former employee) or interested in the business of the Company or any Group Company or use any registered names, domain names or trading names the same as or that could reasonably be expected to be confused with any such names used by the Company or any Group Company.

F. before or after the Termination Date and except in the proper performance of his or her duties of employment for the Company or Group Company directly or indirectly use for his or her own purposes or those of a third party or disclose to any third party any Confidential Information. The Grantee will use his or her best endeavours to prevent any unauthorised use or disclosure of Confidential Information. The obligations contained in this subsection F will not apply to any disclosures required by law or to any information or documents which after the Termination Date are in the public domain other than by way of unauthorised disclosure.

- 32 -

The Grantee gives the covenants above to the Company as trustee for itself (and any company forming part of the Group).

Each restriction contained in this Section 3(e) is an entirely separate and independent restriction, despite the fact that they may be contained in the same phrase, and if any part is found to be unenforceable the remainder will remain valid and enforceable.

While the restrictions in this Section 3(e) are considered by the parties to be fair and reasonable in the circumstances, it is agreed that if any such restriction should be held to be void or ineffective for any reason but would be treated as valid and effective if some part of parts of the restriction were deleted, the restriction in question will apply with such deletion as may be necessary to make it valid and effective.

The period of any restraint on the Grantee’s activities after the Termination Date imposed pursuant to sub-section A to D of Section 3(e) shall be reduced pro rata by any period of garden leave served by the Grantee pursuant to his or her service agreement with the Company or any Group Company.

The determination as to whether the Grantee has engaged in a Competitive Action shall be made by the Committee in its sole and absolute discretion. The Committee has sole and absolute discretion to determine whether, notwithstanding its determination that Grantee has engaged in a Competitive Action, recapture or forfeiture as provided herein shall not occur. The Committee’s exercise or nonexercise of its discretion with respect to any particular event or occurrence by or with respect to the Grantee or any other recipient of restricted stock units shall not in any way reduce or eliminate the authority of the Committee to (i) determine that any event or occurrence by or with respect to the Grantee constitutes engaging in a Competitive Action or (ii) determine the related Competitive Action date.

In this Agreement, the following definitions shall apply:

- 33 -

“Client”	means any person, firm, company or other business entity whom or which during the Relevant Period: (a) to whom the Company or any Group Company provided insurance or reinsurance; or (b) was an insurance intermediary which introduced such insurance or reinsurance business to the Company or any Group Company, and in each case with whom or which during the Relevant Period: i)the Grantee (or any person reporting to the Grantee) had Material Dealings in relation to Relevant Business; or ii)about whom or which the Grantee has had Confidential Information during the course of his or her employment.
“Competitive Action”	means any of the activities, individually or in the aggregate, described in sub-sections A through F of Section 3(e).
“Competing Business”	means any business which at any time is in or which intends to be in competition with any Relevant Business.

- 34 -

“Confidential Information” means any and all information which is of a confidential nature or which the Company reasonably regards as being confidential or a trade secret concerning the business, business performance or prospective business, financial information or arrangements, plans or internal affairs of the Company, any Group Company or any of their respective Clients or Prospective Clients including without prejudice to the generality of the foregoing all information, records and materials relating to: (1)underwriting premiums or quotes, income and receipts, claims records and levels, renewals, policy wording and terms, reinsurance quotas, profit commission; (2)syndicate or other business projections and forecasts; (3)Client lists, brokers lists and price sensitive information; (4)technical information, reports, interpretations, forecasts, corporate and business plans and accounts, business methods, financial details, projections and targets; (5)remuneration and personnel details; (6)planned products, planned services, marketing surveys, research reports, market share and pricing statistics, budgets, fee levels; (7)computer passwords, the contents of any databases, tables, know how documents or materials; (8)commissions, commission charges, pricing policies and all information about research and development; and (9)the Company’s or any Group Company’s suppliers’, Clients’ or Prospective Clients’ names, addresses (including email addresses), telephone, facsimile or other contact numbers and contact names, the nature of their business operations, their requirements for services supplied by the Company or any Group Company and all confidential aspects of their relationship with the Company or any Group Company.

- 35 -

“directly or indirectly”	means (without prejudice to the generality of the expression) either alone or jointly with or on behalf of any other person and whether on his or her own account or in partnership with another or others or as the holder of any interest in or as officer, employee or agent of or consultant to any other person.
“Group”	means the Company, its subsidiaries or holding companies from time to time and any subsidiary of any holding company from time to time; and “Group Company” means any company within the Group.
“Key Employee”	means any director or officer of the Company or any Group Company and/or any employee (other than administrative or clerical personnel) of the Company or any Group Company, in each case who, at any time during the Relevant Period: i)was employed by the Company or any Group Company; and ii)with whom the Grantee has had Material Dealings or exercised control or had management responsibility for; and/or iii)has had access to or has obtained Confidential Information during the Relevant Period.
“Material Dealings”	means receiving orders, instructions or enquiries from, contracting or making preparations to contract with, making sales or presenting to or with, tendering for business from, having responsibility with or for, having personal knowledge of or otherwise having significant other contact.

- 36 -

“Prospective Client”	means any person, firm, company or other business entity who was at any time during the Relevant Period: (a) in negotiations with the Company or any Group Company for the provision of insurance or reinsurance; or (b) an insurance intermediary who may introduce such insurance or reinsurance business to the Company or any Group Company, and in each case with whom or which during the Relevant Period: i)the Grantee (or any person reporting to the Grantee) had Material Dealings in relation to Relevant Business; or ii)about whom or which the Grantee has had Confidential Information during the course of Grantee’s employment. Provided that this definition shall not apply to any such person, firm, company or other business entity which has withdrawn from or discontinued such negotiations or discussions, having stated its intention to do so (other than through any unlawful activity by the Grantee).
“Relevant Business”	means any class or classes of insurance or reinsurance business which was underwritten in the twelve months immediately prior to the Termination Date by the Company or any Group Company and with which the Grantee was directly or indirectly materially concerned or involved or had personal knowledge in the course of Grantee’s duties during the Relevant Period.
“Relevant Period”	means (1) during employment, the twelve month period immediately prior to the action or activity that may be in breach of clauses 2.1.1 to 2.1.4 and (2) after termination of employment, the twelve month period immediately prior to the Termination Date.
“Termination Date”	means the date on which the Grantee’s employment or engagement with the Company terminates for any reason.

- 37 -

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, W. Robert Berkley, Jr., President and Chief Executive Officer of W. R. Berkley Corporation (the “registrant”), certify that:

1. I have reviewed this quarterly report on Form 10-Q of the registrant;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 8, 2017

/s/ W. Robert Berkley, Jr.

W. Robert Berkley, Jr.

President and

Chief Executive Officer 

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Richard M. Baio, Senior Vice President - Chief Financial Officer and Treasurer of W. R. Berkley Corporation (the “registrant”), certify that:

1. I have reviewed this quarterly report on Form 10-Q of the registrant;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 8, 2017

/s/ Richard M. Baio

Richard M. Baio

Senior Vice President — Chief Financial Officer and Treasurer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of W. R. Berkley Corporation (the “Company”) on Form 10-Q for the period ended September 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, W. Robert Berkley, Jr., President and Chief Executive Officer of the Company, and Richard M. Baio, Senior Vice President - Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ W. Robert Berkley, Jr.

W. Robert Berkley, Jr.

President and Chief Executive Officer

/s/ Richard M. Baio

Richard M. Baio

Senior Vice President — Chief Financial Officer and Treasurer

November 8, 2017

A signed original of this written statement required by Section 906 has been provided to W. R. Berkley Corporation (the “Company”) and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2017	Nov. 06, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	BERKLEY W R CORP
Entity Central Index Key	0000011544
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Sep. 30, 2017
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Common Stock, Shares Outstanding		121,794,758

XML

Consolidated Balance Sheets Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Investments:
Fixed maturity securities	$ 13,873,690	$ 13,190,668
Investment funds	1,119,907	1,198,146
Real estate	1,391,274	1,184,981
Arbitrage trading account	488,238	299,999
Equity securities available for sale	614,025	669,200
Loans receivable	74,229	106,798
Total investments	17,561,363	16,649,792
Cash and cash equivalents	773,997	795,285
Premiums and fees receivable	1,818,836	1,701,854
Due from reinsurers	1,739,835	1,743,980
Deferred policy acquisition costs	534,091	537,890
Prepaid reinsurance premiums	473,766	413,140
Trading account receivables from brokers and clearing organizations	297,208	484,593
Property, furniture and equipment	399,924	349,432
Goodwill	173,422	144,513
Accrued investment income	139,864	127,047
Other assets	423,770	402,550
Total assets	24,336,076	23,350,076
Liabilities:
Reserves for losses and loss expenses	11,654,346	11,197,195
Unearned premiums	3,409,628	3,283,300
Due to reinsurers	228,539	213,128
Trading account securities sold but not yet purchased	44,937	51,179
Federal and foreign income taxes	116,608	119,597
Other liabilities	923,369	916,318
Senior notes and other debt	1,759,929	1,760,595
Subordinated debentures	728,071	727,630
Total liabilities	18,865,427	18,268,942
Equity:
Preferred stock, par value $.10 per share: Authorized 5,000,000 shares; issued and outstanding - none	0	0
Common stock, par value $.20 per share: Authorized 500,000,000 shares, issued and outstanding, net of treasury shares, 121,769,109 and 121,193,599 shares, respectively	47,024	47,024
Additional paid-in capital	1,040,575	1,037,446
Retained earnings	6,880,062	6,595,987
Accumulated other comprehensive income	153,759	55,568
Treasury stock, at cost, 113,348,809 and 113,924,319 shares, respectively	2,690,884	2,688,817
Total stockholders’ equity	5,430,536	5,047,208
Noncontrolling interests	40,113	33,926
Total equity	5,470,649	5,081,134
Total liabilities and equity	$ 24,336,076	$ 23,350,076

XML

Consolidated Balance Sheets Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollar per share)	$ 0.1	$ 0.1
Preferred shares authorized	5,000,000	5,000,000
Preferred shares issued	0	0
Preferred shares outstanding	0	0
Common stock, par value (in dollar per share)	$ 0.2	$ 0.2
Common shares authorized	500,000,000	500,000,000
Common shares issued	121,769,109	121,193,599
Common shares outstanding	121,769,109	121,193,599
Treasury stock issued at cost	113,348,809	113,924,319

XML

Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
REVENUES:
Net premiums written	$ 1,571,183	$ 1,607,365	$ 4,782,272	$ 4,913,656
Change in net unearned premiums	10,317	(21,421)	(62,028)	(240,584)
Net premiums earned	1,581,500	1,585,944	4,720,244	4,673,072
Net investment income	142,479	145,668	426,601	404,850
Net realized investment gains	183,959	175,738	276,760	207,508
Other-than-temporary impairments	0	0	0	(18,114)
Insurance service fees	33,612	32,135	100,475	109,437
Revenues from non-insurance businesses	89,786	80,242	225,033	305,787
Other income	6	0	695	0
Total revenues	2,031,342	2,019,727	5,749,808	5,682,540
OPERATING COSTS AND EXPENSES:
Losses and loss expenses	1,081,174	965,856	3,025,475	2,852,339
Other operating costs and expenses	600,822	606,348	1,821,155	1,770,450
Expenses from non-insurance businesses	86,412	78,865	221,389	291,127
Interest expense	36,821	37,043	110,419	104,019
Total operating costs and expenses	1,805,229	1,688,112	5,178,438	5,017,935
Income before income taxes	226,113	331,615	571,370	664,605
Income tax expense	(63,295)	(110,952)	(174,305)	(214,789)
Net income before noncontrolling interests	162,818	220,663	397,065	449,816
Noncontrolling interests	(764)	(13)	(2,560)	(689)
Net income to common stockholders	$ 162,054	$ 220,650	$ 394,505	$ 449,127
NET INCOME PER SHARE:
Basic (in dollar per share)	$ 1.29	$ 1.80	$ 3.17	$ 3.66
Diluted (in dollar per share)	$ 1.26	$ 1.72	$ 3.05	$ 3.50

XML

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Statement of Comprehensive Income [Abstract]
Net income before noncontrolling interests	$ 162,818	$ 220,663	$ 397,065	$ 449,816
Other comprehensive income (loss):
Change in unrealized currency translation adjustments	28,592	(19,470)	71,574	(77,389)
Change in unrealized investment gains (losses), net of taxes	(8,168)	(47,676)	26,598	134,213
Other comprehensive income (loss)	20,424	(67,146)	98,172	56,824
Comprehensive income	183,242	153,517	495,237	506,640
Noncontrolling interests	(731)	44	(2,541)	(623)
Comprehensive income to common stockholders	$ 182,511	$ 153,561	$ 492,696	$ 506,017

XML

Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Retained earnings	Accumulated Other Comprehensive Income (Loss)	Unrealized investment gain	Currency Translation Adjustments	Treasury stock	Noncontrolling interest
Beginning of period at Dec. 31, 2015		$ 47,024	$ 1,005,455	$ 6,178,070		$ 180,695	$ (247,393)	$ (2,563,605)	$ 32,962
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units issued			(3,421)
Restricted stock units expensed			25,431
Net income before noncontrolling interests	$ 449,816			449,127					689
Dividends				(107,661)
Unrealized gains on securities not other-than-temporarily impaired	134,213					133,866
Unrealized gains on other-than-temporarily impaired securities						413
Net change in period	(77,389)						(77,389)
Stock exercised/vested								5,023
Stock repurchased								(99,870)
Stock incentive plans expensed								0
Contributions									2,474
Other comprehensive loss, net of tax	56,824				$ 56,824		(77,389)		(66)
End of period at Sep. 30, 2016			1,027,465	6,519,536	(9,808)	314,974	(324,782)	(2,658,452)	36,059
Beginning of period at Dec. 31, 2016	5,081,134	$ 47,024	1,037,446	6,595,987		427,154	(371,586)	(2,688,817)	33,926
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units issued			(27,047)
Restricted stock units expensed			30,176
Net income before noncontrolling interests	397,065			394,505					2,560
Dividends				(110,430)
Unrealized gains on securities not other-than-temporarily impaired	26,598					25,712
Unrealized gains on other-than-temporarily impaired securities						905
Net change in period	71,574						71,574
Stock exercised/vested								25,584
Stock repurchased								(28,378)
Stock incentive plans expensed								727
Contributions									3,646
Other comprehensive loss, net of tax	98,172				98,172		71,574		(19)
End of period at Sep. 30, 2017	$ 5,470,649		$ 1,040,575	$ 6,880,062	$ 153,759	$ 453,771	$ (300,012)	$ (2,690,884)	$ 40,113

XML

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
CASH FROM OPERATING ACTIVITIES:
Net income to common stockholders	$ 394,505	$ 449,127
Adjustments to reconcile net income to net cash from operating activities:
Net investment gains	(276,760)	(189,394)
Depreciation and amortization	78,137	69,153
Noncontrolling interests	2,560	689
Investment funds	(51,907)	(60,387)
Stock incentive plans	31,883	27,033
Change in:
Arbitrage trading account	(2,835)	(4,777)
Premiums and fees receivable	(112,420)	(92,372)
Reinsurance accounts	(42,319)	(154,939)
Deferred policy acquisition costs	4,483	(51,795)
Income taxes	(15,451)	89,007
Reserves for losses and loss expenses	422,657	440,486
Unearned premiums	121,583	269,287
Other	(32,258)	(64,608)
Net cash from operating activities	521,858	726,510
CASH USED IN INVESTING ACTIVITIES:
Proceeds from sale of fixed maturity securities	3,081,619	1,074,630
Proceeds from sale of equity securities	137,062	123,187
Distributions from investment funds	265,371	5,630
Proceeds from maturities and prepayments of fixed maturity securities	2,860,678	2,189,365
Purchase of fixed maturity securities	(6,530,466)	(4,280,457)
Purchase of equity securities	(17,049)	(127,303)
Real estate purchased	(159,006)	(207,829)
Change in loans receivable	32,574	159,128
Net additions to property, furniture and equipment	(74,268)	(37,895)
Change in balances due to security brokers	39,978	102,981
Cash received in connection with business disposition	0	250,216
Payment for business purchased net of cash aquired	(70,570)	(53,524)
Net cash used in investing activities	(434,077)	(801,871)
CASH (USED IN) FROM FINANCING ACTIVITIES:
Repayment of senior notes and other debt	(1,788)	(70,567)
Net proceeds from issuance of debt	0	386,848
Cash dividends to common stockholders	(93,371)	(30,654)
Purchase of common treasury shares	(28,378)	(99,870)
Other, net	(3,835)	(1,376)
Net cash (used in) from financing activities	(127,372)	184,381
Net impact on cash due to change in foreign exchange rates	18,303	413
Net change in cash and cash equivalents	(21,288)	109,433
Cash and cash equivalents at beginning of year	795,285	763,631
Cash and cash equivalents at end of period	$ 773,997	$ 873,064

XML

General

9 Months Ended

Sep. 30, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

General

General

The unaudited consolidated financial statements, which include the accounts of W. R. Berkley Corporation and its subsidiaries (the “Company”) have been prepared on the basis of U.S. generally accepted accounting principles (“GAAP”) for interim financial information. Accordingly, they do not include all the information and notes required by GAAP for annual financial statements. The unaudited consolidated financial statements reflect all adjustments, consisting only of normal recurring items, which are necessary to present fairly the Company’s financial position and results of operations on a basis consistent with the prior audited consolidated financial statements. Operating results for interim periods are not necessarily indicative of the results that may be expected for the year. All significant intercompany accounts and transactions have been eliminated. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the revenues and expenses reflected during the reporting period. For further information related to a description of areas of judgment and estimates and other information necessary to understand the Company’s financial position and results of operations, refer to the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016. Reclassifications have been made in the 2016 financial statements as originally reported to conform to the presentation of the 2017 financial statements.

The income tax provision has been computed based on the Company’s estimated annual effective tax rate. The effective tax rate for the quarter differs from the federal income tax rate of 35% principally because of tax-exempt investment income, as well as the new requirement in 2017 to recognize tax benefits for stock compensation in income tax expense.

XML

Per Share Data

9 Months Ended

Sep. 30, 2017

Earnings Per Share [Abstract]

Per Share Data

Per Share Data

The Company presents both basic and diluted net income per share (“EPS”) amounts. Basic EPS is calculated by dividing net income by the weighted average number of common shares outstanding during the period (including 4,087,731 common shares held in a grantor trust established in March 2017). The common shares held in the grantor trust are for delivery upon settlement of vested but mandatorily deferred restricted stock units ("RSUs"). Shares held by the grantor trust do not affect diluted shares outstanding since the shares deliverable under vested RSUs were already included in diluted shares outstanding. Diluted EPS is based upon the weighted average number of basic and common equivalent shares outstanding during the period and is calculated using the treasury stock method for stock incentive plans. Common equivalent shares are excluded from the computation in periods in which they have an anti-dilutive effect.

The weighted average number of common shares used in the computation of basic and diluted earnings per share was as follows:

	For the Three Months		For the Nine Months
	Ended September 30,		Ended September 30,
(In thousands)	2017	2016	2017	2016
Basic	125,818	122,562	124,363	122,652
Diluted	128,944	128,556	129,289	128,501

XML

Recent Accounting Pronouncements

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Recent Accounting Pronouncements

Recent Accounting Pronouncements

Recently adopted accounting pronouncements:

In May 2015, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2015-09, Disclosures about Short-Duration Contracts. ASU 2015-09 requires companies that issue short duration insurance contracts to disclose additional information, including: (i) incurred and paid claims development tables; (ii) frequency and severity of claims; and (iii) information about material changes in judgments made in calculating the liability for unpaid claim adjustment expenses, including reasons for the change and the effects on the financial statements. The Company adopted this updated guidance on January 1, 2016 with regard to the annual requirements and on January 1, 2017 with regard to the interim requirements. The amendments in ASU 2015-09 are applied retrospectively by providing comparative disclosures for each period presented, except for those requirements that apply only to the current period. As the requirements are disclosure only, the adoption of this guidance did not impact our financial condition or results of operations, but did result in additional disclosures.

In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting. ASU 2016-09 includes provisions intended to simplify various previous provisions related to how share-based payments are accounted for and presented in the financial statements. Under the new guidance, excess tax benefits (deductions for share based payment awards for tax purposes that exceed the compensation cost recognized for financial reporting purposes) are reported within the income tax expense financial statement line item. Previously, excess tax benefits were reported within additional paid in capital. The Company adopted this updated guidance on January 1, 2017 prospectively. The adoption of this guidance did not have a material impact on the Company's financial condition or results of operations.

All other accounting and reporting standards that became effective in 2017 were either not applicable to the Company or their adoption did not have a material impact on the Company. 

Accounting and reporting standards that are not yet effective:

In May 2014, the FASB issued ASU 2014-09, Revenue from Customers. ASU 2014-09 clarifies the principles for recognizing revenue. While insurance contracts are not within the scope of this updated guidance, the Company’s insurance service fee revenue and non-insurance business revenue will be subject to this updated guidance. The updated guidance requires an entity to recognize revenue as performance obligations are met, in order to reflect the transfer of promised goods or services to customers in an amount that reflects the consideration the entity is entitled to receive for those goods or services. The updated guidance, as amended by ASU 2015-14, is effective for public business entities for annual and interim reporting periods beginning after December 15, 2017. The adoption of this guidance is not expected to have a material effect on the Company’s financial condition or results of operations.

In January 2016, the FASB issued ASU 2016-01, Financial Instruments.  ASU 2016-01 amends the accounting guidance for financial instruments to require all equity investments to be measured at fair value with changes in the fair value recognized through net income (other than those accounted for under equity method of accounting or those that result in consolidation of the investee).  The updated guidance is effective for public business entities for annual reporting periods beginning after December 15, 2017 and interim periods within those years.  The adoption of this guidance is not expected to have a material effect on the Company’s financial condition upon adoption, but will impact results of operations after adoption of this guidance as unrealized gains and losses on equity securities will no longer be reported directly in accumulated other comprehensive income (AOCI), but will instead be reported in net income.

In February 2016, the FASB issued ASU 2016-02, Leases, which amends the accounting and disclosure guidance for leases.  This guidance retains the two classifications of a lease, as either an operating or finance lease, both of which will require lessees to recognize a right-of-use asset and a lease liability for leases with terms of more than 12 months. The right-of-use asset and the lease liability will be determined based upon the present value of cash flows. Finance leases will reflect the financial arrangement by recognizing interest expense on the lease liability separately from the amortization expense of the right-of-use asset. Operating leases will recognize lease expense (with no separate recognition of interest expense) on a straight-line basis over the term of the lease. The accounting by lessors is not significantly changed by the updated guidance.  The updated guidance is effective for reporting periods beginning after December 15, 2018, and will require that the earliest comparative period presented include the measurement and recognition of existing leases with an adjustment to equity as if the updated guidance had always been applied. The Company is currently evaluating the impact that the adoption of this guidance will have on its results of operations, financial position and liquidity.

     In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses, which amends the accounting guidance for credit losses on financial instruments. The updated guidance amends the current other-than-temporary impairment model for available-for-sale debt securities by requiring the recognition of impairments relating to credit losses through an allowance account and limits the amount of credit loss to the difference between a security’s amortized cost basis and its fair value. This guidance also applies a new current expected credit loss model for determining credit-related impairments for financial instruments measured at amortized cost.  The updated guidance is effective for reporting periods beginning after December 15, 2019. The Company will not be able to determine the impact the adoption of this guidance will have on its results of operations, financial position or liquidity until the year the guidance becomes effective.

All other recently issued but not yet effective accounting and reporting standards are either not applicable to the Company or are not expected to have a material impact on the Company.

XML

Acquisitions/Dispositions

9 Months Ended

Sep. 30, 2017

Business Combinations [Abstract]

Acquisitions/Dispositions

Acquisitions/Disposition

In March 2017, the Company acquired an 89.5% ownership interest for $73.3 million in a company engaged in providing textile solutions world-wide. The fair value of the assets acquired and liabilities assumed have been estimated based on a third party valuation.

The following table summarizes the estimated fair value of net assets acquired and liabilities assumed for the business combination completed in 2017:

(In thousands)	2017
Cash and cash equivalents	$	2,721
Real estate, furniture and equipment	7,042
Goodwill	28,522
Intangible assets	32,395
Other assets	9,862
Total assets acquired	80,542
Other liabilities assumed	(2,251		)
Noncontrolling interest	(5,000		)
Net assets acquired	$	73,291

In February 2016, the Company acquired an 85% ownership interest for $42.3 million in a company engaged in the distribution of promotional merchandise.

XML

Consolidated Statements of Comprehensive Income

9 Months Ended

Sep. 30, 2017

Equity [Abstract]

Consolidated Statements of Comprehensive Income

Consolidated Statement of Comprehensive Income

The following table presents the components of the changes in accumulated other comprehensive income ("AOCI"):

(In thousands)	Unrealized Investment Gains (Losses)				Currency Translation Adjustments			Accumulated Other Comprehensive Income
As of and for the nine months ended September 30, 2017:
Changes in AOCI
Beginning of period	$	427,154			$	(371,586	)	$	55,568
Other comprehensive income before reclassifications	109,277				71,574			180,851
Amounts reclassified from AOCI	(82,679		)		—			(82,679		)
Other comprehensive income	26,598				71,574			98,172
Unrealized investment loss related to non-controlling interest	19				—			19
End of period	$	453,771			$	(300,012	)	$	153,759
Amounts reclassified from AOCI
Pre-tax	$	(127,198	)	(1)	$	—		$	(127,198	)
Tax effect	44,519			(2)	—			44,519
After-tax amounts reclassified	$	(82,679	)		$	—		$	(82,679	)
Other comprehensive income
Pre-tax	$	50,148			$	71,574		$	121,722
Tax effect	(23,550		)		—			(23,550		)
Other comprehensive income	$	26,598			$	71,574		$	98,172
As of and for the three months ended September 30, 2017:
Changes in AOCI
Beginning of period	$	461,906			$	(328,604	)	$	133,302
Other comprehensive income before reclassifications	19,968				28,592			48,560
Amounts reclassified from AOCI	(28,136		)		—			(28,136		)
Other comprehensive (loss) income	(8,168		)		28,592			20,424
Unrealized investment loss related to non-controlling interest	33				—			33
End of period	$	453,771			$	(300,012	)	$	153,759
Amounts reclassified from AOCI
Pre-tax	$	(43,286	)	(1)	$	—		$	(43,286	)
Tax effect	15,150			(2)	—			15,150
After-tax amounts reclassified	$	(28,136	)		$	—		$	(28,136	)
Other comprehensive (loss) income
Pre-tax	$	(8,563	)		$	28,592		$	20,029
Tax effect	395				—			395
Other comprehensive (loss) income	$	(8,168	)		$	28,592		$	20,424

_________________________

⁽¹⁾ Net investment gains in the consolidated statements of income.

⁽²⁾ Income tax expense in the consolidated statements of income.

(In thousands)	Unrealized Investment Gains (Losses)				Currency Translation Adjustments			Accumulated Other Comprehensive Income (Loss)
As of and for the nine months ended September 30, 2016:
Changes in AOCI
Beginning of period	$	180,695			$	(247,393	)	$	(66,698	)
Other comprehensive income (loss) before reclassifications	170,824				(77,389		)	93,435
Amounts reclassified from AOCI	(36,611		)		—			(36,611		)
Other comprehensive income (loss)	134,213				(77,389		)	56,824
Unrealized investment loss related to non-controlling interest	66				—			66
End of period	$	314,974			$	(324,782	)	$	(9,808	)
Amounts reclassified from AOCI
Pre-tax	$	(56,325	)	(1)	$	—		$	(56,325	)
Tax effect	19,714			(2)	—			19,714
After-tax amounts reclassified	$	(36,611	)		$	—		$	(36,611	)
Other comprehensive income (loss)
Pre-tax	$	198,808			$	(77,389	)	$	121,419
Tax effect	(64,595		)		—			(64,595		)
Other comprehensive income (loss)	$	134,213			$	(77,389	)	$	56,824
As of and for the three months ended September 30, 2016:
Changes in AOCI
Beginning of period	$	362,593			$	(305,312	)	$	57,281
Other comprehensive loss before reclassifications	(20,968		)		(19,470		)	(40,438		)
Amounts reclassified from AOCI	(26,708		)		—			(26,708		)
Other comprehensive loss	(47,676		)		(19,470		)	(67,146		)
Unrealized investment loss related to non-controlling interest	57				—			57
End of period	$	314,974			$	(324,782	)	$	(9,808	)
Amounts reclassified from AOCI
Pre-tax	$	(41,090	)	(1)	$	—		$	(41,090	)
Tax effect	14,382			(2)	—			14,382
After-tax amounts reclassified	$	(26,708	)		$	—		$	(26,708	)
Other comprehensive loss
Pre-tax	$	(72,188	)		$	(19,470	)	$	(91,658	)
Tax effect	24,512				—			24,512
Other comprehensive loss	$	(47,676	)		$	(19,470	)	$	(67,146	)

_______________

(1) Net investment gains in the consolidated statements of income.

(2) Income tax expense in the consolidated statements of income.

XML

Statements of Cash Flow

9 Months Ended

Sep. 30, 2017

Supplemental Cash Flow Elements [Abstract]

Statements of Cash Flow

Statements of Cash Flow

Interest payments were $134,291,000 and $124,791,000 and income taxes paid were $182,487,000 and $99,161,000 in the nine months ended September 30, 2017 and 2016, respectively.

XML

Investments In Fixed Maturity Securities

9 Months Ended

Sep. 30, 2017

Debt securities

Schedule of Available-for-sale Securities [Line Items]

Investments In Fixed Maturity Securities

Investments in Fixed Maturity Securities

At September 30, 2017 and December 31, 2016, investments in fixed maturity securities were as follows:

(In thousands)	Amortized Cost		Gross Unrealized					Fair Value		Carrying Value
			Gains		Losses
September 30, 2017
Held to maturity:
State and municipal	$	65,372	$	15,212	$	—		$	80,584	$	65,372
Residential mortgage-backed	14,024		1,452		—			15,476		14,024
Total held to maturity	79,396		16,664		—			96,060		79,396
Available for sale:
U.S. government and government agency	402,901		10,828		(2,124		)	411,605		411,605
State and municipal:
Special revenue	2,730,653		80,144		(5,469		)	2,805,328		2,805,328
State general obligation	481,070		21,377		(565		)	501,882		501,882
Pre-refunded	282,488		21,052		(173		)	303,367		303,367
Corporate backed	380,351		11,775		(499		)	391,627		391,627
Local general obligation	384,930		26,566		(531		)	410,965		410,965
Total state and municipal	4,259,492		160,914		(7,237		)	4,413,169		4,413,169
Mortgage-backed securities:
Residential (1)	1,064,705		12,696		(8,860		)	1,068,541		1,068,541
Commercial	251,387		1,641		(1,450		)	251,578		251,578
Total mortgage-backed securities	1,316,092		14,337		(10,310		)	1,320,119		1,320,119
Asset-backed	2,389,187		9,836		(10,405		)	2,388,618		2,388,618
Corporate:
Industrial	2,569,673		70,054		(2,842		)	2,636,885		2,636,885
Financial	1,335,101		43,636		(4,716		)	1,374,021		1,374,021
Utilities	255,478		12,760		(907		)	267,331		267,331
Other	42,183		2		(48		)	42,137		42,137
Total corporate	4,202,435		126,452		(8,513		)	4,320,374		4,320,374
Foreign	909,608		32,889		(2,088		)	940,409		940,409
Total available for sale	13,479,715		355,256		(40,677		)	13,794,294		13,794,294
Total investments in fixed maturity securities	$	13,559,111	$	371,920	$	(40,677	)	$	13,890,354	$	13,873,690

(In thousands)	Amortized Cost		Gross Unrealized					Fair Value		Carrying Value
			Gains		Losses
December 31, 2016
Held to maturity:
State and municipal	$	72,582	$	12,453	$	—		$	85,035	$	72,582
Residential mortgage-backed	15,944		1,693		—			17,637		15,944
Total held to maturity	88,526		14,146		—			102,672		88,526
Available for sale:
U.S. government and government agency	496,187		20,208		(2,593		)	513,802		513,802
State and municipal:
Special revenue	2,791,211		58,559		(26,315		)	2,823,455		2,823,455
State general obligation	524,682		16,964		(5,139		)	536,507		536,507
Pre-refunded	356,535		19,181		(165		)	375,551		375,551
Corporate backed	410,933		6,172		(6,452		)	410,653		410,653
Local general obligation	360,022		15,682		(2,367		)	373,337		373,337
Total state and municipal	4,443,383		116,558		(40,438		)	4,519,503		4,519,503
Mortgage-backed securities:
Residential (1)	1,034,301		15,431		(12,950		)	1,036,782		1,036,782
Commercial	155,540		304		(2,981		)	152,863		152,863
Total mortgage-backed securities	1,189,841		15,735		(15,931		)	1,189,645		1,189,645
Asset-backed	1,913,830		5,971		(11,941		)	1,907,860		1,907,860
Corporate:
Industrial	2,315,567		71,007		(7,174		)	2,379,400		2,379,400
Financial	1,369,001		39,543		(11,270		)	1,397,274		1,397,274
Utilities	229,154		10,801		(2,411		)	237,544		237,544
Other	54,073		299		(63		)	54,309		54,309
Total corporate	3,967,795		121,650		(20,918		)	4,068,527		4,068,527
Foreign	858,773		46,794		(2,762		)	902,805		902,805
Total available for sale	12,869,809		326,916		(94,583		)	13,102,142		13,102,142
Total investments in fixed maturity securities	$	12,958,335	$	341,062	$	(94,583	)	$	13,204,814	$	13,190,668

____________

(1) Gross unrealized gains and (losses) for residential mortgage-backed securities include $85,907 and $(818,691) as of September 30, 2017 and December 31, 2016, respectively, related to securities with the non-credit portion of other-than-temporary impairments (“OTTI”) recognized in accumulated other comprehensive income.

The amortized cost and fair value of fixed maturity securities at September 30, 2017, by contractual maturity, are shown below. Actual maturities may differ from contractual maturities because certain issuers may have the right to call or prepay obligations.

(In thousands)	Amortized Cost		Fair Value
Due in one year or less	$	745,010	$	750,479
Due after one year through five years	5,089,768		5,210,268
Due after five years through ten years	3,248,254		3,396,461
Due after ten years	3,145,963		3,197,551
Mortgage-backed securities	1,330,116		1,335,595
Total	$	13,559,111	$	13,890,354

At September 30, 2017 and December 31, 2016, there were no investments that exceeded 10% of common stockholders' equity, other than investments in United States government and government agency securities.

XML

Investments in Equity Securities Available for Sale

9 Months Ended

Sep. 30, 2017

Equity securities available for sale

Schedule of Available-for-sale Securities [Line Items]

Investments in Equity Securities Available for Sale

Investments in Equity Securities Available for Sale

At September 30, 2017 and December 31, 2016, investments in equity securities were as follows:

(In thousands)	Cost		Gross Unrealized					Fair Value		Carrying Value
			Gains		Losses
September 30, 2017
Common stocks	$	83,709	$	339,297	$	(3,486	)	$	419,520	$	419,520
Preferred stocks	125,076		71,147		(1,718		)	194,505		194,505
Total	$	208,785	$	410,444	$	(5,204	)	$	614,025	$	614,025
December 31, 2016
Common stocks	$	94,998	$	351,906	$	(1,046	)	$	445,858	$	445,858
Preferred stocks	125,589		101,392		(3,639		)	223,342		223,342
Total	$	220,587	$	453,298	$	(4,685	)	$	669,200	$	669,200

XML

Arbitrage Trading Account

9 Months Ended

Sep. 30, 2017

Trading Securities [Abstract]

Arbitrage Trading Account

Arbitrage Trading Account

At September 30, 2017 and December 31, 2016, the fair and carrying values of the arbitrage trading account were $488 million and $300 million, respectively. The primary focus of the trading account is merger arbitrage. Merger arbitrage is the business of investing in the securities of publicly held companies which are the targets in announced tender offers and mergers. Arbitrage investing differs from other types of investing in its focus on transactions and events believed likely to bring about a change in value over a relatively short time period (usually four months or less).

The Company uses put options, call options and swap contracts in order to mitigate the impact of potential changes in market conditions on the merger arbitrage trading account. These options and contracts are reported at fair value. As of September 30, 2017, the fair value of long option contracts outstanding was $1 million (notional amount of $33 million) and the fair value of short option contracts outstanding was $1 million (notional amount of $54 million). Other than with respect to the use of these trading account securities, the Company does not make use of derivatives.

XML

Net Investment Income

9 Months Ended

Sep. 30, 2017

Net Investment Income [Abstract]

Net Investment Income

Net Investment Income

Net investment income consists of the following:

	For the Three Months						For the Nine Months
	Ended September 30,						Ended September 30,
(In thousands)	2017			2016			2017			2016
Investment income earned on:
Fixed maturity securities, including cash and cash equivalents and loans receivable	$	118,834		$	114,271		$	347,976		$	331,448
Investment funds	15,200			25,293			50,744			60,385
Arbitrage trading account	4,418			6,441			16,235			12,883
Real estate	5,042			585			14,894			4,552
Equity securities available for sale	604			1,069			1,845			3,217
Gross investment income	144,098			147,659			431,694			412,485
Investment expense	(1,619		)	(1,991		)	(5,093		)	(7,635		)
Net investment income	$	142,479		$	145,668		$	426,601		$	404,850

XML

Investment Funds

9 Months Ended

Sep. 30, 2017

Equity Method Investments and Joint Ventures [Abstract]

Investment Funds

Investment Funds

The Company evaluates whether it is an investor in a variable interest entity (VIE). Such entities do not have sufficient equity at risk to finance their activities without additional subordinated financial support, or the equity investors, as a group, do not have the characteristics of a controlling financial interest (primary beneficiary).  The Company determines whether it is the primary beneficiary of an entity subject to consolidation based on a qualitative assessment of the VIE's capital structure, contractual terms, nature of the VIE's operations and purpose, and the Company's relative exposure to the related risks of the VIE on the date it becomes initially involved in the VIE and on an ongoing basis. The Company is not the primary beneficiary in any of its investment funds, and accordingly, carries its interests in investment funds under the equity method of accounting.

The Company’s maximum exposure to loss with respect to these investments is limited to the carrying amount reported on the Company’s consolidated balance sheet and its unfunded commitments which were $442 million as of September 30, 2017.

Investment funds consisted of the following:

	Carrying Value as of				Income (Loss) from Investment Funds
	September 30,		December 31,		For the Nine Months Ended September 30,
(In thousands)	2017		2016		2017			2016
Real estate	$	614,508	$	641,783	$	30,661		$	33,028
Energy	85,817		91,448		(12,763		)	7,174
Hedge equity	—		73,913		(1,164		)	791
Other funds	419,582		391,002		34,010			19,392
Total	$	1,119,907	$	1,198,146	$	50,744		$	60,385

The Company's share of the earnings or losses of investment funds is generally reported on a one-quarter lag in order to facilitate the timely completion of the Company's consolidated financial statements.

XML

Real Estate

9 Months Ended

Sep. 30, 2017

Real Estate [Abstract]

Real Estate

Real Estate

Investment in real estate represents directly owned property held for investment, as follows:    

	Carrying Value
	September 30,		December 31,
(In thousands)	2017		2016
Properties in operation	$	451,669	$	457,237
Properties under development	939,605		727,744
Total	$	1,391,274	$	1,184,981

In 2017, properties in operation included a long-term ground lease in Washington, D.C., a hotel in Memphis, Tennessee, an office complex in New York City and office buildings in West Palm Beach and Palm Beach, Florida. Properties in operation are net of accumulated depreciation and amortization of $20,378,000 and $14,996,000 as of September 30, 2017 and December 31, 2016, respectively. Related depreciation expense was $5,382,000 and $4,117,000 for the nine months ended September 30, 2017 and 2016, respectively. Future minimum rental income expected on operating leases relating to properties in operation is $4,966,133 in 2017, $28,251,980 in 2018, $30,174,146 in 2019, $29,415,103 in 2020, $30,054,813 in 2021, $29,966,679 in 2022 and $467,192,215 thereafter.

Properties under development include an office building in London and a mixed-use project in Washington, D.C.

XML

Loans Receivable

9 Months Ended

Sep. 30, 2017

Receivables [Abstract]

Loans Receivable

Loans Receivable

Loans receivable are as follows:

(In thousands)	September 30, 2017			December 31, 2016
Amortized cost (net of valuation allowance):
Real estate loans	$	59,487		$	92,415
Commercial loans	14,742			14,383
Total	$	74,229		$	106,798
Fair value:
Real estate loans	$	60,372		$	92,415
Commercial loans	16,243			15,884
Total	$	76,615		$	108,299
Valuation allowance:
Specific	$	1,200		$	1,200
General	2,183			2,197
Total	$	3,383		$	3,397
	For the Three Months Ended September 30,
	2017			2016
Increase in valuation allowance	$	—		$	467
	For the Nine Months Ended September 30,
	2017			2016
(Decrease) increase in valuation allowance	$	(14	)	$	1,128

Loans receivable in non-accrual status were $4.5 million and $5.4 million as of September 30, 2017 and December 31, 2016, respectively.

The Company monitors the performance of its loans receivable and assesses the ability of the borrower to pay principal and interest based upon loan structure, underlying property values, cash flow and related financial and operating performance of the property and market conditions. Loans receivable with a potential for default are further assessed using discounted cash flow analysis and comparable cost and sales methodologies, if appropriate.

The real estate loans are secured by commercial real estate primarily located in New York. These loans generally earn interest at floating LIBOR-based interest rates and have maturities (inclusive of extension options) through August 2025. The commercial loans are with small business owners who have secured the related financing with the assets of the business. Commercial loans primarily earn interest on a fixed basis and have varying maturities generally not exceeding 10 years.

In evaluating the real estate loans, the Company considers their credit quality indicators, including loan to value ratios, which compare the outstanding loan amount to the estimated value of the property, the borrower’s financial condition and performance with respect to loan terms, the position in the capital structure, the overall leverage in the capital structure and other market conditions. Based on these considerations, none of the real estate loans were considered to be impaired at September 30, 2017, and accordingly, the Company determined that a specific valuation allowance was not required.

XML

Realized And Unrealized Investment Gains (Losses)

9 Months Ended

Sep. 30, 2017

Realized and Unrealized Investment Gains (Losses) [Abstract]

Realized and Unrealized Investment Gains (Losses)

Realized and Unrealized Investment Gains (Losses)

Realized and unrealized investment gains (losses) are as follows:

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
(In thousands)	2017			2016			2017			2016
Realized investment gains (losses):
Fixed maturity securities:
Gains	$	8,763		$	33,798		$	21,795		$	66,972
Losses	(197		)	(1,150		)	(4,162		)	(5,570		)
Equity securities available for sale	34,720			8,441			109,566			13,037
Investment funds (1)	124,228			(3,788		)	125,383			(9,041		)
Real estate	1,956			687			4,892			5,247
Other (2)	14,489			137,750			19,286			136,863
Net realized gains on investments sales	183,959			175,738			276,760			207,508
Other-than-temporary impairments (3)	—			—			—			(18,114		)
Net investment gains	183,959			175,738			276,760			189,394
Income tax expense	(64,386		)	(61,508		)	(96,866		)	(66,288		)
After-tax net realized investment gains	$	119,573		$	114,230		$	179,894		$	123,106

Change in unrealized investment gains of available for sale securities:
Fixed maturity securities	$	(10,627	)	$	(45,388	)	$	84,214		$	169,933
Previously impaired fixed maturity securities	61			(1,406		)	905			413
Equity securities available for sale	(2,126		)	(28,517		)	(44,812		)	12,433
Investment funds	4,129			3,143			9,841			16,028
Total change in unrealized investment gains	(8,563		)	(72,168		)	50,148			198,807
Income tax benefit (expense)	423			24,493			(23,550		)	(64,594		)
Noncontrolling interests	5			57			19			66
After-tax change in unrealized investment gains of available for sale securities	$	(8,135	)	$	(47,618	)	$	26,617		$	134,279

______________________

(1) Investment funds includes a gain of $124.3 million from the sale of an investment in an office building located in Washington, D.C. for the three and nine months ended September 30, 2017.

(2) Other includes a gain of $134.9 million from the sale of Aero Precision Industries and certain related aviation services business for the three and nine months ended September 30, 2016.

(3) There were no other than temporary impairments (OTTI) for the three and nine months ended September 30, 2017, or for the three months ended September 30, 2016. OTTI for the nine months ended September 30, 2016 of $18.1 million were related to common stock.

XML

Securities In An Unrealized Loss Position

9 Months Ended

Sep. 30, 2017

Investments [Abstract]

Securities in Unrealized Loss Position

Securities in an Unrealized Loss Position

The following tables summarize all securities in an unrealized loss position at September 30, 2017 and December 31, 2016 by the length of time those securities have been continuously in an unrealized loss position:

	Less Than 12 Months				12 Months or Greater				Total
(In thousands)	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
September 30, 2017
U.S. government and government agency	$	118,066	$	1,048	$	48,880	$	1,076	$	166,946	$	2,124
State and municipal	650,353		5,797		119,087		1,440		769,440		7,237
Mortgage-backed securities	527,034		5,000		221,923		5,310		748,957		10,310
Asset-backed securities	1,116,878		8,033		130,734		2,372		1,247,612		10,405
Corporate	651,373		5,395		57,557		3,118		708,930		8,513
Foreign government	220,860		2,072		1,599		16		222,459		2,088
Fixed maturity securities	3,284,564		27,345		579,780		13,332		3,864,344		40,677
Common stocks	4,678		3,095		9,387		391		14,065		3,486
Preferred stocks	—		—		23,957		1,718		23,957		1,718
Equity securities available for sale	4,678		3,095		33,344		2,109		38,022		5,204
Total	$	3,289,242	$	30,440	$	613,124	$	15,441	$	3,902,366	$	45,881
December 31, 2016
U.S. government and government agency	$	112,709	$	1,252	$	35,450	$	1,341	$	148,159	$	2,593
State and municipal	1,562,614		35,553		133,034		4,885		1,695,648		40,438
Mortgage-backed securities	625,903		11,103		109,066		4,828		734,969		15,931
Asset-backed securities	1,010,836		5,340		201,693		6,601		1,212,529		11,941
Corporate	1,035,245		13,448		65,147		7,470		1,100,392		20,918
Foreign government	213,246		1,985		24,820		777		238,066		2,762
Fixed maturity securities	4,560,553		68,681		569,210		25,902		5,129,763		94,583
Common stocks	336		22		8,755		1,024		9,091		1,046
Preferred stocks	—		—		22,034		3,639		22,034		3,639
Equity securities available for sale	336		22		30,789		4,663		31,125		4,685
Total	$	4,560,889	$	68,703	$	599,999	$	30,565	$	5,160,888	$	99,268

Fixed Maturity Securities – A summary of the Company’s non-investment grade fixed maturity securities that were in an unrealized loss position at September 30, 2017 is presented in the table below:

($ in thousands)	Number of Securities	Aggregate Fair Value		Gross Unrealized Loss
Foreign government	9	$	55,292	$	462
Mortgage-backed securities	6	5,975		150
Corporate	3	2,852		211
Asset-backed securities	3	1,331		115
Total	21	$	65,450	$	938

For OTTI of fixed maturity securities that management does not intend to sell or, to be required to sell, the portion of the decline in value that is considered to be due to credit factors is recognized in earnings, and the portion of the decline in value that is considered to be due to non-credit factors is recognized in other comprehensive income.

The Company has evaluated its fixed maturity securities in an unrealized loss position and believes the unrealized losses are due primarily to temporary market and sector-related factors rather than to issuer-specific factors. None of these securities are delinquent or in default under financial covenants. Based on its assessment of these issuers, the Company expects them to continue to meet their contractual payment obligations as they become due and does not consider any of these securities to be OTTI.

Preferred Stocks – At September 30, 2017, there was one preferred stock in an unrealized loss position, with a fair value of $24.0 million and a gross unrealized loss of $1.7 million. Based upon management’s view of the underlying value of the security, the Company does not consider the equity security to be OTTI. For the nine months ended September 30, 2017 and 2016, there was no OTTI for preferred stocks.

Common Stocks – At September 30, 2017, there were threecommon stocks in an unrealized loss position, with an aggregate fair value of $14.1 million and a gross unrealized loss of $3.5 million. Based upon management's view of the underlying value of these securities, the Company does not consider these equity securities to be OTTI. There was no OTTI of common stocks for the nine months ended September 30, 2017. For the nine months ended September 30, 2016, OTTI for common stocks was $18.1 million.

XML

Fair Value Measurements

9 Months Ended

Sep. 30, 2017

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements

The Company’s fixed maturity and equity securities classified as available for sale and its trading account securities are carried at fair value. Fair value is defined as “the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.” The Company utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels, as follows:

Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.  

Level 2 - Quoted prices for similar assets or valuations based on inputs that are observable.

Level 3 - Estimates of fair value based on internal pricing methodologies using unobservable inputs. Unobservable inputs are only used to measure fair value to the extent that observable inputs are not available.

Substantially, all of the Company’s fixed maturity securities were priced by independent pricing services. The prices provided by the independent pricing services are estimated based on observable market data in active markets utilizing pricing models and processes, which may include benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, sector groupings, matrix pricing and reference data. The pricing services may prioritize inputs differently on any given day for any security based on market conditions, and not all inputs are available for each security evaluation on any given day. The pricing services used by the Company have indicated that they will only produce an estimate of fair value if objectively verifiable information is available. The determination of whether markets are active or inactive is based upon the volume and level of activity for a particular asset class. The Company reviews the prices provided by pricing services for reasonableness and periodically performs independent price tests of a sample of securities to ensure proper valuation.

If prices from independent pricing services are not available for fixed maturity securities, the Company estimates the fair value. For Level 2 securities, the Company utilizes pricing models and processes which may include benchmark yields, sector groupings, matrix pricing, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, bids, offers and reference data. Where broker quotes are used, the Company generally requests two or more quotes and sets a price within the range of quotes received based on its assessment of the credibility of the quote and its own evaluation of the security. The Company generally does not adjust quotes received from brokers. For securities traded only in private negotiations, the Company determines fair value based primarily on the cost of such securities, which is adjusted to reflect prices of recent placements of securities of the same issuer, financial projections, credit quality and business developments of the issuer and other relevant information.

For Level 3 securities, the Company generally uses a discounted cash flow model to estimate the fair value of fixed maturity securities. The cash flow models are based upon assumptions as to prevailing credit spreads, interest rate and interest rate volatility, time to maturity and subordination levels. Projected cash flows are discounted at rates that are adjusted to reflect illiquidity, where appropriate.

The following tables present the assets and liabilities measured at fair value on a recurring basis as of September 30, 2017 and December 31, 2016 by level:

(In thousands)	Total		Level 1		Level 2		Level 3
September 30, 2017
Assets:
Fixed maturity securities available for sale:
U.S. government and government agency	$	411,605	$	—	$	411,605	$	—
State and municipal	4,413,169		—		4,413,169		—
Mortgage-backed securities	1,320,119		—		1,320,119		—
Asset-backed securities	2,388,618		—		2,388,444		174
Corporate	4,320,374		—		4,320,374		—
Foreign government	940,409		—		940,409		—
Total fixed maturity securities available for sale	13,794,294		—		13,794,120		174
Equity securities available for sale:
Common stocks	419,520		410,133		—		9,387
Preferred stocks	194,505		—		190,649		3,856
Total equity securities available for sale	614,025		410,133		190,649		13,243
Arbitrage trading account	488,238		275,818		212,420		—
Total	$	14,896,557	$	685,951	$	14,197,189	$	13,417
Liabilities:
Trading account securities sold but not yet purchased	$	44,937	$	44,851	$	86	$	—
December 31, 2016
Assets:
Fixed maturity securities available for sale:
U.S. government and government agency	$	513,802	$	—	$	513,802	$	—
State and municipal	4,519,503		—		4,519,503		—
Mortgage-backed securities	1,189,645		—		1,189,645		—
Asset-backed securities	1,907,860		—		1,907,677		183
Corporate	4,068,527		—		4,068,527		—
Foreign government	902,805		—		902,805		—
Total fixed maturity securities available for sale	13,102,142		—		13,101,959		183
Equity securities available for sale:
Common stocks	445,858		429,647		7,457		8,754
Preferred stocks	223,342		—		219,680		3,662
Total equity securities available for sale	669,200		429,647		227,137		12,416
Arbitrage trading account	299,999		224,623		75,376		—
Total	$	14,071,341	$	654,270	$	13,404,472	$	12,599
Liabilities:
Trading account securities sold but not yet purchased	$	51,179	$	51,089	$	90	$	—

There were no significant transfers between Levels 1 and 2 during the nine months ended September 30, 2017 or during the year ended December 31, 2016.

The following tables summarize changes in Level 3 assets and liabilities for the nine months ended September 30, 2017 and for the year ended December 31, 2016:

	Gains (Losses) Included in:
(In thousands)	Beginning Balance		Earnings (Losses)			Other Comprehensive Income (Loss)		Impairments		Purchases		(Sales)			Paydowns / Maturities			Transfers		Ending Balance
																		In / (Out)
Nine months ended September 30, 2017:
Assets:
Fixed maturities securities available for sale:
Asset-backed securities	$	183	$	2		$	32	$	—	$	—	$	(43	)	$	—		$	—	$	174
Corporate	—		—			—		—		—		—			—			—		—
Total	183		2			32		—		—		(43		)	—			—		174
Equity securities available for sale:
Common stocks	8,754		—			633		—		—		—			—			—		9,387
Preferred stocks	3,662		19			—		—		175		—			—			—		3,856
Total	12,416		19			633		—		175		—			—			—		13,243
Arbitrage trading account	—		8			—		—		—		(8		)	—			—		—
Total	$	12,599	$	29		$	665	$	—	$	175	$	(51	)	$	—		$	—	$	13,417
Year ended December 31, 2016:
Assets:
Fixed maturities securities available for sale:
Asset-backed securities	$	199	$	3		$	16	$	—	$	—	$	—		$	(35	)	$	—	$	183
Corporate	154		177			—		—		—		(331		)	—			—		—
Total	353		180			16		—		—		(331		)	(35		)	—		183
Equity securities available for sale:
Common stocks	7,829		—			160		—		765		—			—			—		8,754
Preferred stocks	3,624		38			—		—		—		—			—			—		3,662
Total	11,453		38			160		—		765		—			—			—		12,416
Arbitrage trading account	176		(176		)	—		—		—		—			—			—		—
Total	$	11,982	$	42		$	176	$	—	$	765	$	(331	)	$	(35	)	$	—	$	12,599

During the nine months ended September 30, 2017 and for the year ended December 31, 2016, there were no transfers out of Level 3.

Fair Value of Financial Instruments

The following table presents the carrying amounts and estimated fair values of the Company’s financial instruments:

	September 30, 2017				December 31, 2016
(In thousands)	Carrying Value		Fair Value		Carrying Value		Fair Value
Assets:
Fixed maturity securities	$	13,873,690	$	13,890,354	$	13,190,668	$	13,204,814
Equity securities available for sale	614,025		614,025		669,200		669,200
Arbitrage trading account	488,238		488,238		299,999		299,999
Loans receivable	74,229		76,615		106,798		108,299
Cash and cash equivalents	773,997		773,997		795,285		795,285
Trading account receivables from brokers and clearing organizations	297,208		297,208		484,593		484,593
Liabilities:
Due to broker	58,973		58,973		19,416		19,416
Trading account securities sold but not yet purchased	44,937		44,937		51,179		51,179
Subordinated debentures	728,071		728,291		727,630		687,504
Senior notes and other debt	1,759,929		1,946,700		1,760,595		1,914,727

The estimated fair values of the Company’s fixed maturity securities, equity securities available for sale and arbitrage trading account securities are based on various valuation techniques that rely on fair value measurements as described in Note 16 above. The fair value of loans receivable are estimated by using current institutional purchaser yield requirements for loans with similar credit characteristics, which is considered a Level 2 input. The fair value of the senior notes and other debt and the subordinated debentures is based on spreads for similar securities, which is considered a Level 2 input.

XML

Reserves for Loss and Loss Expenses

9 Months Ended

Sep. 30, 2017

Insurance [Abstract]

Reserves for Loss and Loss Expenses

Reserves for Loss and Loss Expenses

The Company's reserves for losses and loss expenses are comprised of case reserves and incurred but not reported liabilities (IBNR). When a claim is reported, a case reserve is established for the estimated ultimate payment based upon known information about the claim. As more information about the claim becomes available over time, case reserves are adjusted up or down as appropriate. Reserves are also established on an aggregate basis to provide for IBNR liabilities and expected loss reserve development on reported claims.

Loss reserves included in the Company’s financial statements represent management’s best estimates based upon an actuarially derived point estimate and other considerations. The Company uses a variety of actuarial techniques and methods to derive an actuarial point estimate for each operating unit. These methods include paid loss development, incurred loss development, paid and incurred Bornhuetter-Ferguson methods and frequency and severity methods. In circumstances where one actuarial method is considered more credible than the others, that method is used to set the point estimate. The actuarial point estimate may also be based on a judgmental weighting of estimates produced from each of the methods considered. Industry loss experience is used to supplement the Company’s own data in selecting “tail factors” in areas where the Company’s own data is limited. The actuarial data is analyzed by line of business, coverage and accident or policy year, as appropriate, for each operating unit.

The establishment of the actuarially derived loss reserve point estimate also includes consideration of qualitative factors that may affect the ultimate losses. These qualitative considerations include, among others, the impact of re-underwriting initiatives, changes in the mix of business, changes in distribution sources and changes in policy terms and conditions.

The key assumptions used to arrive at the best estimate of loss reserves are the expected loss ratios, rate of loss cost inflation, and reported and paid loss emergence patterns. Expected loss ratios represent management’s expectation of losses at the time the business is priced and written, before any actual claims experience has emerged. This expectation is a significant determinant of the estimate of loss reserves for recently written business where there is little paid or incurred loss data to consider. Expected loss ratios are generally derived from historical loss ratios adjusted for the impact of rate changes, loss cost trends and known changes in the type of risks underwritten. Expected loss ratios are estimated for each key line of business within each operating unit. Expected loss cost inflation is particularly important for the long-tail lines, such as excess casualty, and claims with a high medical component, such as workers’ compensation. Reported and paid loss emergence patterns are used to project current reported or paid loss amounts to their ultimate settlement value. Loss development factors are based on the historical emergence patterns of paid and incurred losses, and are derived from the Company’s own experience and industry data. The paid loss emergence pattern is also significant to excess and assumed workers’ compensation reserves because those reserves are discounted to their estimated present value based upon such estimated payout patterns.

Loss frequency and severity are measures of loss activity that are considered in determining the key assumptions described in our discussion of loss and loss expense reserves, including expected loss ratios, rate of loss cost inflation and reported and paid loss emergence patterns. Loss frequency is a measure of the number of claims per unit of insured exposure, and loss severity is a measure of the average size of claims. Factors affecting loss frequency include the effectiveness of loss controls and safety programs and changes in economic activity or weather patterns. Factors affecting loss severity include changes in policy limits, retentions, rate of inflation and judicial interpretations.

Another factor affecting estimates of loss frequency and severity is the loss reporting lag, which is the period of time between the occurrence of a loss and the date the loss is reported to the Company. The length of the loss reporting lag affects our ability to accurately predict loss frequency (loss frequencies are more predictable for lines with short reporting lags) as well as the amount of reserves needed for incurred but not reported losses (less IBNR is required for lines with short reporting lags). As a result, loss reserves for lines with short reporting lags are likely to have less variation from initial loss estimates. For lines with short reporting lags, which include commercial automobile, primary workers’ compensation, other liability (claims-made) and property business, the key assumption is the loss emergence pattern used to project ultimate loss estimates from known losses paid or reported to date. For lines of business with long reporting lags, which include other liability (occurrence), products liability, excess workers’ compensation and liability reinsurance, the key assumption is the expected loss ratio since there is often little paid or incurred loss data to consider. Historically, the Company has experienced less variation from its initial loss estimates for lines of businesses with short reporting lags than for lines of business with long reporting lags.

The key assumptions used in calculating the most recent estimate of the loss reserves are reviewed each quarter and adjusted, to the extent necessary, to reflect the latest reported loss data, current trends and other factors observed.

The table below provides a reconciliation of the beginning and ending reserve balances:

	September 30,
(In thousands)	2017			2016
Net reserves at beginning of year	$	9,590,265		$	9,244,872
Net provision for losses and loss expenses:
Claims occurring during the current year (1)	2,998,687			2,838,777
Decrease in estimates for claims occurring in prior years (2) (3)	(7,648		)	(23,518		)
Loss reserve discount accretion	34,436			37,080
Total	3,025,475			2,852,339
Net payments for claims:
Current year	628,078			612,615
Prior year	1,996,977			1,931,454
Total	2,625,055			2,544,069
Foreign currency translation	57,789			(6,266		)
Net reserves at end of period	10,048,474			9,546,876
Ceded reserve at end of period	1,605,872			1,550,954
Gross reserves at end of period	$	11,654,346		$	11,097,830

_______________________________________

(1) Claims occurring during the current year are net of loss reserve discounts of $16,787,000 and $12,085,000 for the nine months ended September 30, 2017 and 2016, respectively.

(2) The decrease in estimates for claims occurring in prior years is net of loss reserve discount. On an undiscounted basis, the estimates for claims occurring in prior years decreased by $30,609,000 and $45,813,000 for the nine months ended September 30, 2017 and 2016, respectively.

(3) For certain retrospectively rated insurance policies and reinsurance agreements, reserve development is offset by additional or return premiums. Favorable development, net of additional and return premiums, was $31 million and $42 million for the nine months ended September 30, 2017 and 2016, respectively.

In 2017, favorable prior year development (net of additional and return premiums) of $31 million included $62 million of favorable development for the Insurance segment, partially offset by $31 million of adverse development for the Reinsurance segment. The favorable development for the Insurance segment was primarily attributable to workers' compensation business (including excess workers' compensation). The favorable workers' compensation development was spread across many accident years, including prior to 2008, but was most significant in accident years 2014 and 2015. The favorable workers' compensation development reflects a continuation of the benign loss cost trends experienced during 2016, particularly the favorable claim frequency trends (i.e., number of reported claims per unit of exposure). The adverse development for the Reinsurance segment was due to reserve strengthening associated with claims impacted by the change in the Ogden discount rate in the U.K., as well as adverse development in the U.S. facultative casualty excess of loss business. The Ogden rate is the discount rate used to calculate lump-sum bodily injury payouts in the U.K., and was reduced by the U.K. Ministry of Justice from +2.5% to -0.75%; the adverse development mostly related to U.K. motor bodily injury claims which we reinsured on an excess of loss basis in accident years 2012 through 2016. The adverse development on U.S. facultative casualty business related to construction-related risks in accident years 2008 and prior.

In 2016, favorable prior year development (net of additional and return premiums) of $42 million included $38 million for the Insurance segment and $4 million for the Reinsurance segment. The favorable development for the Insurance segment was primarily attributable to workers' compensation business, partially offset by adverse development for commercial auto liability and medical and other professional liability. The favorable development for workers' compensation stems from accident years 2003 through 2015, but is concentrated in accident years 2014 and 2015; it reflects claims frequency trends (i.e., number of reported claims per unit of exposure) that continue to be better than we expected. The unfavorable development for commercial auto liability was driven by higher large loss activity than expected in accident years 2014 and 2015, and the unfavorable development for medical professional liability was primarily in accident years prior to 2013 and stemmed from a class of medical professional liability business that we discontinued writing in 2013.

XML

Fair Value Of Financial Instruments

9 Months Ended

Sep. 30, 2017

Fair Value Disclosures [Abstract]

Fair Value Of Financial Instruments

Fair Value Measurements

The Company’s fixed maturity and equity securities classified as available for sale and its trading account securities are carried at fair value. Fair value is defined as “the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.” The Company utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels, as follows:

Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.  

Level 2 - Quoted prices for similar assets or valuations based on inputs that are observable.

Level 3 - Estimates of fair value based on internal pricing methodologies using unobservable inputs. Unobservable inputs are only used to measure fair value to the extent that observable inputs are not available.

Substantially, all of the Company’s fixed maturity securities were priced by independent pricing services. The prices provided by the independent pricing services are estimated based on observable market data in active markets utilizing pricing models and processes, which may include benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, sector groupings, matrix pricing and reference data. The pricing services may prioritize inputs differently on any given day for any security based on market conditions, and not all inputs are available for each security evaluation on any given day. The pricing services used by the Company have indicated that they will only produce an estimate of fair value if objectively verifiable information is available. The determination of whether markets are active or inactive is based upon the volume and level of activity for a particular asset class. The Company reviews the prices provided by pricing services for reasonableness and periodically performs independent price tests of a sample of securities to ensure proper valuation.

If prices from independent pricing services are not available for fixed maturity securities, the Company estimates the fair value. For Level 2 securities, the Company utilizes pricing models and processes which may include benchmark yields, sector groupings, matrix pricing, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, bids, offers and reference data. Where broker quotes are used, the Company generally requests two or more quotes and sets a price within the range of quotes received based on its assessment of the credibility of the quote and its own evaluation of the security. The Company generally does not adjust quotes received from brokers. For securities traded only in private negotiations, the Company determines fair value based primarily on the cost of such securities, which is adjusted to reflect prices of recent placements of securities of the same issuer, financial projections, credit quality and business developments of the issuer and other relevant information.

For Level 3 securities, the Company generally uses a discounted cash flow model to estimate the fair value of fixed maturity securities. The cash flow models are based upon assumptions as to prevailing credit spreads, interest rate and interest rate volatility, time to maturity and subordination levels. Projected cash flows are discounted at rates that are adjusted to reflect illiquidity, where appropriate.

The following tables present the assets and liabilities measured at fair value on a recurring basis as of September 30, 2017 and December 31, 2016 by level:

(In thousands)	Total		Level 1		Level 2		Level 3
September 30, 2017
Assets:
Fixed maturity securities available for sale:
U.S. government and government agency	$	411,605	$	—	$	411,605	$	—
State and municipal	4,413,169		—		4,413,169		—
Mortgage-backed securities	1,320,119		—		1,320,119		—
Asset-backed securities	2,388,618		—		2,388,444		174
Corporate	4,320,374		—		4,320,374		—
Foreign government	940,409		—		940,409		—
Total fixed maturity securities available for sale	13,794,294		—		13,794,120		174
Equity securities available for sale:
Common stocks	419,520		410,133		—		9,387
Preferred stocks	194,505		—		190,649		3,856
Total equity securities available for sale	614,025		410,133		190,649		13,243
Arbitrage trading account	488,238		275,818		212,420		—
Total	$	14,896,557	$	685,951	$	14,197,189	$	13,417
Liabilities:
Trading account securities sold but not yet purchased	$	44,937	$	44,851	$	86	$	—
December 31, 2016
Assets:
Fixed maturity securities available for sale:
U.S. government and government agency	$	513,802	$	—	$	513,802	$	—
State and municipal	4,519,503		—		4,519,503		—
Mortgage-backed securities	1,189,645		—		1,189,645		—
Asset-backed securities	1,907,860		—		1,907,677		183
Corporate	4,068,527		—		4,068,527		—
Foreign government	902,805		—		902,805		—
Total fixed maturity securities available for sale	13,102,142		—		13,101,959		183
Equity securities available for sale:
Common stocks	445,858		429,647		7,457		8,754
Preferred stocks	223,342		—		219,680		3,662
Total equity securities available for sale	669,200		429,647		227,137		12,416
Arbitrage trading account	299,999		224,623		75,376		—
Total	$	14,071,341	$	654,270	$	13,404,472	$	12,599
Liabilities:
Trading account securities sold but not yet purchased	$	51,179	$	51,089	$	90	$	—

There were no significant transfers between Levels 1 and 2 during the nine months ended September 30, 2017 or during the year ended December 31, 2016.

The following tables summarize changes in Level 3 assets and liabilities for the nine months ended September 30, 2017 and for the year ended December 31, 2016:

	Gains (Losses) Included in:
(In thousands)	Beginning Balance		Earnings (Losses)			Other Comprehensive Income (Loss)		Impairments		Purchases		(Sales)			Paydowns / Maturities			Transfers		Ending Balance
																		In / (Out)
Nine months ended September 30, 2017:
Assets:
Fixed maturities securities available for sale:
Asset-backed securities	$	183	$	2		$	32	$	—	$	—	$	(43	)	$	—		$	—	$	174
Corporate	—		—			—		—		—		—			—			—		—
Total	183		2			32		—		—		(43		)	—			—		174
Equity securities available for sale:
Common stocks	8,754		—			633		—		—		—			—			—		9,387
Preferred stocks	3,662		19			—		—		175		—			—			—		3,856
Total	12,416		19			633		—		175		—			—			—		13,243
Arbitrage trading account	—		8			—		—		—		(8		)	—			—		—
Total	$	12,599	$	29		$	665	$	—	$	175	$	(51	)	$	—		$	—	$	13,417
Year ended December 31, 2016:
Assets:
Fixed maturities securities available for sale:
Asset-backed securities	$	199	$	3		$	16	$	—	$	—	$	—		$	(35	)	$	—	$	183
Corporate	154		177			—		—		—		(331		)	—			—		—
Total	353		180			16		—		—		(331		)	(35		)	—		183
Equity securities available for sale:
Common stocks	7,829		—			160		—		765		—			—			—		8,754
Preferred stocks	3,624		38			—		—		—		—			—			—		3,662
Total	11,453		38			160		—		765		—			—			—		12,416
Arbitrage trading account	176		(176		)	—		—		—		—			—			—		—
Total	$	11,982	$	42		$	176	$	—	$	765	$	(331	)	$	(35	)	$	—	$	12,599

During the nine months ended September 30, 2017 and for the year ended December 31, 2016, there were no transfers out of Level 3.

Fair Value of Financial Instruments

The following table presents the carrying amounts and estimated fair values of the Company’s financial instruments:

	September 30, 2017				December 31, 2016
(In thousands)	Carrying Value		Fair Value		Carrying Value		Fair Value
Assets:
Fixed maturity securities	$	13,873,690	$	13,890,354	$	13,190,668	$	13,204,814
Equity securities available for sale	614,025		614,025		669,200		669,200
Arbitrage trading account	488,238		488,238		299,999		299,999
Loans receivable	74,229		76,615		106,798		108,299
Cash and cash equivalents	773,997		773,997		795,285		795,285
Trading account receivables from brokers and clearing organizations	297,208		297,208		484,593		484,593
Liabilities:
Due to broker	58,973		58,973		19,416		19,416
Trading account securities sold but not yet purchased	44,937		44,937		51,179		51,179
Subordinated debentures	728,071		728,291		727,630		687,504
Senior notes and other debt	1,759,929		1,946,700		1,760,595		1,914,727

The estimated fair values of the Company’s fixed maturity securities, equity securities available for sale and arbitrage trading account securities are based on various valuation techniques that rely on fair value measurements as described in Note 16 above. The fair value of loans receivable are estimated by using current institutional purchaser yield requirements for loans with similar credit characteristics, which is considered a Level 2 input. The fair value of the senior notes and other debt and the subordinated debentures is based on spreads for similar securities, which is considered a Level 2 input.

XML

Reinsurance

9 Months Ended

Sep. 30, 2017

Insurance [Abstract]

Reinsurance

Reinsurance

The following is a summary of reinsurance financial information:

	For the Three Months						For the Nine Months
	Ended September 30,						Ended September 30,
(In thousands)	2017			2016			2017			2016
Written premiums:
Direct	$	1,679,389		$	1,643,870		$	5,127,465		$	5,061,646
Assumed	194,769			224,979			570,052			702,265
Ceded	(302,975		)	(261,484		)	(915,245		)	(850,255		)
Total net premiums written	$	1,571,183		$	1,607,365		$	4,782,272		$	4,913,656
Earned premiums:
Direct	$	1,692,453		$	1,647,033		$	4,972,755		$	4,824,768
Assumed	202,972			216,758			605,281			635,443
Ceded	(313,925		)	(277,847		)	(857,792		)	(787,139		)
Total net premiums earned	$	1,581,500		$	1,585,944		$	4,720,244		$	4,673,072
Ceded losses and loss expenses incurred	$	247,104		$	213,065		$	424,905		$	507,258
Ceded commissions earned	$	63,222		$	47,315		$	177,524		$	143,809

The Company reinsures a portion of its insurance exposures in order to reduce its net liability on individual risks and catastrophe losses. The Company also cedes premiums to state assigned risk plans and captive insurance companies. Estimated amounts due from reinsurers are reported net of reserves for uncollectible reinsurance of $1 million as of September 30, 2017 and December 31, 2016.

XML

Restricted Stock Units

9 Months Ended

Sep. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Restricted Stock Units

Restricted Stock Units

Pursuant to its stock incentive plan, the Company may issue restricted stock units (RSUs) to employees of the Company and its subsidiaries. The RSUs generally vest three to five years from the award date and are subject to other vesting and forfeiture provisions contained in the award agreement. RSUs are expensed pro-ratably over the vesting period. RSU expenses were $30 million and $25 million for the nine months ended September 30, 2017 and 2016, respectively. A summary of RSUs issued in the nine months ended September 30, 2017 and 2016 follows:

($ in thousands)	Units	Fair Value
2017	855,051	$	58,712
2016	990,487	$	57,959

XML

Litigation and Contingent Liabilities

9 Months Ended

Sep. 30, 2017

Commitments and Contingencies Disclosure [Abstract]

Litigation and Contingent Liabilities

Litigation and Contingent Liabilities

In the ordinary course of business, the Company is subject to disputes, litigation and arbitration arising from its insurance and reinsurance businesses. These matters are generally related to insurance and reinsurance claims and are considered in the establishment of loss and loss expense reserves. In addition, the Company may also become involved in legal actions which seek extra-contractual damages, punitive damages or penalties, including claims alleging bad faith in handling of insurance claims. The Company expects its ultimate liability with respect to such matters will not be material to its financial condition. However, adverse outcomes on such matters are possible, from time to time, and could be material to the Company’s results of operations in any particular financial reporting period.

XML

Business Segments

9 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

Business Segments

Business Segments

The Company’s reportable segments include the following two business segments, plus a corporate segment:

• Insurance - primarily commercial insurance business, including excess and surplus lines and admitted lines in the United States, United Kingdom, Continental Europe, South America, Canada, Mexico, Scandinavia, Asia and Australia; and

• Reinsurance - reinsurance business on a facultative and treaty basis, primarily in the United States, United Kingdom, Continental Europe, Australia, the Asia-Pacific Region and South Africa.

Commencing with the first quarter of 2017, the Company reclassified two businesses from the Insurance Segment to the Reinsurance segment. Reclassifications have been made to the Company's 2016 financial information to conform with this presentation.

The accounting policies of the segments are the same as those described in the summary of significant accounting policies. Income tax expense and benefits are calculated based upon the Company's overall effective tax rate.

Summary financial information about the Company's reporting segments is presented in the following tables. Income (loss) before income taxes by segment includes allocated investment income. Identifiable assets by segment are those assets used in or allocated to the operation of each segment.

	Revenues
(In thousands)	Earned Premiums		Investment Income		Other		Total (1)		Pre-Tax Income (Loss)			Net Income (Loss) to Common Stockholders
Three months ended September 30, 2017
Insurance	$	1,433,729	$	105,924	$	—	$	1,539,653	$	171,478		$	123,240
Reinsurance	147,771		21,528		—		169,299		(57,643		)	(35,074		)
Corporate, other and eliminations (2)	—		15,027		123,404		138,431		(71,681		)	(45,685		)
Net investment gains	—		—		183,959		183,959		183,959			119,573
Total	$	1,581,500	$	142,479	$	307,363	$	2,031,342	$	226,113		$	162,054
Three months ended September 30, 2016
Insurance	$	1,423,635	$	111,300	$	—	$	1,534,935	$	210,498		$	140,730
Reinsurance	162,309		27,567		—		189,876		27,321			18,725
Corporate, other and eliminations (2)	—		6,801		112,377		119,178		(81,942		)	(53,035		)
Net investment gains	—		—		175,738		175,738		175,738			114,230
Total	$	1,585,944	$	145,668	$	288,115	$	2,019,727	$	331,615		$	220,650
Nine months ended September 30, 2017:
Insurance	$	4,262,485	320,552		$	—	$	4,583,037	$	557,605		$	381,736
Reinsurance	457,759		67,798		—		525,557		(38,279		)	(20,801		)
Corporate, other and eliminations (2)	—		38,251		326,203		364,454		(224,716		)	(146,324		)
Net investment gains	—		—		276,760		276,760		276,760			179,894
Total	$	4,720,244	$	426,601	$	602,963	$	5,749,808	$	571,370		$	394,505
Nine months ended September 30, 2016:
Insurance	$	4,180,985	$	304,904	$	—	$	4,485,889	$	586,651		$	394,746
Reinsurance	492,087		77,119		—		569,206		79,215			54,885
Corporate, other and eliminations (2)	—		22,827		415,224		438,051		(190,655		)	(123,610		)
Net investment gains	—		—		189,394		189,394		189,394			123,106
Total	$	4,673,072	$	404,850	$	604,618	$	5,682,540	$	664,605		$	449,127

_________________

(1) Revenues for Insurance from foreign countries for the three months ended September 30, 2017 and 2016 were $166 million and $187 million, respectively, and for the nine months ended September 30, 2017 and 2016 were $513 million and $546 million, respectively. Revenues for Reinsurance from foreign countries for the three months ended September 30, 2017 and 2016 were $49 million and $48 million, respectively, and for the nine months ended September 30, 2017 and 2016 were $150 million and $153 million, respectively.

(2) Corporate, other and eliminations represent corporate revenues and expenses that are not allocated to business segments.

Identifiable Assets

(In thousands)	September 30, 2017		December 31, 2016
Insurance	$	19,136,776	$	19,137,758
Reinsurance	3,243,610		2,524,338
Corporate, other and eliminations	1,955,690		1,687,980
Consolidated	$	24,336,076	$	23,350,076

Net premiums earned by major line of business are as follows:

	For the Three Months				For the Nine Months
	Ended September 30,				Ended September 30,
(In thousands)	2017		2016		2017		2016
Insurance:
Other liability	$	466,616	$	455,841	$	1,378,505	$	1,302,841
Workers’ compensation	378,529		354,185		1,106,616		1,042,503
Short-tail lines (1)	287,860		312,865		887,791		962,435
Commercial automobile	163,277		164,540		482,929		481,249
Professional liability	137,447		136,204		406,644		391,957
Total Insurance	1,433,729		1,423,635		4,262,485		4,180,985
Reinsurance:
Casualty	94,478		97,153		282,430		301,571
Property	53,293		65,156		175,329		190,516
Total Reinsurance	147,771		162,309		457,759		492,087
Total	$	1,581,500	$	1,585,944	$	4,720,244	$	4,673,072

______________

(1) Short-tail lines include commercial multi-peril (non-liability), inland marine, accident and health, fidelity and surety, boiler and machinery and other lines.

XML

Recent Accounting Pronouncements (Policies)

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Per Share Data

Per Share Data

The Company presents both basic and diluted net income per share (“EPS”) amounts. Basic EPS is calculated by dividing net income by the weighted average number of common shares outstanding during the period (including 4,087,731 common shares held in a grantor trust established in March 2017). The common shares held in the grantor trust are for delivery upon settlement of vested but mandatorily deferred restricted stock units ("RSUs"). Shares held by the grantor trust do not affect diluted shares outstanding since the shares deliverable under vested RSUs were already included in diluted shares outstanding. Diluted EPS is based upon the weighted average number of basic and common equivalent shares outstanding during the period and is calculated using the treasury stock method for stock incentive plans. Common equivalent shares are excluded from the computation in periods in which they have an anti-dilutive effect.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

Recently adopted accounting pronouncements:

In May 2015, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2015-09, Disclosures about Short-Duration Contracts. ASU 2015-09 requires companies that issue short duration insurance contracts to disclose additional information, including: (i) incurred and paid claims development tables; (ii) frequency and severity of claims; and (iii) information about material changes in judgments made in calculating the liability for unpaid claim adjustment expenses, including reasons for the change and the effects on the financial statements. The Company adopted this updated guidance on January 1, 2016 with regard to the annual requirements and on January 1, 2017 with regard to the interim requirements. The amendments in ASU 2015-09 are applied retrospectively by providing comparative disclosures for each period presented, except for those requirements that apply only to the current period. As the requirements are disclosure only, the adoption of this guidance did not impact our financial condition or results of operations, but did result in additional disclosures.

In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting. ASU 2016-09 includes provisions intended to simplify various previous provisions related to how share-based payments are accounted for and presented in the financial statements. Under the new guidance, excess tax benefits (deductions for share based payment awards for tax purposes that exceed the compensation cost recognized for financial reporting purposes) are reported within the income tax expense financial statement line item. Previously, excess tax benefits were reported within additional paid in capital. The Company adopted this updated guidance on January 1, 2017 prospectively. The adoption of this guidance did not have a material impact on the Company's financial condition or results of operations.

All other accounting and reporting standards that became effective in 2017 were either not applicable to the Company or their adoption did not have a material impact on the Company. 

Accounting and reporting standards that are not yet effective:

In May 2014, the FASB issued ASU 2014-09, Revenue from Customers. ASU 2014-09 clarifies the principles for recognizing revenue. While insurance contracts are not within the scope of this updated guidance, the Company’s insurance service fee revenue and non-insurance business revenue will be subject to this updated guidance. The updated guidance requires an entity to recognize revenue as performance obligations are met, in order to reflect the transfer of promised goods or services to customers in an amount that reflects the consideration the entity is entitled to receive for those goods or services. The updated guidance, as amended by ASU 2015-14, is effective for public business entities for annual and interim reporting periods beginning after December 15, 2017. The adoption of this guidance is not expected to have a material effect on the Company’s financial condition or results of operations.

In January 2016, the FASB issued ASU 2016-01, Financial Instruments.  ASU 2016-01 amends the accounting guidance for financial instruments to require all equity investments to be measured at fair value with changes in the fair value recognized through net income (other than those accounted for under equity method of accounting or those that result in consolidation of the investee).  The updated guidance is effective for public business entities for annual reporting periods beginning after December 15, 2017 and interim periods within those years.  The adoption of this guidance is not expected to have a material effect on the Company’s financial condition upon adoption, but will impact results of operations after adoption of this guidance as unrealized gains and losses on equity securities will no longer be reported directly in accumulated other comprehensive income (AOCI), but will instead be reported in net income.

In February 2016, the FASB issued ASU 2016-02, Leases, which amends the accounting and disclosure guidance for leases.  This guidance retains the two classifications of a lease, as either an operating or finance lease, both of which will require lessees to recognize a right-of-use asset and a lease liability for leases with terms of more than 12 months. The right-of-use asset and the lease liability will be determined based upon the present value of cash flows. Finance leases will reflect the financial arrangement by recognizing interest expense on the lease liability separately from the amortization expense of the right-of-use asset. Operating leases will recognize lease expense (with no separate recognition of interest expense) on a straight-line basis over the term of the lease. The accounting by lessors is not significantly changed by the updated guidance.  The updated guidance is effective for reporting periods beginning after December 15, 2018, and will require that the earliest comparative period presented include the measurement and recognition of existing leases with an adjustment to equity as if the updated guidance had always been applied. The Company is currently evaluating the impact that the adoption of this guidance will have on its results of operations, financial position and liquidity.

     In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses, which amends the accounting guidance for credit losses on financial instruments. The updated guidance amends the current other-than-temporary impairment model for available-for-sale debt securities by requiring the recognition of impairments relating to credit losses through an allowance account and limits the amount of credit loss to the difference between a security’s amortized cost basis and its fair value. This guidance also applies a new current expected credit loss model for determining credit-related impairments for financial instruments measured at amortized cost.  The updated guidance is effective for reporting periods beginning after December 15, 2019. The Company will not be able to determine the impact the adoption of this guidance will have on its results of operations, financial position or liquidity until the year the guidance becomes effective.

All other recently issued but not yet effective accounting and reporting standards are either not applicable to the Company or are not expected to have a material impact on the Company.

XML

Per Share Data (Tables)

9 Months Ended

Sep. 30, 2017

Earnings Per Share [Abstract]

Weighted average number of common shares

The weighted average number of common shares used in the computation of basic and diluted earnings per share was as follows:

	For the Three Months		For the Nine Months
	Ended September 30,		Ended September 30,
(In thousands)	2017	2016	2017	2016
Basic	125,818	122,562	124,363	122,652
Diluted	128,944	128,556	129,289	128,501

XML

Acquisitions/Dispositions (Tables)

9 Months Ended

Sep. 30, 2017

Business Combinations [Abstract]

Summary of fair value of net assets acquired and liabilities assumed

The following table summarizes the estimated fair value of net assets acquired and liabilities assumed for the business combination completed in 2017:

(In thousands)	2017
Cash and cash equivalents	$	2,721
Real estate, furniture and equipment	7,042
Goodwill	28,522
Intangible assets	32,395
Other assets	9,862
Total assets acquired	80,542
Other liabilities assumed	(2,251		)
Noncontrolling interest	(5,000		)
Net assets acquired	$	73,291

XML

Consolidated Statements of Comprehensive Income (Tables)

9 Months Ended

Sep. 30, 2017

Equity [Abstract]

Components of changes in accumulated other comprehensive income (loss)

The following table presents the components of the changes in accumulated other comprehensive income ("AOCI"):

(In thousands)	Unrealized Investment Gains (Losses)				Currency Translation Adjustments			Accumulated Other Comprehensive Income
As of and for the nine months ended September 30, 2017:
Changes in AOCI
Beginning of period	$	427,154			$	(371,586	)	$	55,568
Other comprehensive income before reclassifications	109,277				71,574			180,851
Amounts reclassified from AOCI	(82,679		)		—			(82,679		)
Other comprehensive income	26,598				71,574			98,172
Unrealized investment loss related to non-controlling interest	19				—			19
End of period	$	453,771			$	(300,012	)	$	153,759
Amounts reclassified from AOCI
Pre-tax	$	(127,198	)	(1)	$	—		$	(127,198	)
Tax effect	44,519			(2)	—			44,519
After-tax amounts reclassified	$	(82,679	)		$	—		$	(82,679	)
Other comprehensive income
Pre-tax	$	50,148			$	71,574		$	121,722
Tax effect	(23,550		)		—			(23,550		)
Other comprehensive income	$	26,598			$	71,574		$	98,172
As of and for the three months ended September 30, 2017:
Changes in AOCI
Beginning of period	$	461,906			$	(328,604	)	$	133,302
Other comprehensive income before reclassifications	19,968				28,592			48,560
Amounts reclassified from AOCI	(28,136		)		—			(28,136		)
Other comprehensive (loss) income	(8,168		)		28,592			20,424
Unrealized investment loss related to non-controlling interest	33				—			33
End of period	$	453,771			$	(300,012	)	$	153,759
Amounts reclassified from AOCI
Pre-tax	$	(43,286	)	(1)	$	—		$	(43,286	)
Tax effect	15,150			(2)	—			15,150
After-tax amounts reclassified	$	(28,136	)		$	—		$	(28,136	)
Other comprehensive (loss) income
Pre-tax	$	(8,563	)		$	28,592		$	20,029
Tax effect	395				—			395
Other comprehensive (loss) income	$	(8,168	)		$	28,592		$	20,424

_________________________

⁽¹⁾ Net investment gains in the consolidated statements of income.

⁽²⁾ Income tax expense in the consolidated statements of income.

(In thousands)	Unrealized Investment Gains (Losses)				Currency Translation Adjustments			Accumulated Other Comprehensive Income (Loss)
As of and for the nine months ended September 30, 2016:
Changes in AOCI
Beginning of period	$	180,695			$	(247,393	)	$	(66,698	)
Other comprehensive income (loss) before reclassifications	170,824				(77,389		)	93,435
Amounts reclassified from AOCI	(36,611		)		—			(36,611		)
Other comprehensive income (loss)	134,213				(77,389		)	56,824
Unrealized investment loss related to non-controlling interest	66				—			66
End of period	$	314,974			$	(324,782	)	$	(9,808	)
Amounts reclassified from AOCI
Pre-tax	$	(56,325	)	(1)	$	—		$	(56,325	)
Tax effect	19,714			(2)	—			19,714
After-tax amounts reclassified	$	(36,611	)		$	—		$	(36,611	)
Other comprehensive income (loss)
Pre-tax	$	198,808			$	(77,389	)	$	121,419
Tax effect	(64,595		)		—			(64,595		)
Other comprehensive income (loss)	$	134,213			$	(77,389	)	$	56,824
As of and for the three months ended September 30, 2016:
Changes in AOCI
Beginning of period	$	362,593			$	(305,312	)	$	57,281
Other comprehensive loss before reclassifications	(20,968		)		(19,470		)	(40,438		)
Amounts reclassified from AOCI	(26,708		)		—			(26,708		)
Other comprehensive loss	(47,676		)		(19,470		)	(67,146		)
Unrealized investment loss related to non-controlling interest	57				—			57
End of period	$	314,974			$	(324,782	)	$	(9,808	)
Amounts reclassified from AOCI
Pre-tax	$	(41,090	)	(1)	$	—		$	(41,090	)
Tax effect	14,382			(2)	—			14,382
After-tax amounts reclassified	$	(26,708	)		$	—		$	(26,708	)
Other comprehensive loss
Pre-tax	$	(72,188	)		$	(19,470	)	$	(91,658	)
Tax effect	24,512				—			24,512
Other comprehensive loss	$	(47,676	)		$	(19,470	)	$	(67,146	)

_______________

(1) Net investment gains in the consolidated statements of income.

(2) Income tax expense in the consolidated statements of income.

XML

Investments in Fixed Maturity Securities (Tables)

9 Months Ended

Sep. 30, 2017

Investments, Debt and Equity Securities [Abstract]

Schedule of investments in fixed maturity securities

At September 30, 2017 and December 31, 2016, investments in fixed maturity securities were as follows:

(In thousands)	Amortized Cost		Gross Unrealized					Fair Value		Carrying Value
			Gains		Losses
September 30, 2017
Held to maturity:
State and municipal	$	65,372	$	15,212	$	—		$	80,584	$	65,372
Residential mortgage-backed	14,024		1,452		—			15,476		14,024
Total held to maturity	79,396		16,664		—			96,060		79,396
Available for sale:
U.S. government and government agency	402,901		10,828		(2,124		)	411,605		411,605
State and municipal:
Special revenue	2,730,653		80,144		(5,469		)	2,805,328		2,805,328
State general obligation	481,070		21,377		(565		)	501,882		501,882
Pre-refunded	282,488		21,052		(173		)	303,367		303,367
Corporate backed	380,351		11,775		(499		)	391,627		391,627
Local general obligation	384,930		26,566		(531		)	410,965		410,965
Total state and municipal	4,259,492		160,914		(7,237		)	4,413,169		4,413,169
Mortgage-backed securities:
Residential (1)	1,064,705		12,696		(8,860		)	1,068,541		1,068,541
Commercial	251,387		1,641		(1,450		)	251,578		251,578
Total mortgage-backed securities	1,316,092		14,337		(10,310		)	1,320,119		1,320,119
Asset-backed	2,389,187		9,836		(10,405		)	2,388,618		2,388,618
Corporate:
Industrial	2,569,673		70,054		(2,842		)	2,636,885		2,636,885
Financial	1,335,101		43,636		(4,716		)	1,374,021		1,374,021
Utilities	255,478		12,760		(907		)	267,331		267,331
Other	42,183		2		(48		)	42,137		42,137
Total corporate	4,202,435		126,452		(8,513		)	4,320,374		4,320,374
Foreign	909,608		32,889		(2,088		)	940,409		940,409
Total available for sale	13,479,715		355,256		(40,677		)	13,794,294		13,794,294
Total investments in fixed maturity securities	$	13,559,111	$	371,920	$	(40,677	)	$	13,890,354	$	13,873,690

(In thousands)	Amortized Cost		Gross Unrealized					Fair Value		Carrying Value
			Gains		Losses
December 31, 2016
Held to maturity:
State and municipal	$	72,582	$	12,453	$	—		$	85,035	$	72,582
Residential mortgage-backed	15,944		1,693		—			17,637		15,944
Total held to maturity	88,526		14,146		—			102,672		88,526
Available for sale:
U.S. government and government agency	496,187		20,208		(2,593		)	513,802		513,802
State and municipal:
Special revenue	2,791,211		58,559		(26,315		)	2,823,455		2,823,455
State general obligation	524,682		16,964		(5,139		)	536,507		536,507
Pre-refunded	356,535		19,181		(165		)	375,551		375,551
Corporate backed	410,933		6,172		(6,452		)	410,653		410,653
Local general obligation	360,022		15,682		(2,367		)	373,337		373,337
Total state and municipal	4,443,383		116,558		(40,438		)	4,519,503		4,519,503
Mortgage-backed securities:
Residential (1)	1,034,301		15,431		(12,950		)	1,036,782		1,036,782
Commercial	155,540		304		(2,981		)	152,863		152,863
Total mortgage-backed securities	1,189,841		15,735		(15,931		)	1,189,645		1,189,645
Asset-backed	1,913,830		5,971		(11,941		)	1,907,860		1,907,860
Corporate:
Industrial	2,315,567		71,007		(7,174		)	2,379,400		2,379,400
Financial	1,369,001		39,543		(11,270		)	1,397,274		1,397,274
Utilities	229,154		10,801		(2,411		)	237,544		237,544
Other	54,073		299		(63		)	54,309		54,309
Total corporate	3,967,795		121,650		(20,918		)	4,068,527		4,068,527
Foreign	858,773		46,794		(2,762		)	902,805		902,805
Total available for sale	12,869,809		326,916		(94,583		)	13,102,142		13,102,142
Total investments in fixed maturity securities	$	12,958,335	$	341,062	$	(94,583	)	$	13,204,814	$	13,190,668

____________

(1) Gross unrealized gains and (losses) for residential mortgage-backed securities include $85,907 and $(818,691) as of September 30, 2017 and December 31, 2016, respectively, related to securities with the non-credit portion of other-than-temporary impairments (“OTTI”) recognized in accumulated other comprehensive income.

Amortized cost and fair value of fixed maturity securities by contractual maturity

The amortized cost and fair value of fixed maturity securities at September 30, 2017, by contractual maturity, are shown below. Actual maturities may differ from contractual maturities because certain issuers may have the right to call or prepay obligations.

(In thousands)	Amortized Cost		Fair Value
Due in one year or less	$	745,010	$	750,479
Due after one year through five years	5,089,768		5,210,268
Due after five years through ten years	3,248,254		3,396,461
Due after ten years	3,145,963		3,197,551
Mortgage-backed securities	1,330,116		1,335,595
Total	$	13,559,111	$	13,890,354

XML

Investments in Equity Securities Available for Sale (Tables)

9 Months Ended

Sep. 30, 2017

Equity securities available for sale

Schedule of Available-for-sale Securities [Line Items]

Schedule of Investments in Equity Securities

At September 30, 2017 and December 31, 2016, investments in equity securities were as follows:

(In thousands)	Cost		Gross Unrealized					Fair Value		Carrying Value
			Gains		Losses
September 30, 2017
Common stocks	$	83,709	$	339,297	$	(3,486	)	$	419,520	$	419,520
Preferred stocks	125,076		71,147		(1,718		)	194,505		194,505
Total	$	208,785	$	410,444	$	(5,204	)	$	614,025	$	614,025
December 31, 2016
Common stocks	$	94,998	$	351,906	$	(1,046	)	$	445,858	$	445,858
Preferred stocks	125,589		101,392		(3,639		)	223,342		223,342
Total	$	220,587	$	453,298	$	(4,685	)	$	669,200	$	669,200

XML

Net Investment Income (Tables)

9 Months Ended

Sep. 30, 2017

Net Investment Income [Abstract]

Schedule of Net Investment Income

Net investment income consists of the following:

	For the Three Months						For the Nine Months
	Ended September 30,						Ended September 30,
(In thousands)	2017			2016			2017			2016
Investment income earned on:
Fixed maturity securities, including cash and cash equivalents and loans receivable	$	118,834		$	114,271		$	347,976		$	331,448
Investment funds	15,200			25,293			50,744			60,385
Arbitrage trading account	4,418			6,441			16,235			12,883
Real estate	5,042			585			14,894			4,552
Equity securities available for sale	604			1,069			1,845			3,217
Gross investment income	144,098			147,659			431,694			412,485
Investment expense	(1,619		)	(1,991		)	(5,093		)	(7,635		)
Net investment income	$	142,479		$	145,668		$	426,601		$	404,850

XML

Investment Funds (Tables)

9 Months Ended

Sep. 30, 2017

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Investment Funds

Investment funds consisted of the following:

	Carrying Value as of				Income (Loss) from Investment Funds
	September 30,		December 31,		For the Nine Months Ended September 30,
(In thousands)	2017		2016		2017			2016
Real estate	$	614,508	$	641,783	$	30,661		$	33,028
Energy	85,817		91,448		(12,763		)	7,174
Hedge equity	—		73,913		(1,164		)	791
Other funds	419,582		391,002		34,010			19,392
Total	$	1,119,907	$	1,198,146	$	50,744		$	60,385

XML

Real Estate Real Estate (Tables)

9 Months Ended

Sep. 30, 2017

Real Estate [Abstract]

Schedule of Real Estate Investments

Investment in real estate represents directly owned property held for investment, as follows:    

	Carrying Value
	September 30,		December 31,
(In thousands)	2017		2016
Properties in operation	$	451,669	$	457,237
Properties under development	939,605		727,744
Total	$	1,391,274	$	1,184,981

XML

Loans Receivable Loans Receivable (Tables)

9 Months Ended

Sep. 30, 2017

Receivables [Abstract]

Schedule of Loans Receivable

Loans receivable are as follows:

(In thousands)	September 30, 2017			December 31, 2016
Amortized cost (net of valuation allowance):
Real estate loans	$	59,487		$	92,415
Commercial loans	14,742			14,383
Total	$	74,229		$	106,798
Fair value:
Real estate loans	$	60,372		$	92,415
Commercial loans	16,243			15,884
Total	$	76,615		$	108,299
Valuation allowance:
Specific	$	1,200		$	1,200
General	2,183			2,197
Total	$	3,383		$	3,397
	For the Three Months Ended September 30,
	2017			2016
Increase in valuation allowance	$	—		$	467
	For the Nine Months Ended September 30,
	2017			2016
(Decrease) increase in valuation allowance	$	(14	)	$	1,128

XML

Realized And Unrealized Investment Gains (Losses) (Tables)

9 Months Ended

Sep. 30, 2017

Realized and Unrealized Investment Gains (Losses) [Abstract]

Realized and Unrealized Investment Gains (Losses)

Realized and unrealized investment gains (losses) are as follows:

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
(In thousands)	2017			2016			2017			2016
Realized investment gains (losses):
Fixed maturity securities:
Gains	$	8,763		$	33,798		$	21,795		$	66,972
Losses	(197		)	(1,150		)	(4,162		)	(5,570		)
Equity securities available for sale	34,720			8,441			109,566			13,037
Investment funds (1)	124,228			(3,788		)	125,383			(9,041		)
Real estate	1,956			687			4,892			5,247
Other (2)	14,489			137,750			19,286			136,863
Net realized gains on investments sales	183,959			175,738			276,760			207,508
Other-than-temporary impairments (3)	—			—			—			(18,114		)
Net investment gains	183,959			175,738			276,760			189,394
Income tax expense	(64,386		)	(61,508		)	(96,866		)	(66,288		)
After-tax net realized investment gains	$	119,573		$	114,230		$	179,894		$	123,106

Unrealized Gain (Loss) on Investments

Change in unrealized investment gains of available for sale securities:
Fixed maturity securities	$	(10,627	)	$	(45,388	)	$	84,214		$	169,933
Previously impaired fixed maturity securities	61			(1,406		)	905			413
Equity securities available for sale	(2,126		)	(28,517		)	(44,812		)	12,433
Investment funds	4,129			3,143			9,841			16,028
Total change in unrealized investment gains	(8,563		)	(72,168		)	50,148			198,807
Income tax benefit (expense)	423			24,493			(23,550		)	(64,594		)
Noncontrolling interests	5			57			19			66
After-tax change in unrealized investment gains of available for sale securities	$	(8,135	)	$	(47,618	)	$	26,617		$	134,279

______________________

(1) Investment funds includes a gain of $124.3 million from the sale of an investment in an office building located in Washington, D.C. for the three and nine months ended September 30, 2017.

(2) Other includes a gain of $134.9 million from the sale of Aero Precision Industries and certain related aviation services business for the three and nine months ended September 30, 2016.

(3) There were no other than temporary impairments (OTTI) for the three and nine months ended September 30, 2017, or for the three months ended September 30, 2016. OTTI for the nine months ended September 30, 2016 of $18.1 million were related to common stock.

XML

Securities In An Unrealized Loss Position Securities In An Unrealized Loss Position (Tables)

9 Months Ended

Sep. 30, 2017

Statement of Financial Position [Abstract]

Securities in an unrealized loss position

The following tables summarize all securities in an unrealized loss position at September 30, 2017 and December 31, 2016 by the length of time those securities have been continuously in an unrealized loss position:

	Less Than 12 Months				12 Months or Greater				Total
(In thousands)	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
September 30, 2017
U.S. government and government agency	$	118,066	$	1,048	$	48,880	$	1,076	$	166,946	$	2,124
State and municipal	650,353		5,797		119,087		1,440		769,440		7,237
Mortgage-backed securities	527,034		5,000		221,923		5,310		748,957		10,310
Asset-backed securities	1,116,878		8,033		130,734		2,372		1,247,612		10,405
Corporate	651,373		5,395		57,557		3,118		708,930		8,513
Foreign government	220,860		2,072		1,599		16		222,459		2,088
Fixed maturity securities	3,284,564		27,345		579,780		13,332		3,864,344		40,677
Common stocks	4,678		3,095		9,387		391		14,065		3,486
Preferred stocks	—		—		23,957		1,718		23,957		1,718
Equity securities available for sale	4,678		3,095		33,344		2,109		38,022		5,204
Total	$	3,289,242	$	30,440	$	613,124	$	15,441	$	3,902,366	$	45,881
December 31, 2016
U.S. government and government agency	$	112,709	$	1,252	$	35,450	$	1,341	$	148,159	$	2,593
State and municipal	1,562,614		35,553		133,034		4,885		1,695,648		40,438
Mortgage-backed securities	625,903		11,103		109,066		4,828		734,969		15,931
Asset-backed securities	1,010,836		5,340		201,693		6,601		1,212,529		11,941
Corporate	1,035,245		13,448		65,147		7,470		1,100,392		20,918
Foreign government	213,246		1,985		24,820		777		238,066		2,762
Fixed maturity securities	4,560,553		68,681		569,210		25,902		5,129,763		94,583
Common stocks	336		22		8,755		1,024		9,091		1,046
Preferred stocks	—		—		22,034		3,639		22,034		3,639
Equity securities available for sale	336		22		30,789		4,663		31,125		4,685
Total	$	4,560,889	$	68,703	$	599,999	$	30,565	$	5,160,888	$	99,268

Non-Investment Grade Fixed Maturity Securities

Fixed Maturity Securities – A summary of the Company’s non-investment grade fixed maturity securities that were in an unrealized loss position at September 30, 2017 is presented in the table below:

($ in thousands)	Number of Securities	Aggregate Fair Value		Gross Unrealized Loss
Foreign government	9	$	55,292	$	462
Mortgage-backed securities	6	5,975		150
Corporate	3	2,852		211
Asset-backed securities	3	1,331		115
Total	21	$	65,450	$	938

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2017

Fair Value Disclosures [Abstract]

Assets And Liabilities Measured At Fair value, On A Recurring Basis

The following tables present the assets and liabilities measured at fair value on a recurring basis as of September 30, 2017 and December 31, 2016 by level:

(In thousands)	Total		Level 1		Level 2		Level 3
September 30, 2017
Assets:
Fixed maturity securities available for sale:
U.S. government and government agency	$	411,605	$	—	$	411,605	$	—
State and municipal	4,413,169		—		4,413,169		—
Mortgage-backed securities	1,320,119		—		1,320,119		—
Asset-backed securities	2,388,618		—		2,388,444		174
Corporate	4,320,374		—		4,320,374		—
Foreign government	940,409		—		940,409		—
Total fixed maturity securities available for sale	13,794,294		—		13,794,120		174
Equity securities available for sale:
Common stocks	419,520		410,133		—		9,387
Preferred stocks	194,505		—		190,649		3,856
Total equity securities available for sale	614,025		410,133		190,649		13,243
Arbitrage trading account	488,238		275,818		212,420		—
Total	$	14,896,557	$	685,951	$	14,197,189	$	13,417
Liabilities:
Trading account securities sold but not yet purchased	$	44,937	$	44,851	$	86	$	—
December 31, 2016
Assets:
Fixed maturity securities available for sale:
U.S. government and government agency	$	513,802	$	—	$	513,802	$	—
State and municipal	4,519,503		—		4,519,503		—
Mortgage-backed securities	1,189,645		—		1,189,645		—
Asset-backed securities	1,907,860		—		1,907,677		183
Corporate	4,068,527		—		4,068,527		—
Foreign government	902,805		—		902,805		—
Total fixed maturity securities available for sale	13,102,142		—		13,101,959		183
Equity securities available for sale:
Common stocks	445,858		429,647		7,457		8,754
Preferred stocks	223,342		—		219,680		3,662
Total equity securities available for sale	669,200		429,647		227,137		12,416
Arbitrage trading account	299,999		224,623		75,376		—
Total	$	14,071,341	$	654,270	$	13,404,472	$	12,599
Liabilities:
Trading account securities sold but not yet purchased	$	51,179	$	51,089	$	90	$	—

Summarize Changes In Level 3 Assets

The following tables summarize changes in Level 3 assets and liabilities for the nine months ended September 30, 2017 and for the year ended December 31, 2016:

	Gains (Losses) Included in:
(In thousands)	Beginning Balance		Earnings (Losses)			Other Comprehensive Income (Loss)		Impairments		Purchases		(Sales)			Paydowns / Maturities			Transfers		Ending Balance
																		In / (Out)
Nine months ended September 30, 2017:
Assets:
Fixed maturities securities available for sale:
Asset-backed securities	$	183	$	2		$	32	$	—	$	—	$	(43	)	$	—		$	—	$	174
Corporate	—		—			—		—		—		—			—			—		—
Total	183		2			32		—		—		(43		)	—			—		174
Equity securities available for sale:
Common stocks	8,754		—			633		—		—		—			—			—		9,387
Preferred stocks	3,662		19			—		—		175		—			—			—		3,856
Total	12,416		19			633		—		175		—			—			—		13,243
Arbitrage trading account	—		8			—		—		—		(8		)	—			—		—
Total	$	12,599	$	29		$	665	$	—	$	175	$	(51	)	$	—		$	—	$	13,417
Year ended December 31, 2016:
Assets:
Fixed maturities securities available for sale:
Asset-backed securities	$	199	$	3		$	16	$	—	$	—	$	—		$	(35	)	$	—	$	183
Corporate	154		177			—		—		—		(331		)	—			—		—
Total	353		180			16		—		—		(331		)	(35		)	—		183
Equity securities available for sale:
Common stocks	7,829		—			160		—		765		—			—			—		8,754
Preferred stocks	3,624		38			—		—		—		—			—			—		3,662
Total	11,453		38			160		—		765		—			—			—		12,416
Arbitrage trading account	176		(176		)	—		—		—		—			—			—		—
Total	$	11,982	$	42		$	176	$	—	$	765	$	(331	)	$	(35	)	$	—	$	12,599

XML

Reserves for Loss and Loss Expenses (Tables)

9 Months Ended

Sep. 30, 2017

Insurance [Abstract]

Reserve Balances

The table below provides a reconciliation of the beginning and ending reserve balances:

	September 30,
(In thousands)	2017			2016
Net reserves at beginning of year	$	9,590,265		$	9,244,872
Net provision for losses and loss expenses:
Claims occurring during the current year (1)	2,998,687			2,838,777
Decrease in estimates for claims occurring in prior years (2) (3)	(7,648		)	(23,518		)
Loss reserve discount accretion	34,436			37,080
Total	3,025,475			2,852,339
Net payments for claims:
Current year	628,078			612,615
Prior year	1,996,977			1,931,454
Total	2,625,055			2,544,069
Foreign currency translation	57,789			(6,266		)
Net reserves at end of period	10,048,474			9,546,876
Ceded reserve at end of period	1,605,872			1,550,954
Gross reserves at end of period	$	11,654,346		$	11,097,830

_______________________________________

(1) Claims occurring during the current year are net of loss reserve discounts of $16,787,000 and $12,085,000 for the nine months ended September 30, 2017 and 2016, respectively.

(2) The decrease in estimates for claims occurring in prior years is net of loss reserve discount. On an undiscounted basis, the estimates for claims occurring in prior years decreased by $30,609,000 and $45,813,000 for the nine months ended September 30, 2017 and 2016, respectively.

(3) For certain retrospectively rated insurance policies and reinsurance agreements, reserve development is offset by additional or return premiums. Favorable development, net of additional and return premiums, was $31 million and $42 million for the nine months ended September 30, 2017 and 2016, respectively.

XML

Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2017

Fair Value Disclosures [Abstract]

Carrying Amounts And Estimated Fair Values Of Financial Instruments

The following table presents the carrying amounts and estimated fair values of the Company’s financial instruments:

	September 30, 2017				December 31, 2016
(In thousands)	Carrying Value		Fair Value		Carrying Value		Fair Value
Assets:
Fixed maturity securities	$	13,873,690	$	13,890,354	$	13,190,668	$	13,204,814
Equity securities available for sale	614,025		614,025		669,200		669,200
Arbitrage trading account	488,238		488,238		299,999		299,999
Loans receivable	74,229		76,615		106,798		108,299
Cash and cash equivalents	773,997		773,997		795,285		795,285
Trading account receivables from brokers and clearing organizations	297,208		297,208		484,593		484,593
Liabilities:
Due to broker	58,973		58,973		19,416		19,416
Trading account securities sold but not yet purchased	44,937		44,937		51,179		51,179
Subordinated debentures	728,071		728,291		727,630		687,504
Senior notes and other debt	1,759,929		1,946,700		1,760,595		1,914,727

XML

Reinsurance (Tables)

9 Months Ended

Sep. 30, 2017

Insurance [Abstract]

Reinsurance Financial Information

The following is a summary of reinsurance financial information:

	For the Three Months						For the Nine Months
	Ended September 30,						Ended September 30,
(In thousands)	2017			2016			2017			2016
Written premiums:
Direct	$	1,679,389		$	1,643,870		$	5,127,465		$	5,061,646
Assumed	194,769			224,979			570,052			702,265
Ceded	(302,975		)	(261,484		)	(915,245		)	(850,255		)
Total net premiums written	$	1,571,183		$	1,607,365		$	4,782,272		$	4,913,656
Earned premiums:
Direct	$	1,692,453		$	1,647,033		$	4,972,755		$	4,824,768
Assumed	202,972			216,758			605,281			635,443
Ceded	(313,925		)	(277,847		)	(857,792		)	(787,139		)
Total net premiums earned	$	1,581,500		$	1,585,944		$	4,720,244		$	4,673,072
Ceded losses and loss expenses incurred	$	247,104		$	213,065		$	424,905		$	507,258
Ceded commissions earned	$	63,222		$	47,315		$	177,524		$	143,809

XML

Restricted Stock Units (Tables)

9 Months Ended

Sep. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Summary Of Restricted Stock Units Issued

A summary of RSUs issued in the nine months ended September 30, 2017 and 2016 follows:

($ in thousands)	Units	Fair Value
2017	855,051	$	58,712
2016	990,487	$	57,959

XML

Business Segments (Tables)

9 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

Financial Information Of Company Operating Segments

Summary financial information about the Company's reporting segments is presented in the following tables. Income (loss) before income taxes by segment includes allocated investment income. Identifiable assets by segment are those assets used in or allocated to the operation of each segment.

	Revenues
(In thousands)	Earned Premiums		Investment Income		Other		Total (1)		Pre-Tax Income (Loss)			Net Income (Loss) to Common Stockholders
Three months ended September 30, 2017
Insurance	$	1,433,729	$	105,924	$	—	$	1,539,653	$	171,478		$	123,240
Reinsurance	147,771		21,528		—		169,299		(57,643		)	(35,074		)
Corporate, other and eliminations (2)	—		15,027		123,404		138,431		(71,681		)	(45,685		)
Net investment gains	—		—		183,959		183,959		183,959			119,573
Total	$	1,581,500	$	142,479	$	307,363	$	2,031,342	$	226,113		$	162,054
Three months ended September 30, 2016
Insurance	$	1,423,635	$	111,300	$	—	$	1,534,935	$	210,498		$	140,730
Reinsurance	162,309		27,567		—		189,876		27,321			18,725
Corporate, other and eliminations (2)	—		6,801		112,377		119,178		(81,942		)	(53,035		)
Net investment gains	—		—		175,738		175,738		175,738			114,230
Total	$	1,585,944	$	145,668	$	288,115	$	2,019,727	$	331,615		$	220,650
Nine months ended September 30, 2017:
Insurance	$	4,262,485	320,552		$	—	$	4,583,037	$	557,605		$	381,736
Reinsurance	457,759		67,798		—		525,557		(38,279		)	(20,801		)
Corporate, other and eliminations (2)	—		38,251		326,203		364,454		(224,716		)	(146,324		)
Net investment gains	—		—		276,760		276,760		276,760			179,894
Total	$	4,720,244	$	426,601	$	602,963	$	5,749,808	$	571,370		$	394,505
Nine months ended September 30, 2016:
Insurance	$	4,180,985	$	304,904	$	—	$	4,485,889	$	586,651		$	394,746
Reinsurance	492,087		77,119		—		569,206		79,215			54,885
Corporate, other and eliminations (2)	—		22,827		415,224		438,051		(190,655		)	(123,610		)
Net investment gains	—		—		189,394		189,394		189,394			123,106
Total	$	4,673,072	$	404,850	$	604,618	$	5,682,540	$	664,605		$	449,127

_________________

(1) Revenues for Insurance from foreign countries for the three months ended September 30, 2017 and 2016 were $166 million and $187 million, respectively, and for the nine months ended September 30, 2017 and 2016 were $513 million and $546 million, respectively. Revenues for Reinsurance from foreign countries for the three months ended September 30, 2017 and 2016 were $49 million and $48 million, respectively, and for the nine months ended September 30, 2017 and 2016 were $150 million and $153 million, respectively.

(2) Corporate, other and eliminations represent corporate revenues and expenses that are not allocated to business segments.

Identifiable Assets By Segment

Identifiable Assets

(In thousands)	September 30, 2017		December 31, 2016
Insurance	$	19,136,776	$	19,137,758
Reinsurance	3,243,610		2,524,338
Corporate, other and eliminations	1,955,690		1,687,980
Consolidated	$	24,336,076	$	23,350,076

Net Premiums Earned By Major Line Of Business

Net premiums earned by major line of business are as follows:

	For the Three Months				For the Nine Months
	Ended September 30,				Ended September 30,
(In thousands)	2017		2016		2017		2016
Insurance:
Other liability	$	466,616	$	455,841	$	1,378,505	$	1,302,841
Workers’ compensation	378,529		354,185		1,106,616		1,042,503
Short-tail lines (1)	287,860		312,865		887,791		962,435
Commercial automobile	163,277		164,540		482,929		481,249
Professional liability	137,447		136,204		406,644		391,957
Total Insurance	1,433,729		1,423,635		4,262,485		4,180,985
Reinsurance:
Casualty	94,478		97,153		282,430		301,571
Property	53,293		65,156		175,329		190,516
Total Reinsurance	147,771		162,309		457,759		492,087
Total	$	1,581,500	$	1,585,944	$	4,720,244	$	4,673,072

______________

(1) Short-tail lines include commercial multi-peril (non-liability), inland marine, accident and health, fidelity and surety, boiler and machinery and other lines.

XML

General (Details)	9 Months Ended
	Sep. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Federal Income Tax Rate	35.00%

XML

Per Share Data (Narrative) (Details)	9 Months Ended
	Sep. 30, 2017 shares
Earnings Per Share [Abstract]
Weighted average number of shares held in grantor trust	4,087,731

XML

Per Share Data (Weighted Average Number of Common Shares Used In the Computation of Basic and Diluted Earnings per Share) (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Earnings Per Share [Abstract]
Basic (shares)	125,818	122,562	124,363	122,652
Diluted (shares)	128,944	128,556	129,289	128,501

XML

Acquisitions/Dispositions (Narrative) (Details) - USD ($) $ in Millions	1 Months Ended
	Mar. 31, 2017	Feb. 29, 2016
Business Combinations [Abstract]
Ownership interest acquired (as percent)	89.50%	85.00%
Consideration transferred to acquire interest	$ 73.3	$ 42.3

XML

Acquisitions/Dispositions (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Mar. 31, 2017	Dec. 31, 2016
Business Combinations [Abstract]
Cash and cash equivalents		$ 2,721
Real estate, furniture and equipment		7,042
Goodwill	$ 173,422	28,522	$ 144,513
Intangible assets		32,395
Other assets		9,862
Total assets acquired		80,542
Other liabilities assumed		(2,251)
Noncontrolling interest		(5,000)
Net assets acquired		$ 73,291

XML

Consolidated Statements of Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning of period			$ 55,568
Other comprehensive income (loss)	$ 20,424	$ (67,146)	98,172	$ 56,824
End of period	153,759		153,759
Net realized investment gains	183,959	175,738	276,760	207,508
Income before income taxes	226,113	331,615	571,370	664,605
Tax effect	(63,295)	(110,952)	(174,305)	(214,789)
Net income before noncontrolling interests	162,818	220,663	397,065	449,816
Net change in period	28,592	(19,470)	71,574	(77,389)
Other comprehensive income (loss), pre-tax	20,029		121,722
Other comprehensive income (loss), tax effect	395		(23,550)
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning of period	133,302	57,281	55,568	(66,698)
Other comprehensive income (loss) before reclassifications	48,560	(40,438)	180,851	93,435
Amounts reclassified from AOCI	(28,136)	(26,708)	(82,679)	(36,611)
Other comprehensive income (loss)	20,424	(67,146)	98,172	56,824
Unrealized investment loss related to non-controlling interest	33	57	19	66
End of period	153,759	(9,808)	153,759	(9,808)
Other comprehensive income (loss), pre-tax		(91,658)		121,419
Other comprehensive income (loss), tax effect		24,512		(64,595)
Accumulated Other Comprehensive Income (Loss) | Amounts reclassified from AOCI
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Income before income taxes	(43,286)	(41,090)	(127,198)	(56,325)
Tax effect	15,150	14,382	44,519	19,714
Net income before noncontrolling interests	(28,136)	(26,708)	(82,679)	(36,611)
Unrealized Investment Gains (Losses)
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning of period	461,906	362,593	427,154	180,695
Other comprehensive income (loss) before reclassifications	19,968	(20,968)	109,277	170,824
Amounts reclassified from AOCI	(28,136)	(26,708)	(82,679)	(36,611)
Other comprehensive income (loss)	(8,168)	(47,676)	26,598	134,213
Unrealized investment loss related to non-controlling interest	33	57	19	66
End of period	453,771	314,974	453,771	314,974
Unrealized investment gains, pre-tax	(8,563)	(72,188)	50,148	198,808
Unrealized investment gains, tax effect	395	24,512	(23,550)	(64,595)
Unrealized investment gains (losses), after-tax amounts	(8,168)	(47,676)	26,598	134,213
Unrealized Investment Gains (Losses) | Amounts reclassified from AOCI
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Net realized investment gains	(43,286)	(41,090)	(127,198)	(56,325)
Tax effect	15,150	14,382	44,519	19,714
Net income before noncontrolling interests	(28,136)	(26,708)	(82,679)	(36,611)
Currency Translation Adjustments
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning of period	(328,604)	(305,312)	(371,586)	(247,393)
Other comprehensive income (loss) before reclassifications	28,592	(19,470)	71,574	(77,389)
Amounts reclassified from AOCI	0	0	0	0
Other comprehensive income (loss)	28,592	(19,470)	71,574	(77,389)
Unrealized investment loss related to non-controlling interest	0	0	0	0
End of period	(300,012)	(324,782)	(300,012)	(324,782)
Currency translation adjustment, pre-tax	28,592	(19,470)	71,574	(77,389)
Currency translation adjustment, tax effect	0	0	0	0
Net change in period	28,592	(19,470)	71,574	(77,389)
Currency Translation Adjustments | Amounts reclassified from AOCI
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Income before income taxes	0	0	0	0
Tax effect	0	0	0	0
Net income before noncontrolling interests	$ 0	$ 0	$ 0	$ 0

XML

Statements of Cash Flow (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Supplemental Cash Flow Elements [Abstract]
Interest payments	$ 134,291	$ 124,791
Income taxes paid	$ 182,487	$ 99,161

XML

Investments in Fixed Maturity Securities (Investments in fixed maturity securities) (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Schedule of Available-for-sale Securities [Line Items]
Total held to maturity, Amortized Cost	$ 79,396,000	$ 88,526,000
Held to Maturity Securities Accumulated Unrecognized Holding Gain	16,664,000	14,146,000
Held to Maturity Securities Accumulated Unrecognized Holding Loss	0	0
Total held to maturity, Fair Value	96,060,000	102,672,000
Total held to maturity, Carrying Value	79,396,000	88,526,000
Total available for sale, Amortized Cost	13,479,715,000	12,869,809,000
Total available for sale, Gross Unrealized Gains	355,256,000	326,916,000
Total available for sale, Gross Unrealized Losses	(40,677,000)	(94,583,000)
Total available for sale, Fair Value	13,794,294,000	13,102,142,000
Total available for sale, Carrying Value	13,794,294,000	13,102,142,000
Total investments in fixed maturity securities, Amortized Value	13,559,111,000	12,958,335,000
Total investments in fixed maturity securities, Gross Unrealized Gains	371,920,000	341,062,000
Total investments in fixed maturity securities, Gross Unrealized Losses	(40,677,000)	(94,583,000)
Total investments in fixed maturity securities, Fair Value	13,890,354,000	13,204,814,000
Total investments in fixed maturity securities, Carrying Value	$ 13,873,690,000	13,190,668,000
Minimum ownership of Common stockholders equity	10.00%
U.S. government and government agency
Schedule of Available-for-sale Securities [Line Items]
Total available for sale, Amortized Cost	$ 402,901,000	496,187,000
Total available for sale, Gross Unrealized Gains	10,828,000	20,208,000
Total available for sale, Gross Unrealized Losses	(2,124,000)	(2,593,000)
Total available for sale, Fair Value	411,605,000	513,802,000
Total available for sale, Carrying Value	411,605,000	513,802,000
Special revenue
Schedule of Available-for-sale Securities [Line Items]
Total available for sale, Amortized Cost	2,730,653,000	2,791,211,000
Total available for sale, Gross Unrealized Gains	80,144,000	58,559,000
Total available for sale, Gross Unrealized Losses	(5,469,000)	(26,315,000)
Total available for sale, Fair Value	2,805,328,000	2,823,455,000
Total available for sale, Carrying Value	2,805,328,000	2,823,455,000
State general obligation
Schedule of Available-for-sale Securities [Line Items]
Total available for sale, Amortized Cost	481,070,000	524,682,000
Total available for sale, Gross Unrealized Gains	21,377,000	16,964,000
Total available for sale, Gross Unrealized Losses	(565,000)	(5,139,000)
Total available for sale, Fair Value	501,882,000	536,507,000
Total available for sale, Carrying Value	501,882,000	536,507,000
Pre-refunded
Schedule of Available-for-sale Securities [Line Items]
Total available for sale, Amortized Cost	282,488,000	356,535,000
Total available for sale, Gross Unrealized Gains	21,052,000	19,181,000
Total available for sale, Gross Unrealized Losses	(173,000)	(165,000)
Total available for sale, Fair Value	303,367,000	375,551,000
Total available for sale, Carrying Value	303,367,000	375,551,000
Corporate backed
Schedule of Available-for-sale Securities [Line Items]
Total available for sale, Amortized Cost	380,351,000	410,933,000
Total available for sale, Gross Unrealized Gains	11,775,000	6,172,000
Total available for sale, Gross Unrealized Losses	(499,000)	(6,452,000)
Total available for sale, Fair Value	391,627,000	410,653,000
Total available for sale, Carrying Value	391,627,000	410,653,000
Local general obligation
Schedule of Available-for-sale Securities [Line Items]
Total available for sale, Amortized Cost	384,930,000	360,022,000
Total available for sale, Gross Unrealized Gains	26,566,000	15,682,000
Total available for sale, Gross Unrealized Losses	(531,000)	(2,367,000)
Total available for sale, Fair Value	410,965,000	373,337,000
Total available for sale, Carrying Value	410,965,000	373,337,000
State and municipal
Schedule of Available-for-sale Securities [Line Items]
Total available for sale, Amortized Cost	4,259,492,000	4,443,383,000
Total available for sale, Gross Unrealized Gains	160,914,000	116,558,000
Total available for sale, Gross Unrealized Losses	(7,237,000)	(40,438,000)
Total available for sale, Fair Value	4,413,169,000	4,519,503,000
Total available for sale, Carrying Value	4,413,169,000	4,519,503,000
Mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Total available for sale, Amortized Cost	1,316,092,000	1,189,841,000
Total available for sale, Gross Unrealized Gains	14,337,000	15,735,000
Total available for sale, Gross Unrealized Losses	(10,310,000)	(15,931,000)
Total available for sale, Fair Value	1,320,119,000	1,189,645,000
Total available for sale, Carrying Value	1,320,119,000	1,189,645,000
Residential
Schedule of Available-for-sale Securities [Line Items]
Total available for sale, Amortized Cost	1,064,705,000	1,034,301,000
Total available for sale, Gross Unrealized Gains	12,696,000	15,431,000
Total available for sale, Gross Unrealized Losses	(8,860,000)	(12,950,000)
Total available for sale, Fair Value	1,068,541,000	1,036,782,000
Total available for sale, Carrying Value	1,068,541,000	1,036,782,000
Gross unrealized gains (losses) related to securities	85,907	(818,691)
Commercial
Schedule of Available-for-sale Securities [Line Items]
Total available for sale, Amortized Cost	251,387,000	155,540,000
Total available for sale, Gross Unrealized Gains	1,641,000	304,000
Total available for sale, Gross Unrealized Losses	(1,450,000)	(2,981,000)
Total available for sale, Fair Value	251,578,000	152,863,000
Total available for sale, Carrying Value	251,578,000	152,863,000
Asset-backed
Schedule of Available-for-sale Securities [Line Items]
Total available for sale, Amortized Cost	2,389,187,000	1,913,830,000
Total available for sale, Gross Unrealized Gains	9,836,000	5,971,000
Total available for sale, Gross Unrealized Losses	(10,405,000)	(11,941,000)
Total available for sale, Fair Value	2,388,618,000	1,907,860,000
Total available for sale, Carrying Value	2,388,618,000	1,907,860,000
Corporate
Schedule of Available-for-sale Securities [Line Items]
Total available for sale, Amortized Cost	4,202,435,000	3,967,795,000
Total available for sale, Gross Unrealized Gains	126,452,000	121,650,000
Total available for sale, Gross Unrealized Losses	(8,513,000)	(20,918,000)
Total available for sale, Fair Value	4,320,374,000	4,068,527,000
Total available for sale, Carrying Value	4,320,374,000	4,068,527,000
Industrial
Schedule of Available-for-sale Securities [Line Items]
Total available for sale, Amortized Cost	2,569,673,000	2,315,567,000
Total available for sale, Gross Unrealized Gains	70,054,000	71,007,000
Total available for sale, Gross Unrealized Losses	(2,842,000)	(7,174,000)
Total available for sale, Fair Value	2,636,885,000	2,379,400,000
Total available for sale, Carrying Value	2,636,885,000	2,379,400,000
Financial
Schedule of Available-for-sale Securities [Line Items]
Total available for sale, Amortized Cost	1,335,101,000	1,369,001,000
Total available for sale, Gross Unrealized Gains	43,636,000	39,543,000
Total available for sale, Gross Unrealized Losses	(4,716,000)	(11,270,000)
Total available for sale, Fair Value	1,374,021,000	1,397,274,000
Total available for sale, Carrying Value	1,374,021,000	1,397,274,000
Utilities
Schedule of Available-for-sale Securities [Line Items]
Total available for sale, Amortized Cost	255,478,000	229,154,000
Total available for sale, Gross Unrealized Gains	12,760,000	10,801,000
Total available for sale, Gross Unrealized Losses	(907,000)	(2,411,000)
Total available for sale, Fair Value	267,331,000	237,544,000
Total available for sale, Carrying Value	267,331,000	237,544,000
Other
Schedule of Available-for-sale Securities [Line Items]
Total available for sale, Amortized Cost	42,183,000	54,073,000
Total available for sale, Gross Unrealized Gains	2,000	299,000
Total available for sale, Gross Unrealized Losses	(48,000)	(63,000)
Total available for sale, Fair Value	42,137,000	54,309,000
Total available for sale, Carrying Value	42,137,000	54,309,000
Foreign
Schedule of Available-for-sale Securities [Line Items]
Total available for sale, Amortized Cost	909,608,000	858,773,000
Total available for sale, Gross Unrealized Gains	32,889,000	46,794,000
Total available for sale, Gross Unrealized Losses	(2,088,000)	(2,762,000)
Total available for sale, Fair Value	940,409,000	902,805,000
Total available for sale, Carrying Value	940,409,000	902,805,000
State and municipal
Schedule of Available-for-sale Securities [Line Items]
Total held to maturity, Amortized Cost	65,372,000	72,582,000
Held to Maturity Securities Accumulated Unrecognized Holding Gain	15,212,000	12,453,000
Held to Maturity Securities Accumulated Unrecognized Holding Loss	0	0
Total held to maturity, Fair Value	80,584,000	85,035,000
Total held to maturity, Carrying Value	65,372,000	72,582,000
Residential
Schedule of Available-for-sale Securities [Line Items]
Total held to maturity, Amortized Cost	14,024,000	15,944,000
Held to Maturity Securities Accumulated Unrecognized Holding Gain	1,452,000	1,693,000
Held to Maturity Securities Accumulated Unrecognized Holding Loss	0	0
Total held to maturity, Fair Value	15,476,000	17,637,000
Total held to maturity, Carrying Value	$ 14,024,000	$ 15,944,000

XML

Investments In Fixed Maturity Securities Investments in Fixed Maturity Securities (Amortized cost and fair value of fixed maturity securities) (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Investments, Debt and Equity Securities [Abstract]
Amortized Cost, Due in one year or less	$ 745,010
Amortized Cost, Due after one year through five years	5,089,768
Amortized Cost, Due after five years through ten years	3,248,254
Amortized Cost, Due after ten years	3,145,963
Amortized Cost, Mortgaged-backed securities	1,330,116
Total investments in fixed maturity securities, Amortized Value	13,559,111	$ 12,958,335
Fair Value, Due in one year or less	750,479
Fair Value, Due after one year through five years	5,210,268
Fair Value, Due after five years through ten years	3,396,461
Fair Value, Due after ten years	3,197,551
Fair Value, Mortgage-backed securities	1,335,595
Total investments in fixed maturity securities, Fair Value	$ 13,890,354	$ 13,204,814

XML

Investments in Equity Securities Available for Sale (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Schedule of Available-for-sale Securities [Line Items]
Cost	$ 208,785	$ 220,587
Gross Unrealized, Gains	410,444	453,298
Gross Unrealized, Losses	(5,204)	(4,685)
Carrying and fair value of equity securities	614,025	669,200
Common stock
Schedule of Available-for-sale Securities [Line Items]
Cost	83,709	94,998
Gross Unrealized, Gains	339,297	351,906
Gross Unrealized, Losses	(3,486)	(1,046)
Carrying and fair value of equity securities	419,520	445,858
Preferred stocks
Schedule of Available-for-sale Securities [Line Items]
Cost	125,076	125,589
Gross Unrealized, Gains	71,147	101,392
Gross Unrealized, Losses	(1,718)	(3,639)
Carrying and fair value of equity securities	$ 194,505	$ 223,342

XML

Arbitrage Trading Account (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Derivative [Line Items]
Arbitrage trading account	$ 488,238	$ 299,999
Long | Options held
Derivative [Line Items]
Fair value of derivative	1,000
Notional amount of derivative	33,000
Short | Options held
Derivative [Line Items]
Fair value of derivative	1,000
Notional amount of derivative	$ 54,000

XML

Net Investment Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Net Investment Income [Line Items]
Gross investment income	$ 144,098	$ 147,659	$ 431,694	$ 412,485
Investment expense	(1,619)	(1,991)	(5,093)	(7,635)
Net investment income	142,479	145,668	426,601	404,850
Fixed maturity securities, including cash and cash equivalents and loans receivable
Net Investment Income [Line Items]
Gross investment income	118,834	114,271	347,976	331,448
Investment funds
Net Investment Income [Line Items]
Gross investment income	15,200	25,293	50,744	60,385
Arbitrage trading account
Net Investment Income [Line Items]
Gross investment income	4,418	6,441	16,235	12,883
Real estate
Net Investment Income [Line Items]
Gross investment income	5,042	585	14,894	4,552
Equity securities available for sale
Net Investment Income [Line Items]
Gross investment income	$ 604	$ 1,069	$ 1,845	$ 3,217

XML

Investment Funds Investment Funds (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Schedule of Equity Method Investments [Line Items]
Unfunded commitments	$ 442,000
Investment funds	1,119,907		$ 1,198,146
Income (Loss) from Investment Funds	50,744	$ 60,385
Real estate
Schedule of Equity Method Investments [Line Items]
Investment funds	614,508		641,783
Income (Loss) from Investment Funds	30,661	33,028
Energy
Schedule of Equity Method Investments [Line Items]
Investment funds	85,817		91,448
Income (Loss) from Investment Funds	(12,763)	7,174
Hedge equity
Schedule of Equity Method Investments [Line Items]
Investment funds	0		73,913
Income (Loss) from Investment Funds	(1,164)	791
Other funds
Schedule of Equity Method Investments [Line Items]
Investment funds	419,582		$ 391,002
Income (Loss) from Investment Funds	$ 34,010	$ 19,392

XML

Real Estate Real Estate (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Real Estate [Abstract]
Properties in operation	$ 451,669	$ 457,237
Properties under development	939,605	727,744
Total	$ 1,391,274	$ 1,184,981

XML

Real Estate Real Estate (Narrative) (Details) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Real Estate [Abstract]
Accumulated depreciation and amortization on properties	$ 20,378,000		$ 14,996,000
Real estate depreciation expense	5,382,000	$ 4,117,000
Lease future minimum payments 2017	4,966,133
Lease future minimum payments 2018	28,251,980
Lease future minimum payments 2019	30,174,146
Lease future minimum payments 2020	29,415,103
Lease future minimum payments 2021	30,054,813
Lease future minimum payments 2022	29,966,679
Lease future minimum payments there after	$ 467,192,215

XML

Loans Receivable (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	$ 74,229		$ 74,229		$ 106,798
Loans receivable	76,615		76,615		108,299
Valuation allowance, specific	1,200		1,200		1,200
Valuation allowance, general	2,183		2,183		2,197
Valuation allowance of loans receivable	3,383		3,383		3,397
(Decrease) increase in valuation allowance	0	$ 467	(14)	$ 1,128
Loans in nonaccrual status	4,500		4,500		5,400
Real estate loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	59,487		59,487		92,415
Loans receivable	60,372		60,372		92,415
Commercial loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	14,742		14,742		14,383
Loans receivable	$ 16,243		$ 16,243		$ 15,884

XML

Realized and Unrealized Investment Gains (Losses) (Realized and unrealized investmetns gains(losses)) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Jun. 30, 2017	Sep. 30, 2017	Sep. 30, 2016
Realized and Unrealized Investment Gains Losses [Line Items]
Fixed maturity securities, gains	$ 8,763	$ 33,798		$ 21,795	$ 66,972
Fixed maturity securities, losses	(197)	(1,150)		(4,162)	(5,570)
Equity securities available for sale	34,720	8,441		109,566	13,037
Investment funds (1)	124,228	(3,788)		125,383	(9,041)
Real estate	1,956	687		4,892	5,247
Other (2)	14,489	137,750		19,286	136,863
Net realized gains on investments sales	183,959	175,738		276,760	207,508
Other-than-temporary impairments	0	0		0	(18,114)
Net investment gains	183,959	175,738		276,760	189,394
Income tax expense	(64,386)	(61,508)		(96,866)	(66,288)
After-tax net realized investment gains	119,573	114,230		179,894	123,106
Office Building in Washington, D.C.
Realized and Unrealized Investment Gains Losses [Line Items]
Investment funds (1)	$ 124,300			$ 124,300
Aero Precision Industries and Certain Related Aviation Services Business
Realized and Unrealized Investment Gains Losses [Line Items]
Other (2)		$ 134,900			$ 134,900
Common stock
Realized and Unrealized Investment Gains Losses [Line Items]
Other-than-temporary impairments			$ (18,100)

XML

Realized and Unrealized Investment Gains (Losses) (Change in Unrealized Gains (Losses) of Available For Sales Securities) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Realized and Unrealized Investment Gains Losses [Line Items]
Total change in unrealized investment gains	$ (8,563)	$ (72,168)	$ 50,148	$ 198,807
Income tax benefit (expense)	423	24,493	(23,550)	(64,594)
Noncontrolling interests	5	57	19	66
Total change in unrealized gains	(8,135)	(47,618)	26,617	134,279
Debt securities
Realized and Unrealized Investment Gains Losses [Line Items]
Total change in unrealized investment gains	(10,627)	(45,388)	84,214	169,933
Previously impaired fixed maturity securities
Realized and Unrealized Investment Gains Losses [Line Items]
Total change in unrealized investment gains	61	(1,406)	905	413
Equity securities available for sale
Realized and Unrealized Investment Gains Losses [Line Items]
Total change in unrealized investment gains	(2,126)	(28,517)	(44,812)	12,433
Investment funds
Realized and Unrealized Investment Gains Losses [Line Items]
Total change in unrealized investment gains	$ 4,129	$ 3,143	$ 9,841	$ 16,028

XML

Securities in an Unrealized Loss Position (Securities in an Unrealized Loss Position) (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Schedule of Available-for-sale Securities [Line Items]
Fair Value, Less than 12 Months	$ 3,289,242	$ 4,560,889
Gross Unrealized Losses, Less than 12 Months	30,440	68,703
Fair Value, 12 Months or Greater	613,124	599,999
Gross Unrealized Losses, 12 Months or Greater	15,441	30,565
Fair Value, Total	3,902,366	5,160,888
Gross Unrealized Losses, Total	45,881	99,268
Debt securities
Schedule of Available-for-sale Securities [Line Items]
Fair Value, Less than 12 Months	3,284,564	4,560,553
Gross Unrealized Losses, Less than 12 Months	27,345	68,681
Fair Value, 12 Months or Greater	579,780	569,210
Gross Unrealized Losses, 12 Months or Greater	13,332	25,902
Fair Value, Total	3,864,344	5,129,763
Gross Unrealized Losses, Total	40,677	94,583
U.S. government and government agency
Schedule of Available-for-sale Securities [Line Items]
Fair Value, Less than 12 Months	118,066	112,709
Gross Unrealized Losses, Less than 12 Months	1,048	1,252
Fair Value, 12 Months or Greater	48,880	35,450
Gross Unrealized Losses, 12 Months or Greater	1,076	1,341
Fair Value, Total	166,946	148,159
Gross Unrealized Losses, Total	2,124	2,593
State and municipal
Schedule of Available-for-sale Securities [Line Items]
Fair Value, Less than 12 Months	650,353	1,562,614
Gross Unrealized Losses, Less than 12 Months	5,797	35,553
Fair Value, 12 Months or Greater	119,087	133,034
Gross Unrealized Losses, 12 Months or Greater	1,440	4,885
Fair Value, Total	769,440	1,695,648
Gross Unrealized Losses, Total	7,237	40,438
Mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Fair Value, Less than 12 Months	527,034	625,903
Gross Unrealized Losses, Less than 12 Months	5,000	11,103
Fair Value, 12 Months or Greater	221,923	109,066
Gross Unrealized Losses, 12 Months or Greater	5,310	4,828
Fair Value, Total	748,957	734,969
Gross Unrealized Losses, Total	10,310	15,931
Asset-backed
Schedule of Available-for-sale Securities [Line Items]
Fair Value, Less than 12 Months	1,116,878	1,010,836
Gross Unrealized Losses, Less than 12 Months	8,033	5,340
Fair Value, 12 Months or Greater	130,734	201,693
Gross Unrealized Losses, 12 Months or Greater	2,372	6,601
Fair Value, Total	1,247,612	1,212,529
Gross Unrealized Losses, Total	10,405	11,941
Corporate
Schedule of Available-for-sale Securities [Line Items]
Fair Value, Less than 12 Months	651,373	1,035,245
Gross Unrealized Losses, Less than 12 Months	5,395	13,448
Fair Value, 12 Months or Greater	57,557	65,147
Gross Unrealized Losses, 12 Months or Greater	3,118	7,470
Fair Value, Total	708,930	1,100,392
Gross Unrealized Losses, Total	8,513	20,918
Foreign government
Schedule of Available-for-sale Securities [Line Items]
Fair Value, Less than 12 Months	220,860	213,246
Gross Unrealized Losses, Less than 12 Months	2,072	1,985
Fair Value, 12 Months or Greater	1,599	24,820
Gross Unrealized Losses, 12 Months or Greater	16	777
Fair Value, Total	222,459	238,066
Gross Unrealized Losses, Total	2,088	2,762
Equity securities available for sale
Schedule of Available-for-sale Securities [Line Items]
Fair Value, Less than 12 Months	4,678	336
Gross Unrealized Losses, Less than 12 Months	3,095	22
Fair Value, 12 Months or Greater	33,344	30,789
Gross Unrealized Losses, 12 Months or Greater	2,109	4,663
Fair Value, Total	38,022	31,125
Gross Unrealized Losses, Total	5,204	4,685
Common stocks
Schedule of Available-for-sale Securities [Line Items]
Fair Value, Less than 12 Months	4,678	336
Gross Unrealized Losses, Less than 12 Months	3,095	22
Fair Value, 12 Months or Greater	9,387	8,755
Gross Unrealized Losses, 12 Months or Greater	391	1,024
Fair Value, Total	14,065	9,091
Gross Unrealized Losses, Total	3,486	1,046
Preferred stocks
Schedule of Available-for-sale Securities [Line Items]
Fair Value, Less than 12 Months	0	0
Gross Unrealized Losses, Less than 12 Months	0	0
Fair Value, 12 Months or Greater	23,957	22,034
Gross Unrealized Losses, 12 Months or Greater	1,718	3,639
Fair Value, Total	23,957	22,034
Gross Unrealized Losses, Total	$ 1,718	$ 3,639

XML

Securities In An Unrealized Loss Position (Non-Investment Grade Fixed Maturity Securities) (Details) $ in Thousands	Sep. 30, 2017 USD ($) position	Dec. 31, 2016 USD ($)
Schedule of Available-for-sale Securities [Line Items]
Aggregate Fair Value	$ 3,902,366	$ 5,160,888
Mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Aggregate Fair Value	748,957	734,969
Corporate
Schedule of Available-for-sale Securities [Line Items]
Aggregate Fair Value	708,930	1,100,392
Asset-backed securities
Schedule of Available-for-sale Securities [Line Items]
Aggregate Fair Value	$ 1,247,612	$ 1,212,529
Noninvestment Grade Investments at Loss Position
Schedule of Available-for-sale Securities [Line Items]
Number of Securities	21
Aggregate Fair Value	$ 65,450
Gross Unrealized Loss	$ 938
Noninvestment Grade Investments at Loss Position | Foreign government
Schedule of Available-for-sale Securities [Line Items]
Number of Securities	9
Aggregate Fair Value	$ 55,292
Gross Unrealized Loss	$ 462
Noninvestment Grade Investments at Loss Position | Mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Number of Securities	6
Aggregate Fair Value	$ 5,975
Gross Unrealized Loss	$ 150
Noninvestment Grade Investments at Loss Position | Corporate
Schedule of Available-for-sale Securities [Line Items]
Number of Securities	3
Aggregate Fair Value	$ 2,852
Gross Unrealized Loss	$ 211
Noninvestment Grade Investments at Loss Position | Asset-backed securities
Schedule of Available-for-sale Securities [Line Items]
Number of Securities | position	3
Aggregate Fair Value	$ 1,331
Gross Unrealized Loss	$ 115

XML

Securities In An Unrealized Loss Position (Narrative) (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2017 USD ($) shares	Sep. 30, 2016 USD ($)	Sep. 30, 2017 USD ($) shares	Sep. 30, 2016 USD ($)	Dec. 31, 2016 USD ($)
Schedule of Available-for-sale Securities [Line Items]
Aggregate Fair Value	$ 3,902,366,000		$ 3,902,366,000		$ 5,160,888,000
Gross unrealized losses	45,881,000		45,881,000		99,268,000
Other-than-temporary impairments	0	$ 0	0	$ 18,114,000
Preferred stocks
Schedule of Available-for-sale Securities [Line Items]
Other-than-temporary impairments			0	0
Common stock
Schedule of Available-for-sale Securities [Line Items]
Other-than-temporary impairments			0	$ 18,100,000
Common stock
Schedule of Available-for-sale Securities [Line Items]
Gross unrealized losses	$ 3,500,000		$ 3,500,000
Noninvestment Grade Investments
Schedule of Available-for-sale Securities [Line Items]
Number of securities | shares	1		1
Preferred stocks
Schedule of Available-for-sale Securities [Line Items]
Aggregate Fair Value	$ 23,957,000		$ 23,957,000		22,034,000
Gross unrealized losses	1,718,000		1,718,000		3,639,000
Common stock
Schedule of Available-for-sale Securities [Line Items]
Aggregate Fair Value	14,065,000		14,065,000		9,091,000
Gross unrealized losses	$ 3,486,000		3,486,000		$ 1,046,000
Other-than-temporary impairment, available for sale securities			$ 14,100,000

XML

Fair Value Measurements (Assets and Liabilities Measured At Fair Value, On a Recurring Basis) (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Assets:
Total fixed maturity securities available for sale	$ 13,794,294	$ 13,102,142
Equity securities available for sale	614,025	669,200
Arbitrage trading account	488,238	299,999
Fair Value, Measurements, Recurring
Assets:
Total fixed maturity securities available for sale	13,794,294	13,102,142
Equity securities available for sale	614,025	669,200
Arbitrage trading account	488,238	299,999
Assets, fair value disclosure	14,896,557	14,071,341
Liabilities:
Securities sold but not yet purchased	44,937	51,179
Fair Value, Measurements, Recurring | U.S. government and government agency
Assets:
Total fixed maturity securities available for sale	411,605	513,802
Fair Value, Measurements, Recurring | State and municipal
Assets:
Total fixed maturity securities available for sale	4,413,169	4,519,503
Fair Value, Measurements, Recurring | Mortgage-backed securities
Assets:
Total fixed maturity securities available for sale	1,320,119	1,189,645
Fair Value, Measurements, Recurring | Asset-backed
Assets:
Total fixed maturity securities available for sale	2,388,618	1,907,860
Fair Value, Measurements, Recurring | Corporate
Assets:
Total fixed maturity securities available for sale	4,320,374	4,068,527
Fair Value, Measurements, Recurring | Foreign government
Assets:
Total fixed maturity securities available for sale	940,409	902,805
Fair Value, Measurements, Recurring | Common stocks
Assets:
Equity securities available for sale	419,520	445,858
Fair Value, Measurements, Recurring | Preferred stocks
Assets:
Equity securities available for sale	194,505	223,342
Level 1 | Fair Value, Measurements, Recurring
Assets:
Total fixed maturity securities available for sale	0	0
Equity securities available for sale	410,133	429,647
Arbitrage trading account	275,818	224,623
Assets, fair value disclosure	685,951	654,270
Liabilities:
Securities sold but not yet purchased	44,851	51,089
Level 1 | Fair Value, Measurements, Recurring | U.S. government and government agency
Assets:
Total fixed maturity securities available for sale	0	0
Level 1 | Fair Value, Measurements, Recurring | State and municipal
Assets:
Total fixed maturity securities available for sale	0	0
Level 1 | Fair Value, Measurements, Recurring | Mortgage-backed securities
Assets:
Total fixed maturity securities available for sale	0	0
Level 1 | Fair Value, Measurements, Recurring | Asset-backed
Assets:
Total fixed maturity securities available for sale	0	0
Level 1 | Fair Value, Measurements, Recurring | Corporate
Assets:
Total fixed maturity securities available for sale	0	0
Level 1 | Fair Value, Measurements, Recurring | Foreign government
Assets:
Total fixed maturity securities available for sale	0	0
Level 1 | Fair Value, Measurements, Recurring | Common stocks
Assets:
Equity securities available for sale	410,133	429,647
Level 1 | Fair Value, Measurements, Recurring | Preferred stocks
Assets:
Equity securities available for sale	0	0
Level 2 | Fair Value, Measurements, Recurring
Assets:
Total fixed maturity securities available for sale	13,794,120	13,101,959
Equity securities available for sale	190,649	227,137
Arbitrage trading account	212,420	75,376
Assets, fair value disclosure	14,197,189	13,404,472
Liabilities:
Securities sold but not yet purchased	86	90
Level 2 | Fair Value, Measurements, Recurring | U.S. government and government agency
Assets:
Total fixed maturity securities available for sale	411,605	513,802
Level 2 | Fair Value, Measurements, Recurring | State and municipal
Assets:
Total fixed maturity securities available for sale	4,413,169	4,519,503
Level 2 | Fair Value, Measurements, Recurring | Mortgage-backed securities
Assets:
Total fixed maturity securities available for sale	1,320,119	1,189,645
Level 2 | Fair Value, Measurements, Recurring | Asset-backed
Assets:
Total fixed maturity securities available for sale	2,388,444	1,907,677
Level 2 | Fair Value, Measurements, Recurring | Corporate
Assets:
Total fixed maturity securities available for sale	4,320,374	4,068,527
Level 2 | Fair Value, Measurements, Recurring | Foreign government
Assets:
Total fixed maturity securities available for sale	940,409	902,805
Level 2 | Fair Value, Measurements, Recurring | Common stocks
Assets:
Equity securities available for sale	0	7,457
Level 2 | Fair Value, Measurements, Recurring | Preferred stocks
Assets:
Equity securities available for sale	190,649	219,680
Level 3 | Fair Value, Measurements, Recurring
Assets:
Total fixed maturity securities available for sale	174	183
Equity securities available for sale	13,243	12,416
Arbitrage trading account	0	0
Assets, fair value disclosure	13,417	12,599
Liabilities:
Securities sold but not yet purchased	0	0
Level 3 | Fair Value, Measurements, Recurring | U.S. government and government agency
Assets:
Total fixed maturity securities available for sale	0	0
Level 3 | Fair Value, Measurements, Recurring | State and municipal
Assets:
Total fixed maturity securities available for sale	0	0
Level 3 | Fair Value, Measurements, Recurring | Mortgage-backed securities
Assets:
Total fixed maturity securities available for sale	0	0
Level 3 | Fair Value, Measurements, Recurring | Asset-backed
Assets:
Total fixed maturity securities available for sale	174	183
Level 3 | Fair Value, Measurements, Recurring | Corporate
Assets:
Total fixed maturity securities available for sale	0	0
Level 3 | Fair Value, Measurements, Recurring | Foreign government
Assets:
Total fixed maturity securities available for sale	0	0
Level 3 | Fair Value, Measurements, Recurring | Common stocks
Assets:
Equity securities available for sale	9,387	8,754
Level 3 | Fair Value, Measurements, Recurring | Preferred stocks
Assets:
Equity securities available for sale	$ 3,856	$ 3,662

XML

Fair Value Measurements (Summarize Changes in Level 3 Assets) (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, impairments	$ 0	$ 0
Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, beginning balance	12,599	11,982
Assets, earnings	29	42
Assets, other comprehensive income	665	176
Assets, purchases	175	765
Assets, (sales)	(51)	(331)
Assets, maturities		(35)
Assets. transfers out		0
Assets, ending balance	13,417	12,599
Level 3 | Debt securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, beginning balance	183	353
Assets, earnings	2	180
Assets, other comprehensive income	32	16
Assets, impairments	0	0
Assets, purchases	0	0
Assets, (sales)	(43)	(331)
Assets, maturities		(35)
Assets. transfers out	0	0
Assets, ending balance	174	183
Level 3 | Asset-backed
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, beginning balance	183	199
Assets, earnings	2	3
Assets, other comprehensive income	32	16
Assets, impairments	0	0
Assets, purchases	0	0
Assets, (sales)	(43)	0
Assets, maturities	0	(35)
Assets. transfers out	0	0
Assets, ending balance	174	183
Level 3 | Corporate
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, beginning balance	0	154
Assets, earnings	0	177
Assets, other comprehensive income	0	0
Assets, impairments	0	0
Assets, purchases	0	0
Assets, (sales)	0	(331)
Assets. transfers out	0	0
Assets, ending balance	0	0
Level 3 | Equity securities available for sale
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, beginning balance	12,416	11,453
Assets, earnings	19	38
Assets, other comprehensive income	633	160
Assets, impairments	0	0
Assets, purchases	175	765
Assets, (sales)	0	0
Assets. transfers out	0	0
Assets, ending balance	13,243	12,416
Level 3 | Common stock
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, beginning balance	8,754	7,829
Assets, earnings	0	0
Assets, other comprehensive income	633	160
Assets, impairments	0	0
Assets, purchases	0	765
Assets, (sales)	0	0
Assets. transfers out	0	0
Assets, ending balance	9,387	8,754
Level 3 | Preferred stocks
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, beginning balance	3,662	3,624
Assets, earnings	19	38
Assets, other comprehensive income	0	0
Assets, impairments	0	0
Assets, purchases	175	0
Assets, (sales)	0	0
Assets. transfers out	0	0
Assets, ending balance	3,856	3,662
Level 3 | Arbitrage trading account
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Assets, beginning balance	0	176
Assets, earnings	8	(176)
Assets, other comprehensive income	0	0
Assets, impairments	0	0
Assets, purchases	0	0
Assets, (sales)	(8)	0
Assets. transfers out	0	0
Assets, ending balance	$ 0	$ 0

XML

Reserves for Loss and Loss Expenses (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Net reserves at beginning of year	$ 9,590,265	$ 9,244,872
Net provision for losses and loss expenses:
Claims occurring during the current year	2,998,687	2,838,777
Decrease in estimates for claims occurring in prior years	(7,648)	(23,518)
Loss reserve discount accretion	34,436	37,080
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims	3,025,475	2,852,339
Net payments for claims:
Current year	628,078	612,615
Prior year	1,996,977	1,931,454
Total	2,625,055	2,544,069
Foreign currency translation	57,789	(6,266)
Net reserves at end of period	10,048,474	9,546,876
Ceded reserve at end of period	1,605,872	1,550,954
Gross reserves at end of period	$ 11,654,346	$ 11,097,830	$ 11,197,195

XML

Reserves for Loss and Loss Expenses (Narrative) (Details) - USD ($) $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Liability for Claims and Claims Adjustment Expense [Line Items]
Net of loss reserve discounts	$ 16,787	$ 12,085
Decrease in estimates for claims	30,609	45,813
Adjustment expense	30,600	$ 42,000	$ 42,000
Insurance
Liability for Claims and Claims Adjustment Expense [Line Items]
Adjustment expense	62,000		38,000
Reinsurance
Liability for Claims and Claims Adjustment Expense [Line Items]
Adjustment expense	$ 31,000		$ 4,000

XML

Fair Value of Financial Instruments (Carrying Amounts and Estimated Fair Values of Financial Instruments) (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Assets:
Arbitrage trading account	$ 488,238	$ 299,999
Loans receivable	76,615	108,299
Carrying Value
Assets:
Fixed maturity securities	13,873,690	13,190,668
Equity securities available for sale	614,025	669,200
Arbitrage trading account	488,238	299,999
Loans receivable	74,229	106,798
Cash and cash equivalents	773,997	795,285
Trading account receivables from brokers and clearing organizations	297,208	484,593
Liabilities:
Due to broker	58,973	19,416
Trading account securities sold but not yet purchased	44,937	51,179
Subordinated debentures	728,071	727,630
Senior notes and other debt	1,759,929	1,760,595
Fair Value
Assets:
Fixed maturity securities	13,890,354	13,204,814
Equity securities available for sale	614,025	669,200
Arbitrage trading account	488,238	299,999
Loans receivable	76,615	108,299
Cash and cash equivalents	773,997	795,285
Trading account receivables from brokers and clearing organizations	297,208	484,593
Liabilities:
Due to broker	58,973	19,416
Trading account securities sold but not yet purchased	44,937	51,179
Subordinated debentures	728,291	687,504
Senior notes and other debt	$ 1,946,700	$ 1,914,727

XML

Reinsurance (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Written premiums:
Written premiums, direct	$ 1,679,389	$ 1,643,870	$ 5,127,465	$ 5,061,646
Written premiums, assumed	194,769	224,979	570,052	702,265
Written premiums, ceded	(302,975)	(261,484)	(915,245)	(850,255)
Total net premiums written	1,571,183	1,607,365	4,782,272	4,913,656
Earned premiums:
Earned premiums, direct	1,692,453	1,647,033	4,972,755	4,824,768
Earned premiums, assumed	202,972	216,758	605,281	635,443
Earned premiums, ceded	(313,925)	(277,847)	(857,792)	(787,139)
Net premiums earned	1,581,500	1,585,944	4,720,244	4,673,072
Ceded losses and loss expenses incurred	247,104	213,065	424,905	507,258
Ceded commissions earned	63,222	$ 47,315	177,524	$ 143,809
Uncollectible reinsurance	$ 1,000		$ 1,000		$ 1,000

XML

Restricted Stock Units (Summary of Restricted Stock Units Issued) (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Share-Based Compensation Arrangement by Share-based Payment Award [Line Item]
Share based compensation expense	$ 30,000	$ 25,000
Restricted stock
Share-Based Compensation Arrangement by Share-based Payment Award [Line Item]
Restricted stock units (in units)	855,051	990,487,000
Fair Value	$ 58,712	$ 57,959
Minimum | Restricted stock
Share-Based Compensation Arrangement by Share-based Payment Award [Line Item]
Award vesting period	3 years
Maximum | Restricted stock
Share-Based Compensation Arrangement by Share-based Payment Award [Line Item]
Award vesting period	5 years

XML

Business Segments (Financial Information of Company Operating Segments) (Details) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2017 USD ($)	Jun. 30, 2017 USD ($)	Sep. 30, 2016 USD ($)	Sep. 30, 2017 USD ($) segment	Sep. 30, 2016 USD ($)
Segment Reporting Information [Line Items]
Number of reportable segments | segment				2
Earned Premiums	$ 1,581,500		$ 1,585,944	$ 4,720,244	$ 4,673,072
Investment Income	142,479		145,668	426,601	404,850
Other	307,363		288,115	602,963	604,618
Total revenues	2,031,342		2,019,727	5,749,808	5,682,540
Pre-Tax Income (Loss)	226,113		331,615	571,370	664,605
Net Income (Loss) to Common Stockholders	162,054		220,650	394,505	449,127
Net investment gains	183,959		175,738	276,760	189,394
Net investment gains, net of tax	119,573		114,230	179,894	123,106
Corporate, other and eliminations
Segment Reporting Information [Line Items]
Earned Premiums	0		0	0	0
Investment Income	15,027		6,801	38,251	22,827
Other	123,404		112,377	326,203	415,224
Total revenues	138,431		119,178	364,454	438,051
Pre-Tax Income (Loss)	(71,681)		(81,942)	(224,716)	(190,655)
Net Income (Loss) to Common Stockholders	(45,685)		(53,035)	(146,324)	(123,610)
Insurance
Segment Reporting Information [Line Items]
Earned Premiums	1,433,729		1,423,635	4,262,485	4,180,985
Insurance | Operating Segments
Segment Reporting Information [Line Items]
Earned Premiums	1,433,729		1,423,635	4,262,485	4,180,985
Investment Income	105,924		111,300	320,552	304,904
Other	0		0	0	0
Total revenues	1,539,653		1,534,935	4,583,037	4,485,889
Pre-Tax Income (Loss)	171,478		210,498	557,605	586,651
Net Income (Loss) to Common Stockholders	123,240		140,730	381,736	394,746
Reinsurance
Segment Reporting Information [Line Items]
Earned Premiums	147,771		162,309	457,759	492,087
Reinsurance | Operating Segments
Segment Reporting Information [Line Items]
Earned Premiums	147,771		162,309	457,759	492,087
Investment Income	21,528		27,567	67,798	77,119
Other	0		0	0	0
Total revenues	169,299		189,876	525,557	569,206
Pre-Tax Income (Loss)	(57,643)		27,321	(38,279)	79,215
Net Income (Loss) to Common Stockholders	(35,074)		18,725	(20,801)	54,885
Re-insurance - International | Operating Segments
Segment Reporting Information [Line Items]
Total revenues	49,000	$ 50,000	48,000	150,000	153,000
Net investment gains
Segment Reporting Information [Line Items]
Earned Premiums	0		0	0	0
Investment Income	0		0	0	0
Insurance-International Segment | Operating Segments
Segment Reporting Information [Line Items]
Total revenues	$ 166,000		$ 187,000	$ 513,000	$ 546,000

XML

Business Segments (Identifiable Assets by Segment) (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Segment Reporting, Asset Reconciling Item [Line Items]
Consolidated Assets	$ 24,336,076	$ 23,350,076
Operating Segments | Insurance
Segment Reporting, Asset Reconciling Item [Line Items]
Consolidated Assets	19,136,776	19,137,758
Operating Segments | Reinsurance
Segment Reporting, Asset Reconciling Item [Line Items]
Consolidated Assets	3,243,610	2,524,338
Corporate, other and eliminations
Segment Reporting, Asset Reconciling Item [Line Items]
Consolidated Assets	$ 1,955,690	$ 1,687,980

XML

Business Segments (Net Premiums Earned By Major Line of Business) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Revenue from External Customer [Line Items]
Net premiums earned	$ 1,581,500	$ 1,585,944	$ 4,720,244	$ 4,673,072
Insurance
Revenue from External Customer [Line Items]
Net premiums earned	1,433,729	1,423,635	4,262,485	4,180,985
Insurance | Other liability
Revenue from External Customer [Line Items]
Net premiums earned	466,616	455,841	1,378,505	1,302,841
Insurance | Workers’ compensation
Revenue from External Customer [Line Items]
Net premiums earned	378,529	354,185	1,106,616	1,042,503
Insurance | Property
Revenue from External Customer [Line Items]
Net premiums earned	287,860	312,865	887,791	962,435
Insurance | Commercial automobile
Revenue from External Customer [Line Items]
Net premiums earned	163,277	164,540	482,929	481,249
Insurance | Professional liability
Revenue from External Customer [Line Items]
Net premiums earned	137,447	136,204	406,644	391,957
Reinsurance
Revenue from External Customer [Line Items]
Net premiums earned	147,771	162,309	457,759	492,087
Reinsurance | Property
Revenue from External Customer [Line Items]
Net premiums earned	53,293	65,156	175,329	190,516
Reinsurance | Casualty
Revenue from External Customer [Line Items]
Net premiums earned	$ 94,478	$ 97,153	$ 282,430	$ 301,571